Cat.No,Compound name,Target Class,Primary Target*,Primary Action,Brief Description,Batch,Product Data Sheet,Plate Number,Plate Location
0523,4F 4PP oxalate,7-TM Receptors,5-HT2A Receptors,Antagonist,Selective 5-HT2A antagonist,3,Datasheet_0523,1,B05
0671,AH 6809,7-TM Receptors,Prostanoid Receptors,Antagonist,EP1 and EP2 receptor antagonist,4,Datasheet_0671,1,C06
0703,Anpirtoline hydrochloride,7-TM Receptors,5-HT1B Receptors,Agonist,Highly potent 5-HT1B agonist; also 5-HT3 antagonist,6,Datasheet_0703,1,C09
0706,7-Hydroxy-DPAT hydrobromide,7-TM Receptors,D3 Receptors,Agonist,Dopamine agonist (D3 ≥ D2 < > D4),3,Datasheet_0706,1,C10
0764,SNC 80,7-TM Receptors,Delta Opioid Receptors,Agonist,Highly selective non-peptide δ agonist,21,Datasheet_0764,1,D05
0778,"ICI 199,441 hydrochloride",7-TM Receptors,Kappa Opioid Receptors,Agonist,Potent κ agonist,2,Datasheet_0778,1,D07
0894,(RS)-(+/-)-Sulpiride,7-TM Receptors,Non-selective Dopamine,Antagonist,Standard selective D2-like antagonist,3,Datasheet_0894,1,D10
0895,(S)-(-)-Sulpiride,7-TM Receptors,Non-selective Dopamine,Antagonist,Standard selective D2-like antagonist,5,Datasheet_0895,1,D11
0909,Tropicamide,7-TM Receptors,M4 Receptors,Antagonist,Selective M4 antagonist,3,Datasheet_0909,1,E04
0921,SB 205607 dihydrobromide,7-TM Receptors,Delta Opioid Receptors,Agonist,"Selective, high affinity non-peptide δ1 agonist",5,Datasheet_0921,1,E06
0937,Pimozide,7-TM Receptors,Non-selective Dopamine,Antagonist,D2-like antagonist; also high affinity 5-HT7 antagonist,9,Datasheet_0937,1,E09
0947,Zaprinast,7-TM Receptors,GPR35,Agonist,GPR35 agonist,10,Datasheet_0947,1,E11
0950,Xamoterol hemifumarate,7-TM Receptors,Adrenergic Beta-1 Receptors,Agonist,Selective β1 partial agonist,4,Datasheet_0950,1,F02
0991,RS 39604 hydrochloride,7-TM Receptors,5-HT4 Receptors,Antagonist,5-HT4 antagonist,3,Datasheet_0991,1,F05
0993,Cyanopindolol hemifumarate,7-TM Receptors,5-HT1A Receptors,Antagonist,5-HT1A and 5-HT1B antagonist; also β-adrenergic antagonist,4,Datasheet_0993,1,F06
0995,Spiperone hydrochloride,7-TM Receptors,5-HT2A Receptors,Antagonist,5-HT2A antagonist; also D2-like antagonist,10,Datasheet_0995,1,F07
1003,"L-741,626",7-TM Receptors,D2 Receptors,Antagonist,High affinity D2 antagonist,5,Datasheet_1003,1,F10
1027,PHCCC,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Antagonist,Potent group I mGlu antagonist,7,Datasheet_1027,1,F11
1028,CPCCOEt,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Antagonist,Selective non-competitive mGlu1 antagonist,12,Datasheet_1028,1,G02
1034,4-P-PDOT,7-TM Receptors,Melatonin (MT) Receptors,Antagonist,MT2 antagonist,6,Datasheet_1034,1,G03
1036,ZM 241385,7-TM Receptors,Adenosine A2A Receptors,Antagonist,Potent and highly selective A2A antagonist,14,Datasheet_1036,1,G04
1050,RS 102221 hydrochloride,7-TM Receptors,5-HT2C Receptors,Antagonist,Selective 5-HT2C antagonist,14,Datasheet_1050,1,G07
1051,Zinterol hydrochloride,7-TM Receptors,Adrenergic Beta-2 Receptors,Agonist,Selective β2 agonist,4,Datasheet_1051,1,G08
1061,(-)-Quinpirole hydrochloride,7-TM Receptors,Non-selective Dopamine,Agonist,Selective D2-like agonist,17,Datasheet_1061,1,G09
1063,CGS 21680 hydrochloride,7-TM Receptors,Adenosine A2A Receptors,Agonist,A2A agonist,16,Datasheet_1063,1,G10
1080,(R)-(+)-8-Hydroxy-DPAT hydrobromide,7-TM Receptors,5-HT1A Receptors,Agonist,Selective 5-HT1A agonist; enantiomer of 8-Hydroxy-DPAT hydrobromide (Cat. No. 0529),8,Datasheet_1080,1,G11
1088,CGP 54626 hydrochloride,7-TM Receptors,GABAB Receptors,Antagonist,Potent and selective GABAB antagonist,2,Datasheet_1088,1,H03
1102,Procaterol hydrochloride,7-TM Receptors,Adrenergic Beta-2 Receptors,Agonist,Potent β2 agonist,3,Datasheet_1102,1,H07
1206,SC 19220,7-TM Receptors,Prostanoid Receptors,Antagonist,Selective EP1 receptor antagonist,3,Datasheet_1206,2,A04
1212,MPEP hydrochloride,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Antagonist,Potent mGlu5 antagonist; also positive allosteric modulator of mGlu4 receptors,10,Datasheet_1212,2,A05
1217,MRS 1220,7-TM Receptors,Adenosine A3 Receptors,Antagonist,Highly potent and selective hA3 antagonist,4,Datasheet_1217,2,A07
1248,CGP 55845 hydrochloride,7-TM Receptors,GABAB Receptors,Antagonist,Potent and selective GABAB antagonist,9,Datasheet_1248,2,A11
1253,(S)-WAY 100135 dihydrochloride,7-TM Receptors,5-HT1A Receptors,Antagonist,Potent and selective 5-HT1A antagonist,6,Datasheet_1253,2,B02
1317,CP 94253 hydrochloride,7-TM Receptors,5-HT1B Receptors,Agonist,Potent and selective 5-HT1B agonist,4,Datasheet_1317,2,B08
1324,RX 821002 hydrochloride,7-TM Receptors,Adrenergic Alpha-2 Receptors,Antagonist,"Potent, selective α2D antagonist",4,Datasheet_1324,2,B09
1372,SB 204741,7-TM Receptors,5-HT2B Receptors,Antagonist,"Potent, selective 5-HT2B antagonist",3,Datasheet_1372,2,C04
1393,SB 222200,7-TM Receptors,NK3 Receptor,Antagonist,"Potent, selective non-peptide NK3 antagonist. Brain penetrant",2,Datasheet_1393,2,C05
1408,YM 022,7-TM Receptors,CCK2 Receptor,Antagonist,"Highly potent, selective non-peptide CCK2 antagonist",1,Datasheet_1408,2,C09
1441,BMS 182874 hydrochloride,7-TM Receptors,Endothelin ETA Receptors,Antagonist,"Highly selective, orally active non-peptide ETA antagonist",1,Datasheet_1441,2,D08
1448,Formoterol hemifumarate,7-TM Receptors,Adrenergic Beta-2 Receptors,Agonist,Potent and selective β2 agonist,2,Datasheet_1448,2,D09
1453,Clemastine fumarate,7-TM Receptors,Histamine H1 Receptors,Antagonist,H1 antagonist,3,Datasheet_1453,2,D10
1483,GR 89696 fumarate,7-TM Receptors,Kappa Opioid Receptors,Agonist,Subtype-selective κ agonist,2,Datasheet_1483,2,E05
1511,SR 59230A hydrochloride,7-TM Receptors,Adrenergic Beta-3 Receptors,Antagonist,Potent and selective β3 antagonist,5,Datasheet_1511,2,E07
1513,CGP 7930,7-TM Receptors,GABAB Receptors,Modulator,Positive allosteric modulator of GABAB receptors,3,Datasheet_1513,2,E08
1579,HEMADO,7-TM Receptors,Adenosine A3 Receptors,Agonist,High affinity selective A3 agonist,1,Datasheet_1579,2,F03
1586,SKF 83566 hydrobromide,7-TM Receptors,D1 and D5 Receptors,Antagonist,Potent and selective D1-like antagonist; also inhibits adenylyl cyclase 2,10,Datasheet_1586,2,F06
1591,NBI 27914 hydrochloride,7-TM Receptors,CRF1 Receptors,Antagonist,Selective non-peptide CRF1 antagonist,2,Datasheet_1591,2,F08
1592,SCH 79797 dihydrochloride,7-TM Receptors,Protease-Activated Receptors,Antagonist,"Potent, selective non-peptide PAR1 antagonist",5,Datasheet_1592,2,F09
1612,SB 269970 hydrochloride,7-TM Receptors,5-HT7 Receptors,Antagonist,Potent and selective 5-HT7 antagonist; brain penetrant,9,Datasheet_1612,2,F11
1635,RP 67580,7-TM Receptors,NK1 Receptor,Antagonist,Potent and selective NK1 antagonist,3,Datasheet_1635,2,G04
1661,SB 206553 hydrochloride,7-TM Receptors,5-HT2C Receptors,Antagonist,Potent and selective 5-HT2B and 5-HT2C antagonist; orally active,4,Datasheet_1661,2,G08
1671,PD 102807,7-TM Receptors,M4 Receptors,Antagonist,Selective M4 antagonist,5,Datasheet_1671,2,G09
1674,LE 300,7-TM Receptors,D1 and D5 Receptors,Antagonist,Potent and selective D1 antagonist,4,Datasheet_1674,2,G10
1691,NECA,7-TM Receptors,Non-selective Adenosine,Agonist,High affinity adenosine agonist,4,Datasheet_1691,2,H02
1695,Cisapride,7-TM Receptors,5-HT4 Receptors,Agonist,5-HT4 agonist; stimulates intestinal ACh release,1,Datasheet_1695,2,H05
1700,BIIE 0246,7-TM Receptors,NPY Receptors,Antagonist,"Potent, selective non-peptide NPY Y2 receptor antagonist",5,Datasheet_1700,2,H06
1705,2-Chloro-N6-cyclopentyladenosine,7-TM Receptors,Adenosine A1 Receptors,Agonist,"Potent, selective A1 agonist",7,Datasheet_1705,2,H07
1742,R-96544 hydrochloride,7-TM Receptors,5-HT2A Receptors,Antagonist,"Potent, selective 5-HT2A antagonist",3,Datasheet_1742,2,H09
1746,Nemonapride,7-TM Receptors,Non-selective Dopamine,Antagonist,Highly potent D2-like antagonist; also 5-HT1A agonist,1,Datasheet_1746,2,H11
1780,NNC 63-0532,7-TM Receptors,NOP Receptors,Agonist,Potent non-peptide NOP agonist; brain penetrant,1,Datasheet_1780,3,A05
1809,Altanserin hydrochloride,7-TM Receptors,5-HT2A Receptors,Antagonist,5-HT2A receptor antagonist,1,Datasheet_1809,3,A09
1810,Raclopride,7-TM Receptors,Non-selective Dopamine,Antagonist,Potent and selective D2 and D3 antagonist,3,Datasheet_1810,3,A10
1854,Ro 60-0175 fumarate,7-TM Receptors,5-HT2C Receptors,Agonist,"Potent, selective 5-HT2C agonist",2,Datasheet_1854,3,A11
1944,Loratidine,7-TM Receptors,Histamine H1 Receptors,Antagonist,Peripheral H1 antagonist; antiallergic agent,1,Datasheet_1944,3,B07
1955,Ritanserin,7-TM Receptors,Non-selective 5-HT2,Antagonist,Potent 5-HT2 antagonist,9,Datasheet_1955,3,B08
1960,SB 334867,7-TM Receptors,OX1 Receptor,Antagonist,Selective non-peptide OX1 antagonist,11,Datasheet_1960,3,B09
1963,SB 408124,7-TM Receptors,OX1 Receptor,Antagonist,Selective non-peptide OX1 antagonist,3,Datasheet_1963,3,B10
1980,"L-817,818",7-TM Receptors,Somatostatin Receptors,Agonist,Potent and selective sst5 agonist,2,Datasheet_1980,3,C03
1985,PNU 142633,7-TM Receptors,5-HT1D Receptors,Agonist,Highly selective 5-HT1D agonist,2,Datasheet_1985,3,C05
2009,PSB 1115,7-TM Receptors,Adenosine A2B Receptors,Antagonist,Selective human A2B antagonist; water-soluble,4,Datasheet_2009,3,D02
2010,PSB 10 hydrochloride,7-TM Receptors,Adenosine A3 Receptors,Antagonist,"Potent, highly selective hA3 receptor antagonist/inverse agonist",1,Datasheet_2010,3,D03
2018,Mirtazapine,7-TM Receptors,Non-selective 5-HT2,Antagonist,"Potent 5-HT2 antagonist; also 5-HT3, H1 and α2 antagonist; antidepressant",2,Datasheet_2018,3,D04
2019,PSB 36,7-TM Receptors,Adenosine A1 Receptors,Antagonist,Potent and selective A1 antagonist,1,Datasheet_2019,3,D05
2089,RS 102895 hydrochloride,7-TM Receptors,Chemokine CC Receptors,Antagonist,CCR2b chemokine receptor antagonist,3,Datasheet_2089,3,D10
2197,"L-755,507",7-TM Receptors,Adrenergic Beta-3 Receptors,Agonist,Very potent and selective β3 partial agonist,3,Datasheet_2197,3,F02
2199,CGP 71683 hydrochloride,7-TM Receptors,NPY Receptors,Antagonist,Highly selective and potent non-peptide NPY Y5 receptor antagonist,3,Datasheet_2199,3,F04
2208,LY 255283,7-TM Receptors,Leukotriene and Related Receptors,Antagonist,"Selective, competitive BLT2 receptor antagonist",1,Datasheet_2208,3,F05
2261,"L-692,585",7-TM Receptors,Ghrelin Receptors,Agonist,"Potent, non-peptide ghrelin receptor agonist",4,Datasheet_2261,3,F09
2270,SCH 58261,7-TM Receptors,Adenosine A2A Receptors,Antagonist,"Potent, highly selective A2A antagonist",9,Datasheet_2270,3,F11
2281,2'-MeCCPA,7-TM Receptors,Adenosine A1 Receptors,Agonist,Very selective and potent A1 receptor agonist,1,Datasheet_2281,3,G04
2288,O-1918,7-TM Receptors,Other Cannabinoids,Other,Silent antagonist for putative abnormal-CBD (Cat. No. 1297) receptor,1,Datasheet_2288,3,G05
2292,AQ-RA 741,7-TM Receptors,M2 Receptors,Antagonist,High affinity and selective M2 antagonist,1,Datasheet_2292,3,G06
2299,SCH 39166 hydrobromide,7-TM Receptors,D1 and D5 Receptors,Antagonist,High affinity D1-like antagonist,5,Datasheet_2299,3,G07
2309,SR 142948,7-TM Receptors,Neurotensin Receptors,Antagonist,Highly potent NTS receptor antagonist,3,Datasheet_2309,3,G10
2310,SR 49059,7-TM Receptors,Vasopressin Receptors,Antagonist,"Selective, orally active vasopressin V1A receptor antagonist",2,Datasheet_2310,3,G11
2311,"L-168,049",7-TM Receptors,Glucagon Receptor,Antagonist,"Potent, orally active human glucagon receptor antagonist",1,Datasheet_2311,3,H02
2333,JNJ 16259685,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Antagonist,"Highly potent, mGlu1-selective non-competitive antagonist",4,Datasheet_2333,3,H07
2339,WEB 2086,7-TM Receptors,Platelet-activating Factor (PAF) Receptors,Antagonist,Potent PAF receptor antagonist,2,Datasheet_2339,3,H09
2382,EMD 386088 hydrochloride,7-TM Receptors,5-HT6 Receptors,Agonist,Potent 5-HT6 agonist,1,Datasheet_2382,4,A05
2385,AMN 082 dihydrochloride,7-TM Receptors,Glutamate (Metabotropic) Group III Receptors,Agonist,Selective mGlu7 agonist,2,Datasheet_2385,4,A06
2386,Fenobam,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Modulator,Potent and selective mGlu5 negative allosteric modulator (NAM),1,Datasheet_2386,4,A07
2392,JTE 013,7-TM Receptors,Sphingosine-1-phosphate Receptors,Antagonist,S1P2 receptor antagonist,6,Datasheet_2392,4,A08
2394,SDZ NKT 343,7-TM Receptors,NK1 Receptor,Antagonist,Highly selective human NK1 antagonist,1,Datasheet_2394,4,A09
2412,BIBO 3304 trifluoroacetate,7-TM Receptors,NPY Receptors,Antagonist,Highly selective NPY Y1 receptor antagonist,2,Datasheet_2412,4,B02
2440,NNC 26-9100,7-TM Receptors,Somatostatin Receptors,Agonist,Selective sst4 agonist,3,Datasheet_2440,4,B04
2451,LY 344864 hydrochloride,7-TM Receptors,5-HT1F Receptors,Agonist,Potent and selective 5-HT1F agonist,1,Datasheet_2451,4,B06
2463,SCH 442416,7-TM Receptors,Adenosine A2A Receptors,Antagonist,"Very selective, high affinity A2A antagonist",5,Datasheet_2463,4,B10
2465,SDZ WAG 994,7-TM Receptors,Adenosine A1 Receptors,Agonist,"Potent, selective A1 agonist",1,Datasheet_2465,4,B11
2478,2-Pyridylethylamine dihydrochloride,7-TM Receptors,Histamine H1 Receptors,Agonist,H1 agonist,2,Datasheet_2478,4,C05
2479,JTE 907,7-TM Receptors,CB2 Receptors,Inverse Agonist,Selective CB2 receptor inverse agonist,1,Datasheet_2479,4,C06
2481,JTC 801,7-TM Receptors,NOP Receptors,Antagonist,Selective NOP antagonist,4,Datasheet_2481,4,C07
2507,J 104129 fumarate,7-TM Receptors,M3 Receptors,Antagonist,Potent and selective M3 antagonist,2,Datasheet_2507,4,C11
2514,"L-161,982",7-TM Receptors,Prostanoid Receptors,Antagonist,Selective EP4 receptor antagonist,2,Datasheet_2514,4,D03
2550,SUN-B 8155,7-TM Receptors,Calcitonin and Related Receptors,Agonist,Non-peptide calcitonin agonist,2,Datasheet_2550,4,D09
2592,TCB-2,7-TM Receptors,5-HT2A Receptors,Agonist,High affinity and potent 5-HT2A agonist,4,Datasheet_2592,4,E07
2598,(+/-)-J 113397,7-TM Receptors,NOP Receptors,Antagonist,Potent and selective NOP antagonist,5,Datasheet_2598,4,E08
2599,OSU 6162 hydrochloride,7-TM Receptors,Dopaminergic-Related,Other,Dopamine stabilizer,2,Datasheet_2599,4,E09
2607,CI 988,7-TM Receptors,CCK2 Receptor,Antagonist,Potent and selective CCK2 antagonist,1,Datasheet_2607,4,E11
2635,NGB 2904,7-TM Receptors,D3 Receptors,Antagonist,Potent and selective D3 antagonist,1,Datasheet_2635,4,F08
2641,"L-368,899 hydrochloride",7-TM Receptors,Oxytocin Receptors,Antagonist,"Potent, non-peptide oxytocin receptor antagonist",3,Datasheet_2641,4,F09
2649,GW 9508,7-TM Receptors,Free Fatty Acid Receptors,Agonist,Potent and selective FFA1 (GPR40) agonist,1,Datasheet_2649,4,F10
2664,Cabergoline,7-TM Receptors,Non-selective Dopamine,Agonist,D2-like agonist (D2>D3>D4),2,Datasheet_2664,4,G03
2685,Carvedilol,7-TM Receptors,Non-selective Adrenergic Beta Receptors,Antagonist,Potent and non-selective β antagonist; also potent α1 antagonist,1,Datasheet_2685,4,G07
2724,SB 265610,7-TM Receptors,Chemokine CXC Receptors,Antagonist,Potent CXCR2 antagonist,6,Datasheet_2724,4,H03
2725,SB 225002,7-TM Receptors,Chemokine CXC Receptors,Antagonist,Potent and selective CXCR2 antagonist,2,Datasheet_2725,4,H04
2726,SB 258719 hydrochloride,7-TM Receptors,5-HT7 Receptors,Antagonist,Selective 5-HT7 antagonist,1,Datasheet_2726,4,H05
2749,Dexmedetomidine hydrochloride,7-TM Receptors,Adrenergic Alpha-2 Receptors,Agonist,"Potent, highly selective α2 agonist. Active isomer of medetomidine (Cat. No. 5160)",1,Datasheet_2749,4,H10
2757,UCB 35625,7-TM Receptors,Chemokine CC Receptors,Antagonist,Potent CCR1 and CCR3 antagonist,3,Datasheet_2757,4,H11
2758,B-HT 933 dihydrochloride,7-TM Receptors,Adrenergic Alpha-2 Receptors,Agonist,Selective α2 agonist,4,Datasheet_2758,5,A02
2760,"L-748,337",7-TM Receptors,Adrenergic Beta-3 Receptors,Antagonist,Selective β3 antagonist,4,Datasheet_2760,5,A03
2767,"L-365,260",7-TM Receptors,CCK2 Receptor,Antagonist,Selective CCK2 antagonist,2,Datasheet_2767,5,A04
2773,Sumanirole maleate,7-TM Receptors,D2 Receptors,Agonist,Selective D2 agonist,1,Datasheet_2773,5,A06
2778,Antalarmin hydrochloride,7-TM Receptors,CRF1 Receptors,Antagonist,CRF1 antagonist,2,Datasheet_2778,5,A07
2779,CP 154526,7-TM Receptors,CRF1 Receptors,Antagonist,"Selective, non-peptide CRF1 antagonist",3,Datasheet_2779,5,A08
2791,SC 51322,7-TM Receptors,Prostanoid Receptors,Antagonist,Potent EP1 receptor antagonist,1,Datasheet_2791,5,A10
2838,(R)-(-)-Phenylephrine hydrochloride,7-TM Receptors,Adrenergic Alpha-1 Receptors,Agonist,α1 agonist,1,Datasheet_2838,5,B06
2893,CP 96345,7-TM Receptors,NK1 Receptor,Antagonist,Potent and selective NK1 antagonist,1,Datasheet_2893,5,C05
2901,SB 242084,7-TM Receptors,5-HT2C Receptors,Antagonist,Selective 5-HT2C antagonist; brain penetrant,3,Datasheet_2901,5,C07
2913,Ro 64-5229,7-TM Receptors,Glutamate (Metabotropic) Group II Receptors,Antagonist,"Selective, non-competitive mGlu2 antagonist",1,Datasheet_2913,5,C11
2921,MTEP hydrochloride,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Antagonist,Potent and selective mGlu5 antagonist,4,Datasheet_2921,5,D03
2937,Atipamezole hydrochloride,7-TM Receptors,Adrenergic Alpha-2 Receptors,Antagonist,Selective α2 antagonist,1,Datasheet_2937,5,D06
2957,Org 27569,7-TM Receptors,CB1 Receptors,Modulator,Potent allosteric modulator of CB1 receptors,1,Datasheet_2957,5,D08
2964,Doxazosin mesylate,7-TM Receptors,Adrenergic Alpha-1 Receptors,Antagonist,α1 antagonist,1,Datasheet_2964,5,D10
2993,RS 127445 hydrochloride,7-TM Receptors,5-HT2B Receptors,Antagonist,High affinity and selective 5-HT2B antagonist,4,Datasheet_2993,5,E07
3026,ONO 1078,7-TM Receptors,Leukotriene and Related Receptors,Antagonist,Selective CysLT1 antagonist; also TREK2 activator,1,Datasheet_3026,5,E11
3036,Loxiglumide,7-TM Receptors,CCK1 Receptor,Antagonist, CCK1 antagonist; active in vivo,1,Datasheet_3036,5,F02
3041,CP 809101 hydrochloride,7-TM Receptors,5-HT2C Receptors,Agonist,Potent and selective 5-HT2C agonist,2,Datasheet_3041,5,F04
3050,Tamsulosin hydrochloride,7-TM Receptors,Adrenergic Alpha-1 Receptors,Antagonist,Selective α1A antagonist,1,Datasheet_3050,5,F06
3077,LY 272015 hydrochloride,7-TM Receptors,5-HT2B Receptors,Antagonist,High affinity 5-HT2B antagonist; orally active,1,Datasheet_3077,5,F10
3078,LY 310762 hydrochloride,7-TM Receptors,5-HT1D Receptors,Antagonist,Selective 5-HT1D antagonist,1,Datasheet_3078,5,F11
3100,NBI 35965 hydrochloride,7-TM Receptors,CRF1 Receptors,Antagonist,Potent and selective CRF1 antagonist,3,Datasheet_3100,5,G07
3129,BMS CCR2 22,7-TM Receptors,Chemokine CC Receptors,Antagonist,"High affinity, potent CCR2 antagonist",3,Datasheet_3129,5,H03
3136,2-Chloroadenosine,7-TM Receptors,Non-selective Adenosine,Agonist,Adenosine receptor agonist,1,Datasheet_3136,5,H06
3188,SB 699551,7-TM Receptors,5-HT5 Receptors,Antagonist,Selective 5-ht5a antagonist,2,Datasheet_3188,5,H08
3189,SB 399885 hydrochloride,7-TM Receptors,5-HT6 Receptors,Antagonist,Potent and selective 5-HT6 antagonist,3,Datasheet_3189,5,H09
3198,PSB 603,7-TM Receptors,Adenosine A2B Receptors,Antagonist,Highly selective A2B antagonist,2,Datasheet_3198,6,A03
3199,PSB 0788,7-TM Receptors,Adenosine A2B Receptors,Antagonist,Selective A2B antagonist,1,Datasheet_3199,6,A04
3200,XAC,7-TM Receptors,Non-selective Adenosine,Antagonist,Adenosine receptor antagonist,3,Datasheet_3200,6,A05
3212,CP 376395 hydrochloride,7-TM Receptors,CRF1 Receptors,Antagonist,Potent and selective CRF1 antagonist; binds at an allosteric site,1,Datasheet_3212,6,A07
3219,CGP 36216 hydrochloride,7-TM Receptors,GABAB Receptors,Antagonist,GABAB antagonist; displays activity at presynaptic receptors,1,Datasheet_3219,6,A08
3235,CDPPB,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Modulator,Positive allosteric modulator of mGlu5 receptors,5,Datasheet_3235,6,A09
3240,SCH 221510,7-TM Receptors,NOP Receptors,Agonist,Potent and selective NOP agonist,2,Datasheet_3240,6,A11
3256,Metoprolol tartrate,7-TM Receptors,Adrenergic Beta-1 Receptors,Antagonist,Selective β1 antagonist,1,Datasheet_3256,6,B07
3282,NAD 299 hydrochloride,7-TM Receptors,5-HT1A Receptors,Antagonist,"Selective, high affinity 5-HT1A antagonist",3,Datasheet_3282,6,C03
3297,SSR 146977 hydrochloride,7-TM Receptors,NK3 Receptor,Antagonist,Potent and selective NK3 antagonist,1,Datasheet_3297,6,C08
3313,rac BHFF,7-TM Receptors,GABAB Receptors,Modulator,Potent and selective postitive allosteric modulator of  GABAB receptors,1,Datasheet_3313,6,D03
3326,BGC 20-761,7-TM Receptors,5-HT6 Receptors,Antagonist,High affinity 5-HT6 antagonist,1,Datasheet_3326,6,D09
3342,"L-798,106",7-TM Receptors,Prostanoid Receptors,Antagonist,Potent and highly selective EP3 antagonist,4,Datasheet_3342,6,E02
3347,SNAP 94847 hydrochloride,7-TM Receptors,Melanin-concentrating Hormone Receptors,Antagonist,Potent and selective MCH1 antagonist,2,Datasheet_3347,6,E03
3351,Selexipag,7-TM Receptors,Prostanoid Receptors,Agonist,Selective prostacyclin IP1 receptor agonist,2,Datasheet_3351,6,E04
3368,SB 271046 hydrochloride,7-TM Receptors,5-HT6 Receptors,Antagonist,Selective 5-HT6 antagonist; orally active,2,Datasheet_3368,6,E11
3370,AC 264613,7-TM Receptors,Protease-Activated Receptors,Agonist,PAR2 receptor agonist,1,Datasheet_3370,6,F02
3371,TCS OX2 29,7-TM Receptors,OX2 Receptor,Antagonist,Potent and selective OX2 antagonist,2,Datasheet_3371,6,F03
3383,VU 152100,7-TM Receptors,M4 Receptors,Modulator,Positive allosteric modulator of M4 receptors,2,Datasheet_3383,6,F07
3417,CP 99994 dihydrochloride,7-TM Receptors,NK1 Receptor,Antagonist,High affinity NK1 antagonist,1,Datasheet_3417,6,G02
3489,Astemizole,7-TM Receptors,Histamine H1 Receptors,Antagonist,"Orally active, potent H1 antagonist; also KV11.1 (hERG) channel blocker",4,Datasheet_3489,6,G04
3496,BX 471,7-TM Receptors,Chemokine CC Receptors,Antagonist,"Potent, selective CCR1 antagonist",3,Datasheet_3496,6,G06
3545,Histamine dihydrochloride,7-TM Receptors,Histamine H1 Receptors,Agonist,Endogenous histamine receptor agonist,1,Datasheet_3545,6,H07
3550,Melatonin,7-TM Receptors,Melatonin (MT) Receptors,Agonist,Endogenous hormone; agonist at MT1 and MT2,1,Datasheet_3550,6,H08
3562,LU AA33810,7-TM Receptors,NPY Receptors,Antagonist,Potent NPY Y5 receptor antagonist,2,Datasheet_3562,6,H09
3569,Xanomeline oxalate,7-TM Receptors,M1 Receptors,Agonist,Functionally selective M1 agonist,4,Datasheet_3569,6,H11
3573,SB 612111 hydrochloride,7-TM Receptors,NOP Receptors,Antagonist,Selective NOP antagonist,3,Datasheet_3573,7,A04
3576,(+/-)-5'-Chloro-5'-deoxy-ENBA,7-TM Receptors,Adenosine A1 Receptors,Agonist,Highly selective A1 agonist,5,Datasheet_3576,7,A06
3581,C 021 dihydrochloride,7-TM Receptors,Chemokine CC Receptors,Antagonist,Potent CCR4 antagonist,1,Datasheet_3581,7,A08
3586,Sumatriptan succinate,7-TM Receptors,5-HT1D Receptors,Agonist,"5-HT1A, 5-HT1B and 5-HT1D agonist",1,Datasheet_3586,7,A09
3601,CYM 5442 hydrochloride,7-TM Receptors,Sphingosine-1-phosphate Receptors,Agonist,Selective S1P1 receptor agonist,3,Datasheet_3601,7,B03
3624,Adenosine,7-TM Receptors,Non-selective Adenosine,Agonist,Endogenous adenosine receptor agonist,1,Datasheet_3624,7,B08
3626,NPS 2143 hydrochloride,7-TM Receptors,Calcium-Sensing Receptor,Antagonist,Selective calcium-sensing receptor (CaSR) antagonist; orally active calcilytic agent,2,Datasheet_3626,7,B09
3634,VU 0238429,7-TM Receptors,M5 Receptors,Modulator,Selective positive allosteric modulator of M5 receptors,1,Datasheet_3634,7,B10
3649,CP 122721 hydrochloride,7-TM Receptors,NK1 Receptor,Antagonist,High affinity NK1 antagonist,1,Datasheet_3649,7,C02
3650,SB 328437,7-TM Receptors,Chemokine CC Receptors,Antagonist,Potent and selective CCR3 antagonist,1,Datasheet_3650,7,C03
3661,BAN ORL 24,7-TM Receptors,NOP Receptors,Antagonist,Potent and selective NOP antagonist,3,Datasheet_3661,7,C07
3695,CHPG Sodium salt,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Agonist,Selective mGlu5 agonist; sodium salt of CHPG (Cat. No. 1049),3,Datasheet_3695,7,D05
3721,SR 48692,7-TM Receptors,Neurotensin Receptors,Antagonist,Selective non-peptide NTS1 antagonist,1,Datasheet_3721,7,D10
3739,Sarpogrelate hydrochloride,7-TM Receptors,5-HT2A Receptors,Antagonist,Selective 5-HT2A antagonist,1,Datasheet_3739,7,E04
3743,BF 2649 hydrochloride,7-TM Receptors,Histamine H3 Receptors,Inverse Agonist,Potent and selective H3 inverse agonist,2,Datasheet_3743,7,E06
3753,A 943931 dihydrochloride,7-TM Receptors,Histamine H4 Receptors,Antagonist,Potent and selective H4 antagonist,1,Datasheet_3753,7,E10
3756,Maraviroc,7-TM Receptors,Chemokine CC Receptors,Antagonist,Selective CCR5 antagonist,1,Datasheet_3756,7,F02
3758,SC 51089,7-TM Receptors,Prostanoid Receptors,Antagonist,Selective EP1 receptor antagonist,1,Datasheet_3758,7,F04
3761,Tolterodine L-tartrate,7-TM Receptors,Non-selective Muscarinics,Antagonist,"Potent, non-selective muscarinic receptor antagonist",1,Datasheet_3761,7,F05
3798,Losartan potassium,7-TM Receptors,Angiotensin AT1 Receptors,Antagonist,"Selective, non-peptide AT1 antagonist",3,Datasheet_3798,7,G02
3815,R 568 hydrochloride,7-TM Receptors,Calcium-Sensing Receptor,Modulator,Positive allosteric modulator of human calcium-sensing receptor (CaSR),1,Datasheet_3815,7,G05
3866,SKF 86466 hydrochloride,7-TM Receptors,Adrenergic Alpha-2 Receptors,Antagonist,Potent and selective α2 antagonist,1,Datasheet_3866,7,H08
3887,PG 01037 dihydrochloride,7-TM Receptors,D3 Receptors,Antagonist,Selective D3 antagonist,2,Datasheet_3887,8,A03
3896,Rotigotine hydrochloride,7-TM Receptors,D2 Receptors,Agonist,D2 and D3 agonist,3,Datasheet_3896,8,A06
3898,SF 11,7-TM Receptors,NPY Receptors,Antagonist,NPY Y2 receptor antagonist,1,Datasheet_3898,8,A07
3904,WAY 208466 dihydrochloride,7-TM Receptors,5-HT6 Receptors,Agonist,Selective 5-HT6 agonist,4,Datasheet_3904,8,A09
3924,OPC 21268,7-TM Receptors,Vasopressin Receptors,Antagonist,Orally active vasopressin V1 antagonist,1,Datasheet_3924,8,B07
3937,ANR 94,7-TM Receptors,Adenosine A2A Receptors,Antagonist,Adenosine A2A antagonist,1,Datasheet_3937,8,B08
3948,Terfenadine,7-TM Receptors,Histamine H1 Receptors,Antagonist,H1 antagonist. Also KV11.1 (hERG) and Kir6 (KATP) channel blocker,1,Datasheet_3948,8,B11
3959,YIL 781,7-TM Receptors,Ghrelin Receptors,Antagonist,Ghrelin receptor (GHS-R1a) antagonist,3,Datasheet_3959,8,C02
3986,SR 58611A hydrochloride,7-TM Receptors,Adrenergic Beta-3 Receptors,Agonist,β3 agonist; displays anxiolytic and antidepressant effects,1,Datasheet_3986,8,C09
4012,SR 140333,7-TM Receptors,NK1 Receptor,Antagonist,Potent NK1 antagonist,1,Datasheet_4012,8,D05
4013,L 760735,7-TM Receptors,NK1 Receptor,Antagonist,High affinity NK1 antagonist,1,Datasheet_4013,8,D06
4021,JNJ 7777120,7-TM Receptors,Histamine H4 Receptors,Antagonist,Selective H4 antagonist,2,Datasheet_4021,8,D07
4048,BINA,7-TM Receptors,Glutamate (Metabotropic) Group II Receptors,Modulator,Selective positive allosteric modulator of mGlu2 receptors,2,Datasheet_4048,8,D10
4053,BMS 470539 dihydrochloride,7-TM Receptors,Melanocortin Receptors,Agonist,"Potent, selective MC1 receptor agonist",1,Datasheet_4053,8,D11
4057,Flupenthixol dihydrochloride,7-TM Receptors,Non-selective Dopamine,Antagonist,Dopamine antagonist,2,Datasheet_4057,8,E03
4081,LY 266097 hydrochloride,7-TM Receptors,5-HT2B Receptors,Antagonist,Selective 5-HT2B antagonist,1,Datasheet_4081,8,E06
4085,Nalmefene hydrochloride,7-TM Receptors,Miscellaneous/Non-selective Opioids,Antagonist,Opioid receptor antagonist,2,Datasheet_4085,8,E08
4134,NPS 2390,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Antagonist,Group I mGlu antagonist,1,Datasheet_4134,8,F11
4167,KW 3902,7-TM Receptors,Adenosine A1 Receptors,Antagonist,Selective A1 antagonist,1,Datasheet_4167,8,G08
4173,MDL 100907,7-TM Receptors,5-HT2A Receptors,Antagonist,Potent and selective 5-HT2A antagonist,3,Datasheet_4173,8,G10
4174,Pramipexole dihydrochloride,7-TM Receptors,D3 Receptors,Agonist,Selective D3 agonist,1,Datasheet_4174,8,G11
4179,AMD 3465 hexahydrobromide,7-TM Receptors,Chemokine CXC Receptors,Antagonist,Potent and selective CXCR4 antagonist,2,Datasheet_4179,8,H02
4185,Sonepiprazole,7-TM Receptors,D4 Receptors,Antagonist,Selective D4 antagonist,1,Datasheet_4185,8,H04
4216,Valsartan,7-TM Receptors,Angiotensin AT1 Receptors,Antagonist,"High affinity, selective AT1 antagonist",1,Datasheet_4216,9,A02
4220,XCC,7-TM Receptors,Non-selective Adenosine,Antagonist,Adenosine receptor antagonist,1,Datasheet_4220,9,A03
4236,CP 945598 hydrochloride,7-TM Receptors,CB1 Receptors,Antagonist,CB1 antagonist,1,Datasheet_4236,9,A06
4255,TC-O 9311,7-TM Receptors,Orphan 7-TM Receptors,Agonist,Potent and selective GPR139 agonist,1,Datasheet_4255,9,A09
4268,Ro 1138452 hydrochloride,7-TM Receptors,Prostanoid Receptors,Antagonist,Selective prostacyclin IP receptor antagonist,1,Datasheet_4268,9,B03
4289,RP 001 hydrochloride,7-TM Receptors,Sphingosine-1-phosphate Receptors,Agonist,Potent S1P1 agonist,1,Datasheet_4289,9,B09
4293,CID 2745687,7-TM Receptors,GPR35,Antagonist,GPR35 antagonist,1,Datasheet_4293,9,B10
4306,INCB 3284 dimesylate,7-TM Receptors,Chemokine CC Receptors,Antagonist,Selective CCR2 antagonist,2,Datasheet_4306,9,C04
4317,JNJ 10397049,7-TM Receptors,OX2 Receptor,Antagonist,Selective OX2 receptor antagonist,1,Datasheet_4317,9,C08
4323,VU 0360172 hydrochloride,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Modulator,Positive allosteric modulator of mGlu5 receptors,3,Datasheet_4323,9,C10
4334,PSB 0777 ammonium salt,7-TM Receptors,Adenosine A2A Receptors,Agonist,Potent adenosine A2A agonist,2,Datasheet_4334,9,D02
4346,Ro 67-7476,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Modulator,Positive allosteric modulator of mGlu1 receptors,1,Datasheet_4346,9,D06
4349,Olanzapine,7-TM Receptors,5-HT2A Receptors,Antagonist, 5-HT2A antagonist; also D2 antagonist; atypical antipsychotic,2,Datasheet_4349,9,D07
4374,BIMU 8,7-TM Receptors,5-HT4 Receptors,Agonist,Potent 5-HT4 agonist,4,Datasheet_4374,9,E03
4387,Calhex 231 hydrochloride,7-TM Receptors,Calcium-Sensing Receptor,Modulator,Negative allosteric modulator of calcium-sensing receptor (CaSR),1,Datasheet_4387,9,E06
4388,MNI 137,7-TM Receptors,Glutamate (Metabotropic) Group II Receptors,Modulator,Selective negative allosteric modulator of group II mGlu receptors,1,Datasheet_4388,9,E07
4407,TC-G 1004,7-TM Receptors,Adenosine A2A Receptors,Antagonist,Potent and selective A2A antagonist,1,Datasheet_4407,9,E10
4416,ADX 10059 hydrochloride,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Modulator,Negative allosteric modulator of mGlu5 receptors,1,Datasheet_4416,9,F02
4457,YE 120,7-TM Receptors,GPR35,Agonist,GPR35 agonist,1,Datasheet_4457,9,G06
4470,EMD 281014 hydrochloride,7-TM Receptors,5-HT2A Receptors,Antagonist,Selective 5-HT2A antagonist,1,Datasheet_4470,9,H02
4472,BAY 60-6583,7-TM Receptors,Adenosine A2B Receptors,Agonist,Potent A2B agonist; cardioprotective,4,Datasheet_4472,9,H03
4478,GPBAR-A,7-TM Receptors,GPBA Receptors,Agonist,GPBA receptor (TGR5) agonist,1,Datasheet_4478,9,H05
4487,(+/-)-AMG 487,7-TM Receptors,Chemokine CXC Receptors,Antagonist,CXCR3 antagonist; inhibits cell migration and metastasis,2,Datasheet_4487,9,H10
4510,SHA 68,7-TM Receptors,Neuropeptide S Receptors,Antagonist,Selective Neuropeptide S receptor antagonist,1,Datasheet_4510,10,A06
4518,EPPTB,7-TM Receptors,Trace Amine 1 Receptor,Antagonist,Trace amine 1 (TA1)  receptor antagonist/inverse agonist,1,Datasheet_4518,10,A10
4551,Purmorphamine,7-TM Receptors,Smoothened Receptors,Agonist,Smo receptor agonist,4,Datasheet_4551,10,B07
4552,A 412997 dihydrochloride,7-TM Receptors,D4 Receptors,Agonist,Selective D4 agonist,1,Datasheet_4552,10,B08
4601,TUG 891,7-TM Receptors,Free Fatty Acid Receptors,Agonist,Potent and selective FFA4 (GPR120) agonist,2,Datasheet_4601,10,C07
4603,LUF 5834,7-TM Receptors,Adenosine A2A Receptors,Agonist,Potent adenosine A2A and A2B receptor partial agonist,1,Datasheet_4603,10,C09
4613,Tegaserod maleate,7-TM Receptors,5-HT4 Receptors,Agonist,5-HT4 partial agonist,1,Datasheet_4613,10,D03
4616,Olmesartan,7-TM Receptors,Angiotensin AT1 Receptors,Antagonist,Potent AT1 antagonist,1,Datasheet_4616,10,D04
4622,MK 1903,7-TM Receptors,Hydroxycarboxylic Acid Receptors,Agonist,Potent and selective GPR109A (HCA2) agonist,2,Datasheet_4622,10,D06
4624,TC-FPR 43,7-TM Receptors,Formyl Peptide Receptors,Agonist,Potent FPR2 agonist,1,Datasheet_4624,10,D07
4625,TC OT 39,7-TM Receptors,Oxytocin Receptors,Agonist,Potent non-peptide oxytocin receptor partial agonist; also V1a receptor antagonist,1,Datasheet_4625,10,D08
4642,4-CMTB,7-TM Receptors,Free Fatty Acid Receptors,Agonist,FFA2 agonist; also exhibits positive allosteric modulatory activity,1,Datasheet_4642,10,E03
4647,GR 203040,7-TM Receptors,NK1 Receptor,Antagonist,Potent and selective NK1 antagonist,1,Datasheet_4647,10,E04
4657,Zolmitriptan,7-TM Receptors,5-HT1D Receptors,Agonist,Potent 5-HT1B/1D/1F agonist,1,Datasheet_4657,10,E08
4668,GW 627368,7-TM Receptors,Prostanoid Receptors,Antagonist,Selective EP4 receptor competitive antagonist,1,Datasheet_4668,10,E11
4677,CYM 50260,7-TM Receptors,Sphingosine-1-phosphate Receptors,Agonist,Potent and selective S1P4 agonist,1,Datasheet_4677,10,F02
4708,TC LPA5 4,7-TM Receptors,Lysophosphatidic Acid Receptors,Antagonist,LPA5 receptor antagonist,1,Datasheet_4708,10,F06
4712,Salmeterol xinafoate,7-TM Receptors,Adrenergic Beta-2 Receptors,Agonist,Long-acting β2 agonist; bronchodilator,1,Datasheet_4712,10,F07
4735,Quetiapine hemifumarate,7-TM Receptors,Non-selective 5-HT2,Antagonist,5-HT2 antagonist; also D2 antagonist; atypical antipsychotic,1,Datasheet_4735,10,G03
4778,BETP,7-TM Receptors,Glucagon-Like Peptide 1 Receptors,Modulator,Positive allosteric modulator of GLP-1 receptors,1,Datasheet_4778,10,H05
4780,VUF 11207 fumarate,7-TM Receptors,Chemokine CXC Receptors,Agonist,Potent ACKR3 (CXCR7) agonist,1,Datasheet_4780,10,H06
4791,Candesartan,7-TM Receptors,Angiotensin AT1 Receptors,Antagonist,AT1 antagonist,1,Datasheet_4791,10,H11
4818,PF 04418948,7-TM Receptors,Prostanoid Receptors,Antagonist,Potent and selective EP2 receptor antagonist,1,Datasheet_4818,11,A07
4854,ML 00253764 hydrochloride,7-TM Receptors,Melanocortin Receptors,Antagonist,Melanocortin MC4 receptor antagonist; brain penetrant,2,Datasheet_4854,11,B06
4862,PPTN hydrochloride,7-TM Receptors,Purinergic P2Y Receptors,Antagonist,High affinity and selective P2Y14 antagonist,1,Datasheet_4862,11,B08
4870,H2L 5765834,7-TM Receptors,Lysophosphatidic Acid Receptors,Antagonist,"LPA1,3,5 antagonist",1,Datasheet_4870,11,C02
4897,CYM 5541,7-TM Receptors,Sphingosine-1-phosphate Receptors,Agonist,Selective S1P3 receptor allosteric agonist,1,Datasheet_4897,11,C10
4959,CID 16020046,7-TM Receptors,GPR55,Antagonist,Selective GPR55 antagonist,2,Datasheet_4959,11,D11
4982,ML 337,7-TM Receptors,Glutamate (Metabotropic) Group II Receptors,Modulator,Selective negative allosteric modulator of mGlu3 receptors,1,Datasheet_4982,11,E09
5041,PAOPA,7-TM Receptors,D2 Receptors,Modulator,Allosteric modulator of D2 receptors,1,Datasheet_5041,11,F08
5080,TC-G 1003,7-TM Receptors,Somatostatin Receptors,Agonist,High affinity somatostatin sst2 agonist,1,Datasheet_5080,11,G11
5087,TC NTR1 17,7-TM Receptors,Neurotensin Receptors,Partial Agonist,Selective NTS1 partial agonist,1,Datasheet_5087,11,H05
5096,AdipoRon hydrochloride,7-TM Receptors,Other Peptide Receptors,Other,Orally active AdipoR1 and AdipoR2 agonist; antidiabetic,1,Datasheet_5096,11,H08
5129,TC-G 1005,7-TM Receptors,GPBA Receptors,Agonist,Potent and selective GPBA receptor (TGR5) agonist,2,Datasheet_5129,12,A04
5160,Medetomidine hydrochloride,7-TM Receptors,Adrenergic Alpha-2 Receptors,Agonist,Potent and highly selective α2 agonist,1,Datasheet_5160,12,A11
5181,Tolvaptan,7-TM Receptors,Vasopressin Receptors,Antagonist,Potent and selective vasopressin V2 receptor antagonist; renoprotective and orally active,1,Datasheet_5181,12,B06
5256,AH 7614,7-TM Receptors,Free Fatty Acid Receptors,Antagonist,Selective FFA4 (GPR120) antagonist,1,Datasheet_5256,12,C07
5257,GSK 137647,7-TM Receptors,Free Fatty Acid Receptors,Agonist,Potent and selective FFA4 (GPR120) agonist,1,Datasheet_5257,12,C08
5262,PF 5274857 hydrochloride,7-TM Receptors,Smoothened Receptors,Antagonist,High affinity and selective Smoothened (Smo) receptor antagonist,1,Datasheet_5262,12,C11
5272,MK 0677,7-TM Receptors,Ghrelin Receptors,Agonist,High affinity ghrelin receptor agonist,1,Datasheet_5272,12,D07
5316,Elinogrel,7-TM Receptors,Purinergic P2Y Receptors,Antagonist,P2Y12 antagonist,1,Datasheet_5316,12,E11
5321,PSNCBAM-1,7-TM Receptors,CB1 Receptors,Modulator,Negative allosteric modulator of CB1 receptors,1,Datasheet_5321,12,F03
5322,VU 0409106,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Modulator,Potent and selective negative allosteric modulator of mGlu5 receptors,1,Datasheet_5322,12,F04
5327,BGC 20-1531 hydrochloride,7-TM Receptors,Prostanoid Receptors,Antagonist,High affinity and selective EP4 antagonist,1,Datasheet_5327,12,F08
5328,TY 52156,7-TM Receptors,Sphingosine-1-phosphate Receptors,Antagonist,S1P3 receptor antagonist,2,Datasheet_5328,12,F09
5355,TC-G 1008,7-TM Receptors,Orphan 7-TM Receptors,Agonist,Potent and selective GPR39 agonist,3,Datasheet_5355,12,G07
5357,DC 260126,7-TM Receptors,Free Fatty Acid Receptors,Antagonist,FFA1 (GPR40) antagonist,1,Datasheet_5357,12,G09
5362,TASP 0433864,7-TM Receptors,Glutamate (Metabotropic) Group II Receptors,Modulator,Selective positive allosteric modulator of mGlu2 receptors,1,Datasheet_5362,12,H02
5406,ONO 8130,7-TM Receptors,Prostanoid Receptors,Antagonist,EP1 receptor antagonist,1,Datasheet_5406,12,H10
5438,NTRC 824,7-TM Receptors,Neurotensin Receptors,Antagonist,Potent and selective non-peptide NTS2 antagonist,1,Datasheet_5438,13,A09
5443,AM 6545,7-TM Receptors,CB1 Receptors,Antagonist,High affinity and selective CB1 antagonist,2,Datasheet_5443,13,A10
5584,Aripiprazole,7-TM Receptors,D2 Receptors,Agonist,High affinity D2 and 5-HT1A receptor partial agonist; also 5-HT2A antagonist,1,Datasheet_5584,13,C06
5589,WAY 181187 oxalate,7-TM Receptors,5-HT6 Receptors,Agonist,High affinity and selective 5-HT6 agonist,2,Datasheet_5589,13,C09
5614,AZD 2066,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Antagonist,mGlu5 antagonist; orally bioavailable and brain penetrant,1,Datasheet_5614,13,D05
5621,GLPG 0974,7-TM Receptors,Free Fatty Acid Receptors,Antagonist,Potent FFA2 antagonist,2,Datasheet_5621,13,D08
5666,JNJ 63533054,7-TM Receptors,Orphan 7-TM Receptors,Agonist,Potent and selective GPR139 agonist,1,Datasheet_5666,13,E10
5671,SB 332235,7-TM Receptors,Chemokine CXC Receptors,Antagonist,Potent CXCR2 antagonist,1,Datasheet_5671,13,E11
5693,VU 0409551,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Modulator,Selective positive allosteric modulator of mGlu5 receptors; brain penetrant and orally bioavailable,1,Datasheet_5693,13,F09
5715,(+/-)-ADX 71743,7-TM Receptors,Glutamate (Metabotropic) Group III Receptors,Modulator,Negative allosteric modulator of mGlu7 receptors; brain penetrant,2,Datasheet_5715,13,G05
5722,Ogerin,7-TM Receptors,Orphan 7-TM Receptors,Modulator,Selective positive allosteric modulator at GPR68,2,Datasheet_5722,13,G06
5729,TASP 0390325,7-TM Receptors,Vasopressin Receptors,Antagonist,Potent and selective V1B receptor antagonist; orally bioavailable,1,Datasheet_5729,13,G07
5730,A 127722,7-TM Receptors,Endothelin ETA Receptors,Antagonist,"Highly potent, selective ETA antagonist; orally bioavailable",1,Datasheet_5730,13,G08
5815,SCH 336,7-TM Receptors,CB2 Receptors,Inverse Agonist,Highly potent and selective CB2 inverse agonist,1,Datasheet_5815,14,A05
5826,LEI 101 hydrochloride,7-TM Receptors,CB2 Receptors,Agonist,Potent and selective CB2 partial agonist; orally biovailable,1,Datasheet_5826,14,A06
5828,Ambrisentan,7-TM Receptors,Endothelin ETA Receptors,Antagonist,Selective ETA antagonist,1,Datasheet_5828,14,A07
5833,Ex 26,7-TM Receptors,Sphingosine-1-phosphate Receptors,Antagonist,Potent and selective S1P1 receptor antagonist,1,Datasheet_5833,14,A09
5872,AZ 10397767,7-TM Receptors,Chemokine CXC Receptors,Antagonist,Potent CXCR2 antagonist,1,Datasheet_5872,14,B08
5902,Tiotropium bromide,7-TM Receptors,Non-selective Muscarinics,Antagonist,Potent muscarinic receptor antagonist,2,Datasheet_5902,14,B09
5904,Montelukast sodium,7-TM Receptors,Leukotriene and Related Receptors,Antagonist,CysLT1 and GPR17 antagonist,1,Datasheet_5904,14,B10
5913,Ro 6842262,7-TM Receptors,Lysophosphatidic Acid Receptors,Antagonist,Potent LPA1 antagonist,1,Datasheet_5913,14,C02
5943,ML 339,7-TM Receptors,Chemokine CXC Receptors,Antagonist,Potent and selective hCXCR6 antagonist,1,Datasheet_5943,14,C09
5983,BMS 986187,7-TM Receptors,Delta Opioid Receptors,Modulator,Potent positive allosteric modulator of δ receptor,1,Datasheet_5983,14,D05
6082,AMG 837 hemicalcium salt,7-TM Receptors,Free Fatty Acid Receptors,Agonist,Potent free fatty acid receptor 1 (FFA1/GPR40) partial agonist,1,Datasheet_6082,14,F05
6085,AZD 1283,7-TM Receptors,Purinergic P2Y Receptors,Antagonist,High affinity P2Y12 antagonist,1,Datasheet_6085,14,F06
6116,BHPI,7-TM Receptors,Estrogen (GPER) Receptors,Antagonist,ERα antagonist; also activates unfolded protein response; active in vivo,1,Datasheet_6116,14,G04
6137,"8-Cyclopentyl-1,3-dimethylxanthine",7-TM Receptors,Adenosine A1 Receptors,Antagonist,High affinity adenosine A1 receptor antagonist,1,Datasheet_6137,14,G07
6163,AR 420626,7-TM Receptors,Free Fatty Acid Receptors,Agonist,FFA3 agonist,1,Datasheet_6163,14,H02
6165,AC 265347,7-TM Receptors,Calcium-Sensing Receptor,Modulator,Biased allosteric modulator of calcium-sensing receptor (CaSR),1,Datasheet_6165,14,H04
6170,Cinacalcet hydrochloride,7-TM Receptors,Calcium-Sensing Receptor,Agonist,Allosteric Calcium-sensing receptor (CaSR) agonist; also CYP2D2 inhibitor and Ca2+ channel blocker; orally bioavailable,1,Datasheet_6170,14,H05
6171,MLS 1547,7-TM Receptors,D2 Receptors,Agonist,G protein-biased D2 partial agonist,1,Datasheet_6171,14,H06
6176,FTY 720,7-TM Receptors,Sphingosine-1-phosphate Receptors,Agonist,Potent S1P receptor agonist; also immunosuppressant,1,Datasheet_6176,14,H08
6193,AM 4113,7-TM Receptors,CB1 Receptors,Antagonist,High affinity and selective CB1 antagonist,1,Datasheet_6193,14,H11
6195,SSR 149415,7-TM Receptors,Vasopressin Receptors,Antagonist,Potent and selective vasopressin V1B antagonist,1,Datasheet_6195,15,A03
6201,J 2156,7-TM Receptors,Somatostatin Receptors,Agonist,Selective high affinity human sst4 agonist,1,Datasheet_6201,15,A06
6202,Vilazodone hydrochloride,7-TM Receptors,5-HT1A Receptors,Agonist,Potent 5-HT1A partial agonist and SSRI; antidepressant,1,Datasheet_6202,15,A07
6219,Arformoterol tartrate,7-TM Receptors,Adrenergic Beta-2 Receptors,Agonist,Long-acting β2 agonist (LABA),1,Datasheet_6219,15,A10
6232,Bosentan,7-TM Receptors,Non-selective Endothelin,Antagonist,High affinity dual ETA and ETB receptor antagonist;orally bioavailable,1,Datasheet_6232,15,B04
6279,JNJ 39758979 dihydrochloride,7-TM Receptors,Histamine H4 Receptors,Antagonist,High affinity and selective histamine H4 antagonist; orally bioavailable,1,Datasheet_6279,15,C06
6298,MS 21570,7-TM Receptors,GPR171,Antagonist,GPR171 antagonist,1,Datasheet_6298,15,D02
6299,MS 15203,7-TM Receptors,GPR171,Agonist,Potent and selective GPR171 partial agonist,1,Datasheet_6299,15,D03
6336,Trazodone hydrochloride,7-TM Receptors,5-HT2A Receptors,Antagonist,5-HT2A and α1 adrenoceptor antagonist; also enhances neural differentiation; antidepressant and neuroprotectant,1,Datasheet_6336,15,D10
6347,PF 04628935,7-TM Receptors,Ghrelin Receptors,Inverse Agonist,Potent ghrelin receptor inverse agonist,1,Datasheet_6347,15,E06
6351,(R)-ZINC 3573,7-TM Receptors,Mas-related G Protein-Coupled Receptors,Agonist,MRGPRX2 agonist,1,Datasheet_6351,15,E08
6411,tBPC,7-TM Receptors,NPY Receptors,Modulator,Positive allosteric modulator of NPY Y4 receptor,1,Datasheet_6411,15,F11
6431,Phentolamine Mesylate,7-TM Receptors,Non-selective Adrenergic Alpha Receptors,Antagonist,Adrenergic α receptor antagonist; antihypertensive,1,Datasheet_6431,15,G03
6486,Aprepitant,7-TM Receptors,NK1 Receptor,Antagonist,Potent long-acting hNK1 antagonist,1,Datasheet_6486,15,H02
6538,PF 04449913 maleate,7-TM Receptors,Smoothened Receptors,Antagonist,Potent Smo antagonist,1,Datasheet_6538,16,A05
6541,AZD 2098,7-TM Receptors,Chemokine CC Receptors,Antagonist,Potent and selective CCR4 antagonist,1,Datasheet_6541,16,A07
6544,CID 1375606,7-TM Receptors,Orphan 7-TM Receptors,Agonist,GPR27 agonist,1,Datasheet_6544,16,A09
6657,PA 8,7-TM Receptors,PACAP Receptors,Antagonist,PAC1 receptor antagonist,1,Datasheet_6657,16,C09
6663,Silodosin,7-TM Receptors,Adrenergic Alpha-1 Receptors,Antagonist,Selective α1A antagonist,1,Datasheet_6663,16,C11
6668,ML 184,7-TM Receptors,GPR55,Agonist,Selective GPR55 agonist; also promotes NSC proliferation and differentiation,1,Datasheet_6668,16,D02
6709,GSK 2018682,7-TM Receptors,Sphingosine-1-phosphate Receptors,Agonist,S1P1 and S1P5 agonist,1,Datasheet_6709,16,D08
6777,TAK 375,7-TM Receptors,Melatonin (MT) Receptors,Agonist,Very high affinity and selective melatonin receptor agonist,1,Datasheet_6777,16,F04
6784,FTBMT,7-TM Receptors,Orphan 7-TM Receptors,Agonist,Potent and selective GPR52 agonist; orally bioavailable and BBB permeable,1,Datasheet_6784,16,F05
6787,KI-7,7-TM Receptors,Adenosine A2B Receptors,Modulator,Positive allosteric modulator of A2B receptors,1,Datasheet_6787,16,F06
6830,Conivaptan hydrochloride,7-TM Receptors,Vasopressin Receptors,Antagonist,Very high affinity vasopressin V1A and V2 antagonist; orally bioavailable,1,Datasheet_6830,16,G04
6859,FITM,7-TM Receptors,Glutamate (Metabotropic) Group I Receptors,Modulator,Potent and selective negative allosteric modulator of mGlu1 receptors,1,Datasheet_6859,16,G06
6893,VU 6005649,7-TM Receptors,Glutamate (Metabotropic) Group III Receptors,Modulator,Positive allosteric modulators of mGlu7 and mGlu8 receptors; also NK1 antagonist; brain penetrant,1,Datasheet_6893,16,H03
7027,LY 2033298,7-TM Receptors,M4 Receptors,Modulator,Selective positive allosteric modulator of M4 receptors; active in vivo; antipsychotic,1,Datasheet_7027,16,H11
0357,N-Acetyltryptamine,Enzymes,Other Transferases,Substrate,Substrate for serotonin N-acetyl transferase,2,Datasheet_0357,1,A07
0415,Ro 20-1724,Enzymes,Phosphodiesterases,Inhibitor,PDE4 inhibitor,4,Datasheet_0415,1,A10
0431,ML 9 hydrochloride,Enzymes,Myosin Light Chain Kinase,Inhibitor,Myosin light chain kinase inhibitor,5,Datasheet_0431,1,B02
0478,Flurofamide,Enzymes,Other Hydrolases,Inhibitor,Urease inhibitor,1,Datasheet_0478,1,B04
0541,Fasudil hydrochloride,Enzymes,Rho-kinases,Inhibitor,Inhibitor of cyclic nucleotide dependent- and Rho-kinases,3,Datasheet_0541,1,B06
0542,H-7 dihydrochloride,Enzymes,Broad Spectrum Protein Kinase Inhibitors,Inhibitor,Protein kinase inhibitor,6,Datasheet_0542,1,B07
0607,17-ODYA,Enzymes,Hydroxylases,Inhibitor,LTB ω-hydroxylase inhibitor,4,Datasheet_0607,1,B11
0665,L-NAME hydrochloride,Enzymes,Non-selective NOS,Inhibitor,Non-selective NOS inhibitor,7,Datasheet_0665,1,C04
0741,GF 109203X,Enzymes,Protein Kinase C,Inhibitor,Protein kinase C inhibitor,6,Datasheet_0741,1,D02
0767,Bifemelane hydrochloride,Enzymes,Monoamine Oxidase,Inhibitor,Non-selective MAO inhibitor,2,Datasheet_0767,1,D06
0905,Rolipram,Enzymes,Phosphodiesterases,Inhibitor,PDE4 inhibitor,19,Datasheet_0905,1,E03
0942,NS 398,Enzymes,Cyclooxygenase,Inhibitor,Cyclooxygenase-2 (COX-2) inhibitor,2,Datasheet_0942,1,E10
1099,Forskolin,Enzymes,Adenylyl Cyclase,Activator,Adenylyl cyclase activator,3,Datasheet_1099,1,H06
1110,Genistein,Enzyme-Linked Receptors,EGFR,Inhibitor,EGFR kinase inhibitor. Also estrogen and PPARγ ligand,4,Datasheet_1110,1,H08
1130,LY 294002 hydrochloride,Enzymes,PI 3-Kinase,Inhibitor,Prototypical PI 3-kinase inhibitor; also inhibits other kinases,4,Datasheet_1130,1,H10
1202,SB 203580,Enzymes,p38,Inhibitor,Selective inhibitor of p38 MAPK,5,Datasheet_1202,2,A03
1213,PD 98059,Enzymes,MEK,Inhibitor,MEK inhibitor,9,Datasheet_1213,2,A06
1226,Etoposide,Enzymes,DNA Topoisomerase,Inhibitor,Topoisomerase II inhibitor,6,Datasheet_1226,2,A09
1264,SB 202190,Enzymes,p38,Inhibitor,"Potent, selective inhibitor of p38 MAPK",5,Datasheet_1264,2,B04
1305,Monastrol,Enzymes,Kinesin,Inhibitor,Selective inhibitor of mitotic kinesin Eg5,4,Datasheet_1305,2,B06
1332,Roscovitine,Enzymes,Cyclin-dependent Kinase,Inhibitor,Cdk inhibitor,2,Datasheet_1332,2,C02
1349,(R)-(-)-Rolipram,Enzymes,Phosphodiesterases,Inhibitor,PDE4 inhibitor. More active enantiomer of rolipram (Cat. No. 0905),15,Datasheet_1349,2,C03
1398,Kenpaullone,Enzymes,Glycogen Synthase Kinase 3,Inhibitor,GSK-3β inhibitor; also inhibits cdks,2,Datasheet_1398,2,C06
1400,SCH 202676 hydrobromide,Enzymes,Heterotrimeric G-protein GTPases,Inhibitor,Inhibitor of ligand binding to G-protein-coupled receptors,1,Datasheet_1400,2,C07
1407,PP 2,Enzymes,Src Kinases,Inhibitor,"Potent, selective Src family kinase inhibitor",3,Datasheet_1407,2,C08
1418,Resveratrol,Enzymes,Cyclooxygenase,Inhibitor,Cyclooxygenase inhibitor,4,Datasheet_1418,2,D02
1430,DuP 697,Enzymes,Cyclooxygenase,Inhibitor,Cyclooxygenase-2 (COX-2) inhibitor,1,Datasheet_1430,2,D05
1435,SQ 22536,Enzymes,Adenylyl Cyclase,Inhibitor,Adenylyl cyclase inhibitor,2,Datasheet_1435,2,D06
1436,MDL 12330A hydrochloride,Enzymes,Adenylyl Cyclase,Inhibitor,Adenylyl cyclase inhibitor; also cyclic nucleotide PDE inhibitor,2,Datasheet_1436,2,D07
1530,Lovastatin,Enzymes,HMG-CoA Reductase,Inhibitor,Potent HMG-CoA reductase inhibitor,1,Datasheet_1530,2,E09
1580,Purvalanol A,Enzymes,Cyclin-dependent Kinase,Inhibitor,"Cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5",3,Datasheet_1580,2,F04
1581,Purvalanol B,Enzymes,Cyclin-dependent Kinase,Inhibitor,"Selective cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5",6,Datasheet_1581,2,F05
1614,SB 431542,Enzyme-Linked Receptors,TGF-beta Receptors,Inhibitor,"Potent, selective inhibitor of TGF-βRI, ALK4 and ALK7",14,Datasheet_1614,2,G02
1637,Argatroban,Enzymes,Other Proteases,Inhibitor,Potent thrombin inhibitor,1,Datasheet_1637,2,G06
1646,Lonidamine,Enzymes,Hexokinases,Inhibitor,Mitochondrial hexokinase inhibitor,3,Datasheet_1646,2,G07
1692,Cilostazol,Enzymes,Phosphodiesterases,Inhibitor,PDE3A inhibitor. Also adenosine uptake inhibitor,1,Datasheet_1692,2,H03
1694,Ibudilast,Enzymes,Phosphodiesterases,Inhibitor,PDE inhibitor (non-selective),1,Datasheet_1694,2,H04
1706,Acetaminophen,Enzymes,Cyclooxygenase,Inhibitor,Cyclooxygenase inhibitor; may be selective for COX-3,1,Datasheet_1706,2,H08
1777,Arctigenin,Enzymes,MEK,Inhibitor,Potent MEK1 inhibitor. Also inhibits IκBα phosphorylation,3,Datasheet_1777,3,A03
1867,NSC 663284,Enzymes,Cdc25 Phosphatase,Inhibitor,"Potent, selective Cdc25 phosphatase inhibitor",1,Datasheet_1867,3,B03
1870,BTS,Enzymes,Myosin,Inhibitor,Selective inhibitor of skeletal muscle myosin II ATPase activity,1,Datasheet_1870,3,B04
1941,m-3M3FBS,Enzymes,Phospholipases,Activator,Phospholipase C activator,1,Datasheet_1941,3,B05
1942,o-3M3FBS,Enzymes,Phospholipases,Activator,Inactive analog of m-3M3FBS (Cat. No. 1941),1,Datasheet_1942,3,B06
1965,Simvastatin,Enzymes,HMG-CoA Reductase,Inhibitor,HMG-CoA reductase inhibitor,3,Datasheet_1965,3,B11
2002,Ro 31-8220 mesylate,Enzymes,Broad Spectrum Protein Kinase Inhibitors,Inhibitor,Protein kinase inhibitor,2,Datasheet_2002,3,C09
2006,Paxilline,Enzymes,Ca2+-ATPase,Blocker,SERCA ATPase blocker. Also potent BKCa channel blocker,7,Datasheet_2006,3,C11
2072,Aminopurvalanol A,Enzymes,Cyclin-dependent Kinase,Inhibitor,"Selective cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5",1,Datasheet_2072,3,D08
2151,API-2,Enzymes,Akt (Protein Kinase B),Inhibitor,Selective inhibitor of Akt/PKB signaling. Antitumor and antiviral,3,Datasheet_2151,3,E02
2161,NSC 23766,Enzymes,Rho,Inhibitor,Selective inhibitor of Rac1-GEF interaction; antioncogenic,5,Datasheet_2161,3,E04
2176,BVT 948,Enzymes,Protein Tyrosine Phosphatases,Inhibitor,Non-competitive protein tyrosine phosphatase inhibitor,3,Datasheet_2176,3,E06
2194,R 59-022,Enzymes,Diacylglycerol Kinase,Inhibitor,Diacylglycerol kinase inhibitor; increases PKC activity,1,Datasheet_2194,3,E10
2227,CI 976,Enzymes,Acyl-CoA:Cholesterol Acyltransferase,Inhibitor,Selective ACAT inhibitor,1,Datasheet_2227,3,F06
2237,BRL 50481,Enzymes,Phosphodiesterases,Inhibitor,Selective PDE7 inhibitor,1,Datasheet_2237,3,F08
2275,TBB,Enzymes,Casein Kinase 2,Inhibitor,Selective cell-permeable CK2 inhibitor,2,Datasheet_2275,3,G02
2318,Pravastatin sodium salt,Enzymes,HMG-CoA Reductase,Inhibitor,HMG-CoA reductase inhibitor,3,Datasheet_2318,3,H04
2324,Necrostatin-1,Enzymes,RIP Kinases,Inhibitor,RIP1 kinase inhibitor; inhibits necroptosis,2,Datasheet_2324,3,H05
2337,Trequinsin hydrochloride,Enzymes,Phosphodiesterases,Inhibitor,Highly potent PDE3 inhibitor,1,Datasheet_2337,3,H08
2347,Salubrinal,Enzymes,Protein Ser/Thr Phosphatases,Inhibitor,Selective inhibitor of eIF2α dephosphorylation,1,Datasheet_2347,3,H11
2416,BIBX 1382 dihydrochloride,Enzyme-Linked Receptors,EGFR,Inhibitor,Highly selective EGFR-kinase inhibitor,1,Datasheet_2416,4,B03
2442,CGP 53353,Enzymes,Protein Kinase C,Inhibitor,Selective inhibitor of PKCβII,1,Datasheet_2442,4,B05
2457,Arcyriaflavin A,Enzymes,Cyclin-dependent Kinase,Inhibitor,Potent cdk4 inhibitor; also potently inhibits CaM kinase II; antiviral,1,Datasheet_2457,4,B08
2458,ZM 447439,Enzymes,Aurora Kinases,Inhibitor,Inhibits Aurora kinase B,4,Datasheet_2458,4,B09
2471,ER 27319 maleate,Enzymes,Syk Kinase,Inhibitor,Selective Syk kinase inhibitor,1,Datasheet_2471,4,C02
2475,ZM 323881 hydrochloride,Enzyme-Linked Receptors,VEGFR,Inhibitor,"Potent, selective inhibitor of VEGFR-2",1,Datasheet_2475,4,C04
2489,C 75,Enzymes,Fatty Acid Synthase,Inhibitor,Potent fatty acid synthase inhibitor; proapoptotic,3,Datasheet_2489,4,C08
2506,SSR 69071,Enzymes,Elastase,Inhibitor,"Potent, orally active human leukocyte elastase inhibitor",2,Datasheet_2506,4,C10
2513,Acyclovir,Enzymes,RNA/DNA Polymerase,Inhibitor,Inhibits viral DNA polymerase; antiherpetic agent,2,Datasheet_2513,4,D02
2520,PD 166793,Enzymes,Matrix Metalloprotease,Inhibitor,Broad spectrum MMP inhibitor,1,Datasheet_2520,4,D04
2539,IKK 16,Enzymes,IkB Kinase,Inhibitor,Selective inhibitor of IKK,2,Datasheet_2539,4,D07
2542,Ki 8751,Enzyme-Linked Receptors,VEGFR,Inhibitor,"Potent, selective VEGFR-2 inhibitor",2,Datasheet_2542,4,D08
2558,10-DEBC hydrochloride,Enzymes,Akt (Protein Kinase B),Inhibitor,Selective Akt/PKB inhibitor,1,Datasheet_2558,4,D11
2559,TPCA-1,Enzymes,IkB Kinase,Inhibitor,"Potent, selective inhibitor of IKKβ",5,Datasheet_2559,4,E02
2560,SB 218078,Enzymes,Checkpoint Kinases,Inhibitor,Chk1 inhibitor,1,Datasheet_2560,4,E03
2580,Tenidap,Enzymes,Cyclooxygenase,Inhibitor,"NSAID, cyclooxygenase (COX-1) inhibitor. Also opener of KIR2.3",1,Datasheet_2580,4,E06
2609,Ryuvidine,Enzymes,Other Lysine Methyltransferases,Inhibitor,SETD8 inhibitor; also CDK4 inhibitor,2,Datasheet_2609,4,F02
2615,PD 158780,Enzyme-Linked Receptors,EGFR,Inhibitor,Potent ErbB receptor family inhibitor,1,Datasheet_2615,4,F03
2624,Decitabine,Enzymes,DNA Methyltransferases,Inhibitor,DNA methyltransferase inhibitor,3,Datasheet_2624,4,F04
2632,CL 82198 hydrochloride,Enzymes,Matrix Metalloprotease,Inhibitor,Selective inhibitor of MMP-13,2,Datasheet_2632,4,F05
2633,WAY 170523,Enzymes,Matrix Metalloprotease,Inhibitor,Potent and selective inhibitor of MMP-13,2,Datasheet_2633,4,F06
2682,Sodium 4-Phenylbutyrate,Enzymes,Non-selective HDACs,Inhibitor,Histone deacetylase inhibitor,5,Datasheet_2682,4,G05
2684,SN 38,Enzymes,DNA Topoisomerase,Inhibitor,DNA topoisomerase I inhibitor; antitumor,2,Datasheet_2684,4,G06
2688,CPT 11,Enzymes,DNA Topoisomerase,Inhibitor,DNA topoisomerase I inhibitor; antitumor,2,Datasheet_2688,4,G08
2694,PD 407824,Enzymes,Checkpoint Kinases,Inhibitor,Potent and selective inhibitor of Chk1 and Wee1,1,Datasheet_2694,4,G09
2718,LY 364947,Enzyme-Linked Receptors,TGF-beta Receptors,Inhibitor,Selective inhibitor of TGF-βRI,1,Datasheet_2718,4,H02
2731,CGP 57380,Enzymes,Mnk,Inhibitor,Selective inhibitor of Mnk1,3,Datasheet_2731,4,H07
2768,PQ 401,Enzyme-Linked Receptors,Insulin and insulin-like Receptors,Inhibitor,IGF1R inhibitor,1,Datasheet_2768,5,A05
2783,DPPI 1c hydrochloride,Enzymes,Dipeptidyl Peptidase IV (DPP-IV),Inhibitor,Dipeptidyl peptidase IV (DPP-IV) inhibitor,4,Datasheet_2783,5,A09
2794,PP 3,Enzymes,Src Kinases,Inhibitor,Negative control for PP 2 (Cat. No. 1407),2,Datasheet_2794,5,A11
2815,"Valproic acid, sodium salt",Enzymes,Non-selective HDACs,Inhibitor,Histone deacetylase inhibitor,1,Datasheet_2815,5,B02
2827,TCS JNK 5a,Enzymes,JNK/c-jun,Inhibitor,Selective inhibitor of JNK2 and JNK3,1,Datasheet_2827,5,B03
2840,AICAR,Enzymes,AMPK,Activator,AMPK activator,7,Datasheet_2840,5,B08
2845,IBMX,Enzymes,Phosphodiesterases,Inhibitor,PDE inhibitor (non-selective),8,Datasheet_2845,5,B09
2849,SecinH3,Enzymes,Arf,Inhibitor,Sec7-specific GEF inhibitor; selective for cytohesin family,3,Datasheet_2849,5,B10
2850,PD 146176,Enzymes,Lipoxygenase,Inhibitor,Selective 15-lipoxygenase inhibitor,1,Datasheet_2850,5,B11
2864,Metformin hydrochloride,Enzymes,AMPK,Activator,Activator of LKB1/AMPK; antidiabetic agent,2,Datasheet_2864,5,C02
2870,BMS 299897,Enzymes,Gamma-Secretase,Inhibitor,Potent γ-secretase inhibitor,2,Datasheet_2870,5,C04
2902,D 4476,Enzymes,Casein Kinase 1,Inhibitor,Selective CK1 inhibitor. Also inhibits TGF-βRI,2,Datasheet_2902,5,C08
2907,SU 9516,Enzymes,Cyclin-dependent Kinase,Inhibitor,Cdk inhibitor; potently inhibits cdk1 and cdk2,2,Datasheet_2907,5,C09
2910,H 89 dihydrochloride,Enzymes,Protein Kinase A,Inhibitor,Protein kinase A inhibitor,6,Datasheet_2910,5,C10
2930,PI 103 hydrochloride,Enzymes,PI 3-Kinase,Inhibitor,"Inhibitor of PI 3-kinase, mTOR and DNA-PK",3,Datasheet_2930,5,D05
2952,CI 994,Enzymes,Class I HDACs,Inhibitor,Class I histone deacetylase inhibitor; orally active,1,Datasheet_2952,5,D07
2966,CGP 3466B maleate,Enzymes,Other Dehydrogenases,Inhibitor,GAPDH inhibitor; neuroprotective,1,Datasheet_2966,5,D11
2977,GW 843682X,Enzymes,Polo-like Kinase,Inhibitor,Selective inhibitor of PLK1 and PLK3,2,Datasheet_2977,5,E04
2979,TCS PIM-1 1,Enzymes,Pim Kinase,Inhibitor,"Selective, ATP-competitive Pim-1 kinase inhibitor",2,Datasheet_2979,5,E05
2981,BIBR 1532,Enzymes,Telomerase,Inhibitor,Selective telomerase inhibitor,3,Datasheet_2981,5,E06
3000,Iressa,Enzyme-Linked Receptors,EGFR,Inhibitor,"Orally active, selective EGFR inhibitor",3,Datasheet_3000,5,E09
3037,SU 5416,Enzyme-Linked Receptors,VEGFR,Inhibitor,"VEGFR inhibitor. Also inhibits KIT, RET, MET and FLT3",6,Datasheet_3037,5,F03
3044,PD 173074,Enzyme-Linked Receptors,FGFR,Inhibitor,FGFR1 and -3 inhibitor,5,Datasheet_3044,5,F05
3063,1-Naphthyl PP1,Enzymes,Src Kinases,Inhibitor,Src family kinase inhibitor; also inhibits c-Abl,2,Datasheet_3063,5,F08
3066,L 006235,Enzymes,Cathepsin,Inhibitor,Potent cathepsin K inhibitor,3,Datasheet_3066,5,F09
3081,Nafamostat mesylate,Enzymes,Other Proteases,Inhibitor,"Serine protease inhibitor, inhibits tryptase",3,Datasheet_3081,5,G02
3093,Dorsomorphin dihydrochloride,Enzymes,AMPK,Inhibitor,Potent AMPK inhibitor; also BMP type I receptor inhibitor,5,Datasheet_3093,5,G05
3094,Flavopiridol hydrochloride,Enzymes,Cyclin-dependent Kinase,Inhibitor,Cdk inhibitor; potently inhibits cdk2 and cdk9,1,Datasheet_3094,5,G06
3118,Ranolazine dihydrochloride,Enzymes,Other Dehydrogenases,Activator,"Antianginal, activates pyruvate dehydrogenase",2,Datasheet_3118,5,H02
3140,PHA 767491 hydrochloride,Enzymes,MK2,Inhibitor,MK2 inhibitor; also cdk inhibitor; potently inhibits cdk9,2,Datasheet_3140,5,H07
3190,Mirin,Enzymes,ATM & ATR Kinase,Inhibitor,MRN-ATM pathway inhibitor,2,Datasheet_3190,5,H10
3211,SB 525334,Enzyme-Linked Receptors,TGF-beta Receptors,Inhibitor,Selective inhibitor of TGF-βRI,4,Datasheet_3211,6,A06
3239,PF 573228,Enzymes,Focal Adhesion Kinase,Inhibitor,Potent and selective FAK inhibitor,3,Datasheet_3239,6,A10
3253,Triptolide,Enzymes,RNA/DNA Polymerase,Other,"Inhibits RNAPII-mediated transcription; antitumor, anti-inflammatory and immunosuppressive",3,Datasheet_3253,6,B04
3254,Ro 61-8048,Enzymes,Kynurenine 3-monooxygenase,Inhibitor,Potent kynurenine 3-monooxygenase (KMO) inhibitor,5,Datasheet_3254,6,B05
3255,PJ 34 hydrochloride,Enzymes,Poly(ADP-ribose) Polymerase,Inhibitor,Potent PARP inhibitor,4,Datasheet_3255,6,B06
3263,SB 505124,Enzyme-Linked Receptors,TGF-beta Receptors,Inhibitor,"Selective inhibitor of TGF-βRI, ALK4 and ALK7",2,Datasheet_3263,6,B09
3264,GW 788388,Enzyme-Linked Receptors,TGF-beta Receptors,Inhibitor,Potent and selective inhibitor of TGF-βRI,1,Datasheet_3264,6,B10
3269,SD 208,Enzyme-Linked Receptors,TGF-beta Receptors,Inhibitor,Potent ATP-competitive TGF-βRI inhibitor,4,Datasheet_3269,6,B11
3291,PF 915275,Enzymes,11b-Hydroxysteroid Dehydrogenase,Inhibitor,Potent and selective 11β-hydroxysteroid dehydrogenase inhibitor,2,Datasheet_3291,6,C04
3292,Metyrapone,Enzymes,Hydroxylases,Inhibitor,11-β hydroxylase inhibitor,4,Datasheet_3292,6,C05
3295,RG 108,Enzymes,DNA Methyltransferases,Inhibitor,Non-nucleoside DNA methyltransferase inhibitor,2,Datasheet_3295,6,C06
3301,NU 6140,Enzymes,Cyclin-dependent Kinase,Inhibitor,Cdk2 inhibitor; also potent inhibitor of aurora kinase A and B,1,Datasheet_3301,6,C09
3304,SU 16f,Enzyme-Linked Receptors,PDGFR,Inhibitor,Potent and selective PDGFRβ inhibitor,1,Datasheet_3304,6,C11
3308,Zileuton,Enzymes,Lipoxygenase,Inhibitor,5-LOX inhibitor; orally bioavailable,1,Datasheet_3308,6,D02
3314,BI 78D3,Enzymes,JNK/c-jun,Inhibitor,"Selective, competitive JNK inhibitor",1,Datasheet_3314,6,D04
3316,PF 670462,Enzymes,Casein Kinase 1,Inhibitor,Potent and selective CK1ε and CK1δ inhibitor,1,Datasheet_3316,6,D05
3319,ARL 17477 dihydrochloride,Enzymes,nNOS,Inhibitor,Selective nNOS inhibitor,1,Datasheet_3319,6,D06
3324,QS 11,Enzymes,Arf,Inhibitor,ARFGAP1 inhibitor; modulates Wnt/β-catenin signaling,3,Datasheet_3324,6,D08
3327,CID 755673,Enzymes,Protein Kinase D,Inhibitor,Selective protein kinase D inhibitor,3,Datasheet_3327,6,D10
3352,JNJ 28871063 hydrochloride,Enzyme-Linked Receptors,EGFR,Inhibitor,Potent ErbB receptor family inhibitor,2,Datasheet_3352,6,E05
3364,BIX 01294,Enzymes,G9a/GLP,Inhibitor,GLP and G9a inhibitor,2,Datasheet_3364,6,E08
3388,Anastrozole,Enzymes,Cytochrome P450,Inhibitor,Potent aromatase (CYP19) inhibitor,1,Datasheet_3388,6,F08
3506,NVP DPP 728 dihydrochloride,Enzymes,Dipeptidyl Peptidase IV (DPP-IV),Inhibitor,"Potent, orally active dipeptidyl peptidase IV (DPP-IV) inhibitor",1,Datasheet_3506,6,G08
3528,SCIO 469 hydrochloride,Enzymes,p38,Inhibitor,Selective p38 MAPK inhibitor,1,Datasheet_3528,6,G11
3530,HQL 79,Enzymes,Other Synthases/Synthetases,Inhibitor,Human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor,1,Datasheet_3530,6,H02
3531,AT 56,Enzymes,Other Synthases/Synthetases,Inhibitor,L-PGDS inhibitor,2,Datasheet_3531,6,H03
3535,Sivelestat sodium salt,Enzymes,Elastase,Inhibitor,Selective leukocyte elastase inhibitor,3,Datasheet_3535,6,H05
3542,CP 316819,Enzymes,Phosphorylases,Inhibitor,Selective glycogen phosphorylase inhibitor,1,Datasheet_3542,6,H06
3567,TC-S 7003,Enzymes,Src Kinases,Inhibitor,Potent Lck inhibitor,1,Datasheet_3567,6,H10
3572,GSK 650394,Enzymes,Other Kinases,Inhibitor,Serum- and glucocorticoid-regulated kinase (SGK) inhibitor,3,Datasheet_3572,7,A03
3575,VU 0155069,Enzymes,Phospholipases,Inhibitor,Potent and selective PLD1 inhibitor,1,Datasheet_3575,7,A05
3587,A 922500,Enzymes,Diacylglycerol O-Acyltransferase,Inhibitor,Potent DGAT-1 inhibitor,2,Datasheet_3587,7,A10
3595,CHR 2797,Enzymes,Aminopeptidases,Inhibitor,Aminopeptidase inhibitor,4,Datasheet_3595,7,A11
3600,FIPI,Enzymes,Phospholipases,Inhibitor,Phospholipase D inhibitor,3,Datasheet_3600,7,B02
3605,(R)-CR8,Enzymes,Cyclin-dependent Kinase,Inhibitor,Cdk inhibitor; potently inhibits cdk1 and cdk2; also inhibits CK1,1,Datasheet_3605,7,B04
3607,SU 3327,Enzymes,JNK/c-jun,Inhibitor,Selective JNK inhibitor,1,Datasheet_3607,7,B05
3642,Src I1,Enzymes,Src Kinases,Inhibitor,Dual site Src kinase inhibitor,1,Datasheet_3642,7,B11
3657,Sal 003,Enzymes,Protein Ser/Thr Phosphatases,Inhibitor,Cell-permeable inhibitor of eIF2α dephosphorylation,1,Datasheet_3657,7,C06
3667,SR 3677 dihydrochloride,Enzymes,Rho-kinases,Inhibitor,"Potent, selective Rho-kinase (ROCK) inhibitor",2,Datasheet_3667,7,C09
3706,FR 180204,Enzymes,ERK,Inhibitor,Selective ERK inhibitor,3,Datasheet_3706,7,D07
3718,AS 1949490,Enzymes,Inositol Phosphatases,Inhibitor,SH2 domain-containing inositol 5'-phosphatase 2 (SHIP2) inhibitor,1,Datasheet_3718,7,D09
3724,PD 161570,Enzyme-Linked Receptors,FGFR,Inhibitor,Selective FGFR inhibitor,1,Datasheet_3724,7,E02
3726,GSK 429286,Enzymes,Rho-kinases,Inhibitor,Selective Rho-kinase (ROCK) inhibitor,3,Datasheet_3726,7,E03
3742,RepSox,Enzyme-Linked Receptors,TGF-beta Receptors,Inhibitor,Potent and selective inhibitor of TGF-βRI,4,Datasheet_3742,7,E05
3748,XAV 939,Enzymes,Tankyrase,Inhibitor,Potent tankyrase inhibitor,5,Datasheet_3748,7,E09
3768,Sunitinib malate,Enzyme-Linked Receptors,VEGFR,Inhibitor,"Potent VEGFR, PDGFRβ and KIT inhibitor",1,Datasheet_3768,7,F06
3784,Sildenafil citrate,Enzymes,Phosphodiesterases,Inhibitor,Potent PDE5 inhibitor; orally active,1,Datasheet_3784,7,F08
3785,PD 166285 dihydrochloride,Enzymes,Src Kinases,Inhibitor,"Potent Src inhibitor; also inhibits FGFR1, PDGFRβ and Wee1",1,Datasheet_3785,7,F09
3786,Celecoxib,Enzymes,Cyclooxygenase,Inhibitor,Selective cyclooxygenase-2 (COX-2) inhibitor,1,Datasheet_3786,7,F10
3835,TWS 119,Enzymes,Glycogen Synthase Kinase 3,Inhibitor,GSK-3β inhibitor; induces neuronal differentiation in ESCs,2,Datasheet_3835,7,G10
3836,JZL 184,Enzymes,MAGL,Inhibitor,Potent MAGL inhibitor,4,Datasheet_3836,7,G11
3842,5-Azacytidine,Enzymes,DNA Methyltransferases,Inhibitor,DNA methyltransferase inhibitor,2,Datasheet_3842,7,H03
3852,Tranylcypromine hydrochloride,Enzymes,Histone Demethylases,Inhibitor,Irreversible inhibitor of LSD1; also inhibits MAO,3,Datasheet_3852,7,H05
3869,TCS 2002,Enzymes,Glycogen Synthase Kinase 3,Inhibitor,Potent GSK-3β inhibitor,1,Datasheet_3869,7,H09
3872,EHT 1864,Enzymes,Rho,Inhibitor,Potent Rac family inhibitor,2,Datasheet_3872,7,H10
3900,TCS 2314,Enzyme-Linked Receptors,Integrins,Inhibitor,α4β1 (VLA-4) antagonist,1,Datasheet_3900,8,A08
3914,A 419259 trihydrochloride,Enzymes,Src Kinases,Inhibitor,Inhibitor of Src family kinases,2,Datasheet_3914,8,B02
3915,VX 745,Enzymes,p38,Inhibitor,Potent and selective p38α inhibitor,1,Datasheet_3915,8,B03
3916,VX 702,Enzymes,p38,Inhibitor,Orally active p38α and p38β inhibitor,1,Datasheet_3916,8,B04
3919,SC 236,Enzymes,Cyclooxygenase,Inhibitor,Selective cyclooxygenase-2 (COX-2) inhibitor,1,Datasheet_3919,8,B05
3920,AMG 548,Enzymes,p38,Inhibitor,Potent and selective p38α inhibitor,1,Datasheet_3920,8,B06
3960,NVP 231,Enzymes,Other Kinases,Inhibitor,"Potent, selective and reversible CerK inhibitor",1,Datasheet_3960,8,C03
3963,AZM 475271,Enzymes,Src Kinases,Inhibitor,Src tyrosine kinase inhibitor,1,Datasheet_3963,8,C05
3966,AR-A 014418,Enzymes,Glycogen Synthase Kinase 3,Inhibitor,Selective GSK-3 inhibitor,1,Datasheet_3966,8,C06
3968,AZD 5438,Enzymes,Cyclin-dependent Kinase,Inhibitor,"Cdk inhibitor; potently inhibits cdk1, 2, 5 and 9",1,Datasheet_3968,8,C07
3984,Nutlin-3,Enzymes,Ubiquitin E3 Ligases,Inhibitor,MDM2 antagonist; inhibits MDM2-p53 interaction,2,Datasheet_3984,8,C08
3988,Hesperadin hydrochloride,Enzymes,Aurora Kinases,Inhibitor,Potent Aurora kinase B inhibitor,1,Datasheet_3988,8,C10
3994,AZ 3146,Enzymes,Monopolar Spindle 1 Kinase,Inhibitor,Potent and selective Mps1 kinase inhibitor,1,Datasheet_3994,8,C11
4000,MRK 560,Enzymes,Gamma-Secretase,Inhibitor,γ-secretase inhibitor; attenuates amyloid plaque deposition,1,Datasheet_4000,8,D02
4005,Alda 1,Enzymes,Aldehyde Dehydrogenase,Activator,ALDH2 activator; cardioprotective,1,Datasheet_4005,8,D03
4009,GSK 269962,Enzymes,Rho-kinases,Inhibitor,Potent and selective ROCK inhibitor,1,Datasheet_4009,8,D04
4032,PF 4708671,Enzymes,RSK,Inhibitor,S6K1 inhibitor,3,Datasheet_4032,8,D08
4076,P7C3,Enzymes,NAMPT,Activator,NAMPT activator; also proneurogenic and neuroprotective,1,Datasheet_4076,8,E05
4083,3F8,Enzymes,Glycogen Synthase Kinase 3,Inhibitor,Potent and selective GSK-3β inhibitor,1,Datasheet_4083,8,E07
4092,Aspirin,Enzymes,Cyclooxygenase,Inhibitor,Cyclooxygenase inhibitor; NSAID,1,Datasheet_4092,8,E10
4102,Mycophenolate mofetil,Enzymes,Other Dehydrogenases,Inhibitor,Inosine monophosphate dehydrogenase inhibitor,2,Datasheet_4102,8,F02
4118,SB 772077B dihydrochloride,Enzymes,Rho-kinases,Inhibitor,Potent Rho-kinase inhibitor; vasodilator,1,Datasheet_4118,8,F06
4126,DMH-1,Enzyme-Linked Receptors,BMP and Other Activin Receptors,Inhibitor,Selective ALK2 inhibitor,3,Datasheet_4126,8,F08
4128,Bisindolylmaleimide II,Enzymes,Protein Kinase C,Inhibitor,Potent PKC inhibitor; also potent nAChR antagonist,1,Datasheet_4128,8,F09
4132,XMD 8-92,Enzymes,ERK,Inhibitor,ERK5/BMK1 inhibitor; also BRD4 inhibitor,2,Datasheet_4132,8,F10
4143,GSK 2334470,Enzymes,Phosphoinositide-dependent Kinase 1,Inhibitor,"Highly potent, selective PDPK1 (PDK1) inhibitor",1,Datasheet_4143,8,G03
4144,GSK 690693,Enzymes,Akt (Protein Kinase B),Inhibitor,Akt kinase inhibitor. Antitumor,1,Datasheet_4144,8,G04
4145,PK 44 phosphate,Enzymes,Dipeptidyl Peptidase IV (DPP-IV),Inhibitor,Potent and selective dipeptidyl peptidase IV (DPP-IV) inhibitor,1,Datasheet_4145,8,G05
4165,Gisadenafil besylate,Enzymes,Phosphodiesterases,Inhibitor,Potent PDE5 inhibitor; orally bioavailable,1,Datasheet_4165,8,G06
4171,VU 0364739 hydrochloride,Enzymes,Phospholipases,Inhibitor,Potent and selective PLD2 inhibitor,2,Datasheet_4171,8,G09
4181,Ro 3306,Enzymes,Cyclin-dependent Kinase,Inhibitor,Cdk1 inhibitor,2,Datasheet_4181,8,H03
4188,UK 383367,Enzymes,Matrix Metalloprotease,Inhibitor,Potent and selective BMP-1 (PCP) inhibitor,1,Datasheet_4188,8,H06
4189,SC 26196,Enzymes,Other Oxygenases/Oxidases,Inhibitor,Selective fatty acid desaturase 2 inhibitor,1,Datasheet_4189,8,H07
4196,HA 130,Enzymes,Autotaxin,Inhibitor,Potent and selective autotaxin inhibitor,1,Datasheet_4196,8,H09
4206,Valdecoxib,Enzymes,Cyclooxygenase,Inhibitor,Selective and potent COX-2 inhibitor,1,Datasheet_4206,8,H11
4222,Dynole 34-2,Enzymes,Dynamin,Inhibitor,Dynamin I inhibitor,1,Datasheet_4222,9,A04
4228,A 286982,Enzyme-Linked Receptors,Integrins,Inhibitor,Potent inhibitor of the LFA-1/ICAM-1 interaction,1,Datasheet_4228,9,A05
4248,Torin 2,Enzymes,mTOR,Inhibitor,Potent and selective mTOR inhibitor,3,Datasheet_4248,9,A07
4257,PP 242,Enzymes,mTOR,Inhibitor,Dual mTORC1/mTORC2 inhibitor,3,Datasheet_4257,9,A11
4266,ML 141,Enzymes,Rho,Inhibitor,Selective Cdc42 Rho family inhibitor,2,Datasheet_4266,9,B02
4273,LRRK2-IN-1,Enzymes,LRRK2,Inhibitor,Potent and selective LRRK2 inhibitor,1,Datasheet_4273,9,B04
4277,PF 477736,Enzymes,Checkpoint Kinases,Inhibitor,Selective Chk1 inhibitor,1,Datasheet_4277,9,B05
4278,PF 431396,Enzymes,Focal Adhesion Kinase,Inhibitor,Dual FAK/PYK2 inhibitor,2,Datasheet_4278,9,B06
4281,PF 4800567 hydrochloride,Enzymes,Casein Kinase 1,Inhibitor,Selective casein kinase 1ε inhibitor,2,Datasheet_4281,9,B07
4307,YC 1,Enzymes,Guanylyl Cyclase,Activator,Soluble guanylyl cyclase (sGC) activator; induces G1 cell cycle arrest,1,Datasheet_4307,9,C05
4308,Rasagiline mesylate,Enzymes,Monoamine Oxidase,Inhibitor,Selective and irreversible MAO-B inhibitor,1,Datasheet_4308,9,C06
4336,TG 003,Enzymes,Cdc2-like kinases,Inhibitor,Potent inhibitor of Clk-family kinases; also inhibits DYRK1A/B,2,Datasheet_4336,9,D03
4343,UNC 0638,Enzymes,G9a/GLP,Inhibitor,Selective G9a and GLP inhibitor,2,Datasheet_4343,9,D04
4350,Axitinib,Enzyme-Linked Receptors,VEGFR,Inhibitor,"Potent VEGFR-1, -2 and -3 inhibitor",1,Datasheet_4350,9,D08
4355,TC-F 2,Enzymes,Fatty Acid Amide Hydrolase (FAAH),Inhibitor,"Potent, reversible and selective FAAH inhibitor",1,Datasheet_4355,9,D11
4361,Bosutinib,Enzymes,Src Kinases,Inhibitor,Dual Src-Abl inhibitor; antiproliferative,1,Datasheet_4361,9,E02
4375,SMER 3,Enzymes,Ubiquitin E3 Ligases,Inhibitor,Selective inhibitor of E3 ubiquitin ligase,1,Datasheet_4375,9,E04
4382,Letrozole,Enzymes,Cytochrome P450,Inhibitor,"Potent, reversible non-steroidal aromatase inhibitor",1,Datasheet_4382,9,E05
4395,Moclobemide,Enzymes,Monoamine Oxidase,Inhibitor,Reversible MAO-A inhibitor,1,Datasheet_4395,9,E08
4417,DBeQ,Enzymes,p97 ATPase,Inhibitor,Selective and reversible p97 ATPase inhibitor,1,Datasheet_4417,9,F03
4423,CHIR 99021,Enzymes,Glycogen Synthase Kinase 3,Inhibitor,Highly selective GSK-3 inhibitor,12,Datasheet_4423,9,F04
4430,BAY 41-2272,Enzymes,Guanylyl Cyclase,Activator,Soluble guanylyl cyclase (sGC) activator,1,Datasheet_4430,9,F05
4431,A 1070722,Enzymes,Glycogen Synthase Kinase 3,Inhibitor,"Highly potent, selective GSK-3 inhibitor",1,Datasheet_4431,9,F06
4432,TTP 22,Enzymes,Casein Kinase 2,Inhibitor,"High affinity, selective CK2 inhibitor",1,Datasheet_4432,9,F07
4440,Rivastigmine tartrate,Enzymes,Cholinesterases,Inhibitor,Dual AChE and BChE inhibitor,1,Datasheet_4440,9,F11
4453,GDC 0879,Enzymes,Raf Kinase,Inhibitor,Potent B-Raf inhibitor,1,Datasheet_4453,9,G05
4459,TC-S 7005,Enzymes,Polo-like Kinase,Inhibitor,Potent and selective PLK2 inhibitor,3,Datasheet_4459,9,G07
4464,IOX 1,Enzymes,Histone Demethylases,Inhibitor,Histone demethylase inhibitor; cell permeable,1,Datasheet_4464,9,G10
4465,TCS ERK 11e,Enzymes,ERK,Inhibitor,Potent and selective ERK2 inhibitor,2,Datasheet_4465,9,G11
4479,4mu8C,Enzymes,IRE1,Inhibitor,Inhibits IRE1α endoribonuclease activity,1,Datasheet_4479,9,H06
4481,Ki 20227,Enzyme-Linked Receptors,Other RTKs,Inhibitor,c-Fms inhibitor; suppresses osteolysis and osteoclast accumulation,5,Datasheet_4481,9,H07
4484,STF 31,Enzymes,NAMPT,Inhibitor,NAMPT inhibitor; also GLUT1 inhibitor,2,Datasheet_4484,9,H08
4485,P 22077,Enzymes,Deubiquitinating Enzymes,Inhibitor,USP7 inhibitor,1,Datasheet_4485,9,H09
4489,DBZ,Enzymes,Gamma-Secretase,Inhibitor,γ-secretase inhibitor; inhibits Notch pathway,3,Datasheet_4489,9,H11
4514,JW 55,Enzymes,Tankyrase,Inhibitor,Tankyrase inhibitor,1,Datasheet_4514,10,A08
4517,NS 2028,Enzymes,Guanylyl Cyclase,Inhibitor,Potent soluble guanylyl cyclase (sGC) inhibitor,2,Datasheet_4517,10,A09
4525,Piclamilast,Enzymes,Phosphodiesterases,Inhibitor,Potent and selective PDE4 inhibitor,1,Datasheet_4525,10,B02
4536,Resiquimod,Enzyme-Linked Receptors,Toll-like Receptors,Agonist,Toll-like receptor 7 (TLR7) agonist,3,Datasheet_4536,10,B03
4540,U 104,Enzymes,Carbonic anhydrases,Inhibitor,Potent carbonic anhydrase (CA) IX and XII inhibitor,1,Datasheet_4540,10,B04
4541,SGC 0946,Enzymes,Other Lysine Methyltransferases,Inhibitor,Highly potent and selective DOT1L inhibitor; cell permeable,2,Datasheet_4541,10,B05
4556,CP 690550 citrate,Enzymes,JAK Kinase,Inhibitor,Potent JAK inhibitor,1,Datasheet_4556,10,B10
4559,GNF 5837,Enzyme-Linked Receptors,Trk Receptors,Inhibitor,"Potent Trk inhibitor; inhibits TrkA, TrkB and TrkC",2,Datasheet_4559,10,B11
4593,GSK J1,Enzymes,Histone Demethylases,Inhibitor,Potent JMJD3/UTX inhibitor,1,Datasheet_4593,10,C04
4594,GSK J4,Enzymes,Histone Demethylases,Inhibitor,Histone KDM inhibitor; cell permeable,2,Datasheet_4594,10,C05
4602,LDN 27219,Enzymes,Other Transferases,Inhibitor,Transglutaminase 2 (TG2) inhibitor; reversible,1,Datasheet_4602,10,C08
4607,LM 22A4,Enzyme-Linked Receptors,Trk Receptors,Agonist,Potent TrkB agonist,2,Datasheet_4607,10,C10
4612,URB 597,Enzymes,Fatty Acid Amide Hydrolase (FAAH),Inhibitor,Potent and selective FAAH inhibitor,1,Datasheet_4612,10,D02
4629,GSK2578215A,Enzymes,LRRK2,Inhibitor,"Potent, selective LRRK2 inhibitor; brain penetrant",1,Datasheet_4629,10,D09
4630,SB 747651A dihydrochloride,Enzymes,Other Kinases,Inhibitor,Potent MSK1 inhibitor; also inhibits other AGC group kinases,3,Datasheet_4630,10,D10
4652,SAHA,Enzymes,Non-selective HDACs,Inhibitor,Class I and II HDAC inhibitor,2,Datasheet_4652,10,E06
4660,KB SRC 4,Enzymes,Src Kinases,Inhibitor,Potent and selective c-Src inhibitor,1,Datasheet_4660,10,E09
4663,Apocynin,Enzymes,NADPH Oxidase,Inhibitor,NADPH-oxidase inhibitor,1,Datasheet_4663,10,E10
4686,Xanthohumol,Enzymes,p97 ATPase,Inhibitor,p97 ATPase (VCP) inhibitor,2,Datasheet_4686,10,F03
4715,JZL 195,Enzymes,Fatty Acid Amide Hydrolase (FAAH),Inhibitor,Dual FAAH and MAGL inhibitor,1,Datasheet_4715,10,F08
4724,BTT 3033,Enzyme-Linked Receptors,Integrins,Inhibitor,Selective inhibitor of integrin α2β1,1,Datasheet_4724,10,F10
4745,LIMKi 3,Enzymes,LIMK,Inhibitor,Potent LIM kinase inhibitor; antitumor,3,Datasheet_4745,10,G05
4754,AK 7,Enzymes,Class III HDACs (Sirtuins),Inhibitor,Selective SIRT2 inhibitor; brain penetrant,1,Datasheet_4754,10,G07
4773,ESI 09,Enzymes,EPAC,Inhibitor,Epac inhibitor,2,Datasheet_4773,10,G10
4774,BMS 536924,Enzyme-Linked Receptors,Insulin and insulin-like Receptors,Inhibitor,Dual IR/IGF1R inhibitor,1,Datasheet_4774,10,G11
4775,SD 2590 hydrochloride,Enzymes,Matrix Metalloprotease,Inhibitor,Potent MMP inhibitor,1,Datasheet_4775,10,H02
4776,BIRT 377,Enzyme-Linked Receptors,Integrins,Modulator,Potent negative allosteric modulator of LFA-1,1,Datasheet_4776,10,H03
4781,ANA 12,Enzyme-Linked Receptors,Trk Receptors,Antagonist,TrkB receptor antagonist,2,Datasheet_4781,10,H07
4793,CE3F4,Enzymes,EPAC,Inhibitor,Noncompetitive Epac1 inhibitor,1,Datasheet_4793,11,A02
4806,BMS 345541,Enzymes,IkB Kinase,Inhibitor,Selective allosteric inhibitor of IKK; anti-inflammatory,1,Datasheet_4806,11,A05
4809,DSR 6434,Enzyme-Linked Receptors,Toll-like Receptors,Agonist,Potent TLR7 agonist,1,Datasheet_4809,11,A06
4825,TC ASK 10,Enzymes,ASK1,Inhibitor,Potent and selective ASK1 inhibitor; orally bioavailable,2,Datasheet_4825,11,A08
4826,SUN 11602,Enzyme-Linked Receptors,FGFR,Other,Basic fibroblast growth factor (bFGF) mimetic; neuroprotective,2,Datasheet_4826,11,A09
4836,AZ 628,Enzymes,Raf Kinase,Inhibitor,Potent Raf kinase inhibitor,1,Datasheet_4836,11,A10
4837,AZD 3988,Enzymes,Diacylglycerol O-Acyltransferase,Inhibitor,Potent and selective DGAT-1 inhibitor,1,Datasheet_4837,11,A11
4839,AZD 6482,Enzymes,PI 3-Kinase,Inhibitor,Potent and selective PI 3-Kβ inhibitor,1,Datasheet_4839,11,B02
4842,BIX 02189,Enzymes,MEK,Inhibitor,Selective MEK5 and ERK5 inhibitor,2,Datasheet_4842,11,B03
4844,HJC 0350,Enzymes,EPAC,Inhibitor,Selective Epac2 inhibitor,1,Datasheet_4844,11,B04
4845,A 939572,Enzymes,Stearoyl-CoA 9-desaturase,Inhibitor,Potent SCD-1 inhibitor,1,Datasheet_4845,11,B05
4857,Amlexanox,Enzymes,TANK binding kinase (TBK),Inhibitor,Selective inhibitor of TBK,1,Datasheet_4857,11,B07
4865,APY 29,Enzymes,IRE1,Other,Inhibits IRE1α autophosphorylation; activates IRE1α endoribonuclease activity,2,Datasheet_4865,11,B09
4872,KML 29,Enzymes,MAGL,Inhibitor,Highly potent and selective MAGL inhibitor,2,Datasheet_4872,11,C03
4880,ML 281,Enzymes,Other Kinases,Inhibitor,STK33 inhibitor,1,Datasheet_4880,11,C06
4883,CU CPT 4a,Enzyme-Linked Receptors,Toll-like Receptors,Inhibitor,Selective TLR3 inhibitor,2,Datasheet_4883,11,C07
4899,ML 120B dihydrochloride,Enzymes,IkB Kinase,Inhibitor,Novel IKK2-selective inhibitor,1,Datasheet_4899,11,C11
4902,NSC 405020,Enzymes,Class I HDACs,Inhibitor,Histone deacetylase inhibitor,1,Datasheet_4902,11,D02
4904,UNC 1999,Enzymes,EZH2,Inhibitor,Potent and selective EZH2/EZH1 inhibitor,1,Datasheet_4904,11,D03
4905,UNC 2400,Enzymes,EZH2,Control,Negative control of UNC 1999 (Cat. No. 4904),1,Datasheet_4905,11,D04
4942,Pitavastatin calcium,Enzymes,HMG-CoA Reductase,Inhibitor,HMG-CoA reductase inhibitor,1,Datasheet_4942,11,D07
4946,AIM 100,Enzymes,Ack1,Inhibitor,Potent and selective Ack1 (TNK2) inhibitor,2,Datasheet_4946,11,D08
4962,SB 204990,Enzymes,ATP Citrate Lyase,Inhibitor,ATP citrate lyase (ACLY) inhibitor,2,Datasheet_4962,11,E02
4968,CCT 241533 dihydrochloride,Enzymes,Checkpoint Kinases,Inhibitor,Potent Chk2 inhibitor,1,Datasheet_4968,11,E04
4970,BMS 688521,Enzyme-Linked Receptors,Integrins,Inhibitor,Potent inhibitor of the LFA-1/ICAM interaction,1,Datasheet_4970,11,E05
4972,JIB 04,Enzymes,Histone Demethylases,Inhibitor,Pan Jumonji inhibitor; active in vivo,2,Datasheet_4972,11,E06
4977,RN 1 dihydrochloride,Enzymes,Histone Demethylases,Inhibitor,LSD1 inhibitor,2,Datasheet_4977,11,E07
4986,K 02288,Enzyme-Linked Receptors,BMP and Other Activin Receptors,Inhibitor,Type 1 BMP receptor inhibitor,1,Datasheet_4986,11,E10
4997,INDY,Enzymes,DYRK,Inhibitor,DYRK1A/B inhibitor,2,Datasheet_4997,11,E11
5009,BMS 509744,Enzymes,ITK,Inhibitor,Potent and selective ITK inhibitor,2,Datasheet_5009,11,F02
5012,PCI 29732,Enzymes,Brutons Tyrosine Kinase (BTK),Inhibitor,Potent BTK inhibitor,1,Datasheet_5012,11,F04
5013,AC 710,Enzyme-Linked Receptors,PDGFR,Inhibitor,Potent and selective PDGFR family inhibitor,1,Datasheet_5013,11,F05
5047,PRT 4165,Enzymes,Ubiquitin E3 Ligases,Inhibitor,Inhibitor of Bmi1/Ring1A; blocks histone H2A ubiquitination,1,Datasheet_5047,11,F09
5050,CASIN,Enzymes,Rho,Inhibitor,Cdc42 inhibitor,2,Datasheet_5050,11,F10
5051,BIO 5192,Enzyme-Linked Receptors,Integrins,Inhibitor,Highly potent and selective inhibitor of integrin α4β1 (VLA-4),1,Datasheet_5051,11,F11
5061,RKI 1447 dihydrochloride,Enzymes,Rho-kinases,Inhibitor,Potent and selective ROCK inhibitor; antitumor,1,Datasheet_5061,11,G03
5068,ITD 1,Enzyme-Linked Receptors,TGF-beta Receptors,Other,Selective inhibitor of TGF-β signaling; induces cardiomyocyte differentiation in ESCs,1,Datasheet_5068,11,G06
5069,Teriflunomide,Enzymes,Dihyroorotate Dehydrogenase,Inhibitor,Inhibitor of DHODH; active metabolite of Leflunomide,1,Datasheet_5069,11,G07
5071,NKY 80,Enzymes,Adenylyl Cyclase,Inhibitor,Adenylyl cyclase inhibitor,1,Datasheet_5071,11,G08
5077,DDR1-IN-1 dihydrochloride,Enzyme-Linked Receptors,Other RTKs,Inhibitor,Selective DDR1 inhibitor,1,Datasheet_5077,11,G10
5088,TC-S 7004,Enzymes,DYRK,Inhibitor,Potent and selective DYRK1A/B inhibitor,1,Datasheet_5088,11,H06
5089,TC-E 5002,Enzymes,Histone Demethylases,Inhibitor,Selective KDM2/7 inhibitor,1,Datasheet_5089,11,H07
5107,GSK 2606414,Enzymes,PERK,Inhibitor,Potent and selective PERK inhibitor; orally bioavailable,2,Datasheet_5107,11,H10
5111,GSK 1838705,Enzyme-Linked Receptors,Insulin and insulin-like Receptors,Inhibitor,Potent IR and IGF1R inhibitor; also inhibits anaplastic lymphoma kinase (ALK),1,Datasheet_5111,11,H11
5116,PACMA 31,Enzymes,Protein Disulfide Isomerase,Inhibitor,Irreversible protein disulfide isomerase (PDI) inhibitor,1,Datasheet_5116,12,A03
5132,UNC 0642,Enzymes,G9a/GLP,Inhibitor,Potent and selective G9a and GLP inhibitor,2,Datasheet_5132,12,A05
5133,GKA 50,Enzymes,Hexokinases,Activator,Glucokinase activator,1,Datasheet_5133,12,A06
5140,GSK 2830371,Enzymes,Protein Ser/Thr Phosphatases,Inhibitor,Potent and selective allosteric inhibitor of Wip1 phosphatase,1,Datasheet_5140,12,A07
5148,Wnt-C59,Enzymes,PORCN,Inhibitor,Highly potent PORCN inhibitor,3,Datasheet_5148,12,A08
5153,ML 240,Enzymes,p97 ATPase,Inhibitor,ATP-competitive inhibitor of p97 ATPase,1,Datasheet_5153,12,A10
5163,A 366,Enzymes,G9a/GLP,Inhibitor,Potent and selective G9a/GLP inhibitor,2,Datasheet_5163,12,B02
5164,CVT 10216,Enzymes,Aldehyde Dehydrogenase,Inhibitor,Potent and selective ALDH2 inhibitor,1,Datasheet_5164,12,B03
5166,Perhexiline maleate,Enzymes,Other Transferases,Inhibitor,Carnitine palmitoyltransferase 1 and 2 (CPT1/2) inhibitor,2,Datasheet_5166,12,B04
5189,GSK 2837808A,Enzymes,Lactate Dehydrogenase A,Inhibitor,"Potent, selective LDHA inhibitor",4,Datasheet_5189,12,B08
5190,FRAX 486,Enzymes,P21-activated Kinases,Inhibitor,Potent PAK inhibitor; brain penetrant and orally bioavailable,1,Datasheet_5190,12,B09
5197,Spautin 1,Enzymes,Deubiquitinating Enzymes,Inhibitor,USP10 and USP13 inhibitor; inhibits autophagy,1,Datasheet_5197,12,B10
5198,AZ 20,Enzymes,ATM & ATR Kinase,Inhibitor,Potent and selective ATR kinase inhibitor; antitumor,1,Datasheet_5198,12,B11
5199,AZD 7762 hydrochloride,Enzymes,Checkpoint Kinases,Inhibitor,Potent and selective ATP-competitive inhibitor of Chk1 and Chk2; also enhances CRISPR-Cpf1-mediated genome editing,1,Datasheet_5199,12,C02
5202,Furamidine dihydrochloride,Enzymes,Protein Arginine Methyltransferases,Inhibitor,Selective PRMT1 inhibitor,1,Datasheet_5202,12,C03
5206,JJKK 048,Enzymes,MAGL,Inhibitor,Potent and selective MAGL inhibitor,1,Datasheet_5206,12,C04
5232,AZ 191,Enzymes,DYRK,Inhibitor,Potent DYRK1B inhibitor,1,Datasheet_5232,12,C05
5240,TC-S 7006,Enzymes,Other Kinases,Inhibitor,Potent and selective Tpl2 (Cot; MAP3K8) inhibitor,1,Datasheet_5240,12,C06
5260,KG 5,Enzymes,Raf Kinase,Inhibitor,"PDGFRβ, B-Raf, c-Raf, FLT3 and KIT inhibitor",1,Datasheet_5260,12,C10
5269,T 5601640,Enzymes,LIMK,Inhibitor,Selective LIMK2 inhibitor; antitumor,1,Datasheet_5269,12,D04
5271,UNC 3230,Enzymes,Other Kinases,Inhibitor,Potent and selective PIP5K1C inhibitor; antinociceptive,1,Datasheet_5271,12,D06
5288,R 268712,Enzyme-Linked Receptors,TGF-beta Receptors,Inhibitor,Potent and selective inhibitor of TGF-βRI,1,Datasheet_5288,12,E02
5291,SIS3,Enzyme-Linked Receptors,TGF-beta Receptors,Other,Selective Smad3 inhibitor; inhibits TGF-βR1 signaling,2,Datasheet_5291,12,E03
5300,BI 605906,Enzymes,IkB Kinase,Inhibitor,Selective IKKβ inhibitor,1,Datasheet_5300,12,E07
5303,GSK 2194069,Enzymes,Fatty Acid Synthase,Inhibitor,Potent human fatty acid synthase (hFASN) inhibitor,1,Datasheet_5303,12,E08
5307,MM 102,Enzymes,WDR5,Other,Potent WDR5/MLL interaction inhibitor,3,Datasheet_5307,12,E09
5317,WWL 123,Enzymes,Other Hydrolases,Inhibitor,α/β-hydrolase domain 6 (ABHD6) inhibitor; antiepileptic,1,Datasheet_5317,12,F02
5323,WDR5 0103,Enzymes,WDR5,Other,WDR5 antagonist,1,Datasheet_5323,12,F05
5329,CKI 7 dihydrochloride,Enzymes,Casein Kinase 1,Inhibitor,CK1 inhibitor,1,Datasheet_5329,12,F10
5332,SP 141,Enzymes,Ubiquitin E3 Ligases,Inhibitor,High affinity MDM2 inhibitor,1,Datasheet_5332,12,G02
5344,ML 349,Enzymes,Other Hydrolases,Inhibitor,Selective and reversible lysophospholipase 2 (LYPLA2) inhibitor,1,Datasheet_5344,12,G05
5345,ML 348,Enzymes,Other Hydrolases,Inhibitor,Selective and reversible lysophospholipase 1 (LYPLA1) inhibitor,1,Datasheet_5345,12,G06
5356,SGX 523,Enzyme-Linked Receptors,MET Receptors,Inhibitor,Selective and potent c-MET kinase inhibitor,1,Datasheet_5356,12,G08
5361,GSK LSD 1 dihydrochloride,Enzymes,Histone Demethylases,Inhibitor,Potent and selective LSD1 inhibitor,2,Datasheet_5361,12,G11
5363,NHI 2,Enzymes,Lactate Dehydrogenase A,Inhibitor,LDHA inhibitor,1,Datasheet_5363,12,H03
5373,C34,Enzyme-Linked Receptors,Toll-like Receptors,Inhibitor,TLR4 inhibitor,2,Datasheet_5373,12,H04
5391,SPP 86,Enzyme-Linked Receptors,Other RTKs,Inhibitor,Potent RET inhibitor,1,Datasheet_5391,12,H08
5393,ERK5-IN-1,Enzymes,ERK,Inhibitor,Potent and selective ERK5 inhibitor,1,Datasheet_5393,12,H09
5408,Ispinesib,Enzymes,Kinesin,Inhibitor,High affinity and selective allosteric KSP inhibitor,1,Datasheet_5408,12,H11
5413,WH-4-023,Enzymes,Src Kinases,Inhibitor,Potent and selective Lck and Src inhibitor; also inhibits SIK,1,Datasheet_5413,13,A03
5414,CU-T12-9,Enzyme-Linked Receptors,Toll-like Receptors,Agonist,Potent TLR1/2 agonist,1,Datasheet_5414,13,A04
5424,Deltarasin,Enzymes,Ras GTPases,Other,High affinity PDEδ-KRas interaction inhibitor; binds to PDEδ,1,Datasheet_5424,13,A05
5430,AS 2444697,Enzymes,IRAK,Inhibitor,Potent and selective IRAK4 inhibitor,1,Datasheet_5430,13,A07
5433,Heclin,Enzymes,Ubiquitin E3 Ligases,Inhibitor,HECT E3 ubiquitin ligase inhibitor,1,Datasheet_5433,13,A08
5445,SM 324405,Enzyme-Linked Receptors,Toll-like Receptors,Agonist,Potent TLR7 agonist,1,Datasheet_5445,13,A11
5495,CW 008,Enzymes,Protein Kinase A,Activator,PKA signaling activator; promotes osteogenesis from hMSCs,1,Datasheet_5495,13,B05
5517,AMG PERK 44,Enzymes,PERK,Inhibitor,Potent and selective PERK inhibitor; orally bioavailable,1,Datasheet_5517,13,B08
5550,E 2012,Enzymes,Gamma-Secretase,Modulator,γ-secretase modulator; Notch-sparing,1,Datasheet_5550,13,B11
5553,Sephin 1,Enzymes,Protein Ser/Thr Phosphatases,Inhibitor,Inhibitor of the regulatory subunit PPP1R15A of protein phosphatase 1,1,Datasheet_5553,13,C02
5565,Tiplaxtinin,Enzymes,Plasminogen Activator Inhibitor 1,Inhibitor,Plasminogen activator inhibitor-1 (PAI-1) inhibitor,2,Datasheet_5565,13,C03
5567,EPZ 004777,Enzymes,Other Lysine Methyltransferases,Inhibitor,Highly potent DOT1L inhibitor,1,Datasheet_5567,13,C04
5577,S4,Enzymes,Carbonic anhydrases,Inhibitor,High affinity and selective CA IX and CA XII inhibitor,1,Datasheet_5577,13,C05
5585,Balicatib,Enzymes,Cathepsin,Inhibitor,Potent and selective cathepsin K inhibitor,1,Datasheet_5585,13,C07
5592,LCB 03-0110 dihydrochloride,Enzymes,Src Kinases,Inhibitor,"Potent c-SRC kinase inhibitor; also inhibits DDR2, BTK and Syk",1,Datasheet_5592,13,C11
5615,AZD 3147,Enzymes,mTOR,Inhibitor,Potent and selective dual mTORC1 and 2 inhibitor; orally bioavailable,1,Datasheet_5615,13,D06
5617,AZD 1480,Enzymes,JAK Kinase,Inhibitor,Potent and selective JAK2 inhibitor; antiangiogenic,1,Datasheet_5617,13,D07
5622,HTH 01-015,Enzymes,NUAK,Inhibitor,Potent and selective NUAK1 inhibitor,1,Datasheet_5622,13,D09
5626,SR 7826,Enzymes,LIMK,Inhibitor,Potent and selective LIMK inhibitor; antitumor,1,Datasheet_5626,13,D11
5632,AZ Dyrk1B 33,Enzymes,DYRK,Inhibitor,Potent and selective Dyrk1B kinase inhibitor,1,Datasheet_5632,13,E02
5641,MSC 2032964A,Enzymes,ASK1,Inhibitor,Potent and selective ASK1 inhibitor; orally bioavailable,2,Datasheet_5641,13,E03
5642,CMPD101,Enzymes,Heterotrimeric G-protein GTPases,Inhibitor,Potent and selective GRK2/3 inhibitor,1,Datasheet_5642,13,E04
5651,ONO 6818,Enzymes,Elastase,Inhibitor,High affinity and selective human neutrophil elastase 1 (HNE1) inhibitor; orally active,1,Datasheet_5651,13,E05
5654,BMS 265246,Enzymes,Cyclin-dependent Kinase,Inhibitor,Cdk inhibitor; potently inhibits cdk1 and cdk2,1,Datasheet_5654,13,E07
5672,GSK 319347A,Enzymes,IkB Kinase,Inhibitor,Potent and selective IKKε inhibitor,1,Datasheet_5672,13,F02
5675,AZ PFKFB3 26,Enzymes,PFKFB3,Inhibitor,Potent and selective PFKFB3 inhibitor,1,Datasheet_5675,13,F03
5679,N-Acetylpuromycin,Enzyme-Linked Receptors,TGF-beta Receptors,Other,Downregulates SnoN and Ski protein expression; promotes TGF-β signaling,2,Datasheet_5679,13,F05
5681,N106,Enzymes,Other Ligases,Activator,"Activator of SUMO-activating enzyme, E1 ligase",1,Datasheet_5681,13,F06
5682,OSU 03012,Enzymes,Phosphoinositide-dependent Kinase 1,Inhibitor,PDPK1 (PDK1) inhibitor; inhibits Akt signaling,1,Datasheet_5682,13,F07
5705,M62812,Enzyme-Linked Receptors,Toll-like Receptors,Inhibitor,TLR-4 inhibitor,1,Datasheet_5705,13,G02
5713,MS 023 dihydrochloride,Enzymes,Protein Arginine Methyltransferases,Inhibitor,Potent and selective type I PRMT inhibitor,1,Datasheet_5713,13,G04
5742,AZ PFKFB3 67,Enzymes,PFKFB3,Inhibitor,Potent and selective PFKFB3 inhibitor,1,Datasheet_5742,13,G10
5752,PF 06260933 dihydrochloride,Enzymes,Other MAPK,Inhibitor,MAP4K4 (HGK) inhibitor; also inhibits MINK and TNIK,1,Datasheet_5752,13,H02
5754,PF 543 hydrochloride,Enzymes,Sphingosine Kinase,Inhibitor,Potent and selective SphK1 inhibitor,1,Datasheet_5754,13,H03
5756,MLi-2,Enzymes,LRRK2,Inhibitor,Potent and selective LRRK2 inhibitor,1,Datasheet_5756,13,H04
5759,SW 033291,Enzymes,Other Dehydrogenases,Inhibitor,High affinity 15-PGDH inhibitor; promotes hematopoiesis and hepatocyte proliferation,1,Datasheet_5759,13,H06
5769,TM 5275 sodium salt,Enzymes,Plasminogen Activator Inhibitor 1,Inhibitor,Plasminogen activator inhibitor-1 (PAI-1) inhibitor; orally bioavailable,1,Datasheet_5769,13,H07
5772,Sacubitril calcium,Enzymes,Other Proteases,Inhibitor,Membrane metallo-endopeptidase (neprilysin) inhibitor prodrug; orally bioavailable,1,Datasheet_5772,13,H08
5775,AZ 6102,Enzymes,Tankyrase,Inhibitor,Potent TNKS1/2 inhibitor,1,Datasheet_5775,13,H09
5777,GSK 591 dihydrochloride,Enzymes,Protein Arginine Methyltransferases,Inhibitor,Potent and selective PRMT5 inhibitor,1,Datasheet_5777,13,H10
5791,Bz 423,Enzymes,Other Synthases/Synthetases,Inhibitor,ATP synthase inhibitor; proapoptotic,1,Datasheet_5791,14,A02
5802,A37,Enzymes,Aldehyde Dehydrogenase,Inhibitor,ALDH1A1 inhibitor,1,Datasheet_5802,14,A03
5832,TGX 221,Enzymes,PI 3-Kinase,Inhibitor,Potent and selective PI 3-kinase β inhibitor,1,Datasheet_5832,14,A08
5843,AX 15836,Enzymes,ERK,Inhibitor,Potent and selective ERK5 inhibitor,1,Datasheet_5843,14,A10
5844,JZP 430,Enzymes,Other Hydrolases,Inhibitor,Potent and irreversible α/β-hydrolase domain 6 (ABHD6) inhibitor,1,Datasheet_5844,14,A11
5866,PH 797804,Enzymes,p38,Inhibitor,Potent and selective p38α/β inhibitor,1,Datasheet_5866,14,B04
5869,CDN 1163,Enzymes,Ca2+-ATPase,Activator,SERCA2 allosteric activator,2,Datasheet_5869,14,B06
5871,pCPA methyl ester hydrochloride,Enzymes,Hydroxylases,Inhibitor,Tryptophan hydroxylase inhibitor,1,Datasheet_5871,14,B07
5906,Imatinib mesylate,Enzymes,Abl Kinase,Inhibitor,Potent and selective v-Abl tyrosine kinase inhibitor; also inhibits PDGFR and c-kit,2,Datasheet_5906,14,B11
5915,PF 04449613,Enzymes,Phosphodiesterases,Inhibitor,Potent PDE9 inhibitor; brain penetrant,2,Datasheet_5915,14,C04
5922,CRT 0066854 hydrochloride,Enzymes,Protein Kinase C,Inhibitor,PKCι and PKCζ inhibitor,1,Datasheet_5922,14,C06
5934,NCT 501 hydrochloride,Enzymes,Aldehyde Dehydrogenase,Inhibitor,Potent and selective ALDH1A1 inhibitor,1,Datasheet_5934,14,C08
5952,PDD 00017273,Enzymes,Other Hydrolases,Inhibitor,Potent and selective poly (ADP ribose) glycohydrolase (PARG) inhibitor; cell permeable,2,Datasheet_5952,14,D02
5960,TMI 1,Enzymes,ADAMs,Inhibitor,Adam 17 (TACE) and MMP inhibitor; orally bioavailable,1,Datasheet_5960,14,D03
5986,NAV 2729,Enzymes,Arf,Inhibitor,Selective ARF6 inhibitor,2,Datasheet_5986,14,D07
5989,BIRB 796,Enzymes,p38,Inhibitor,High affinity and selective p38 kinase inhibitor,1,Datasheet_5989,14,D08
6005,PF 3758309 dihydrochloride,Enzymes,P21-activated Kinases,Inhibitor,Potent PAK4 inhibitor; orally available,2,Datasheet_6005,14,E02
6007,INCB 024360-analog,Enzymes,"Indoleamine 2,3 dioxygenase",Inhibitor,"Potent indoleamine 2,3-dioxygenase (IDO) inhibitor",1,Datasheet_6007,14,E03
6008,TP 064,Enzymes,Protein Arginine Methyltransferases,Inhibitor,Potent and selective PRMT 4 inhibitor,1,Datasheet_6008,14,E04
6009,B I09,Enzymes,IRE1,Inhibitor,IRE1 endonuclease inhibitor; cell permeable,1,Datasheet_6009,14,E05
6024,PF 04671536 hydrochloride,Enzymes,Phosphodiesterases,Inhibitor,Potent and selective PDE8B/8A inhibitor,1,Datasheet_6024,14,E06
6025,(S)-Crizotinib,Enzymes,MutT homolog-1 (MTH1),Inhibitor,MTH1 inhibitor,1,Datasheet_6025,14,E07
6029,FRAX 597,Enzymes,P21-activated Kinases,Inhibitor,Potent group I PAK inhibitor,1,Datasheet_6029,14,E08
6037,LM22B 10,Enzyme-Linked Receptors,Trk Receptors,Agonist,TrkB and TrkC agonist; brain penetrant,2,Datasheet_6037,14,E09
6047,BOP,Enzyme-Linked Receptors,Integrins,Inhibitor,Dual α9β1/α4β1 integrin inhibitor; preferentially mobilizes HSCs,1,Datasheet_6047,14,E10
6053,LDN 193189 dihydrochloride,Enzyme-Linked Receptors,BMP and Other Activin Receptors,Inhibitor,Potent and selective ALK2 and ALK3 inhibitor; promotes neural induction of hPSCs,4,Datasheet_6053,14,E11
6071,CZC 25146,Enzymes,LRRK2,Inhibitor,Potent LRRK2 inhibitor,1,Datasheet_6071,14,F03
6075,Nutlin 3a,Enzymes,Ubiquitin E3 Ligases,Inhibitor,MDM2 antagonist; active enantiomer of Nutlin-3 (Cat. No. 3984),1,Datasheet_6075,14,F04
6089,Nexinhib20,Enzymes,Other Small Monomeric GTPases,Inhibitor,Rab27 inhibitor; inhibits neutrophil exocytosis; active in vivo,1,Datasheet_6089,14,F07
6098,Lalistat 1,Enzymes,Lysosomal Acid Lipase (LAL),Inhibitor,Potent and selective LAL inhibitor,1,Datasheet_6098,14,F08
6099,Lalistat 2,Enzymes,Lysosomal Acid Lipase (LAL),Inhibitor,Selective LAL inhibitor,1,Datasheet_6099,14,F09
6106,T 3364366,Enzymes,Other Oxygenases/Oxidases,Inhibitor,Potent and reversible fatty acid desaturase 1 inhibitor; orally bioavailable,1,Datasheet_6106,14,F10
6114,PF 06409577,Enzymes,AMPK,Activator,Potent and selective allosteric activator of AMPK,1,Datasheet_6114,14,G02
6115,PF 06273340,Enzyme-Linked Receptors,Trk Receptors,Inhibitor,Potent and selective pan-Trk inhibitor; peripherally restricted,1,Datasheet_6115,14,G03
6119,OB 24 hydrochloride,Enzymes,Heme Oxygenase,Inhibitor,Potent and selective heme oxygenase 1 (HO-1) inhibitor,1,Datasheet_6119,14,G05
6125,TC JL 37,Enzymes,JAK Kinase,Inhibitor,Potent TYK2 inhibitor,1,Datasheet_6125,14,G06
6156,VH 298,Enzymes,Ubiquitin E3 Ligases,Inhibitor,High-affinity inhibitor of VHL,1,Datasheet_6156,14,G10
6157,cis VH 298,Enzymes,Ubiquitin E3 Ligases,Control,Negative control for VH 298,1,Datasheet_6157,14,G11
6174,CVT 313,Enzymes,Cyclin-dependent Kinase,Inhibitor,Cdk2 and cdk5 inhibitor,1,Datasheet_6174,14,H07
6180,NMS 873,Enzymes,p97 ATPase,Inhibitor,Potent and selective p97 ATPase (VCP) allosteric inhibitor,1,Datasheet_6180,14,H09
6194,TM 5441,Enzymes,Plasminogen Activator Inhibitor 1,Inhibitor,Plasminogen activator inhibitor-1 (PAI-1) inhibitor,1,Datasheet_6194,15,A02
6196,Brequinar sodium,Enzymes,Dihyroorotate Dehydrogenase,Inhibitor,Potent and selective DHODH inhibitor,3,Datasheet_6196,15,A04
6208,MS 275,Enzymes,Class I HDACs,Inhibitor,HDAC (Class I) inhibitor,1,Datasheet_6208,15,A09
6230,Rucaparib camsylate,Enzymes,Poly(ADP-ribose) Polymerase,Inhibitor,PARP inhibitor,1,Datasheet_6230,15,B02
6231,Dacomitinib,Enzyme-Linked Receptors,EGFR,Inhibitor,Potent irreversible pan ErbB inhibitor,1,Datasheet_6231,15,B03
6236,O8 OGG1 Inhibitor,Enzymes,Glycosylases,Inhibitor,Potent and selective 8-oxoguanine DNA glycosylase 1 (OGG1) inhibitor,1,Datasheet_6236,15,B05
6245,SM 16,Enzyme-Linked Receptors,TGF-beta Receptors,Inhibitor,Potent TGF-βRI inhibitor; orally bioavailable,1,Datasheet_6245,15,B09
6248,EHop 016,Enzymes,Rho,Inhibitor,Rac inhibitor,1,Datasheet_6248,15,B10
6249,Givinostat hydrochloride,Enzymes,Non-selective HDACs,Inhibitor,Histone deacetylase inhibitor,1,Datasheet_6249,15,B11
6258,CC 401 dihydrochloride,Enzymes,JNK/c-jun,Inhibitor,High affinity JNK inhibitor; also inhibits HCMV replication,1,Datasheet_6258,15,C03
6273,CRT 0105950,Enzymes,LIMK,Inhibitor,Potent LIMK1/2 inhibitor,1,Datasheet_6273,15,C04
6281,SLM 6031434 hydrochloride,Enzymes,Sphingosine Kinase,Inhibitor,Selective sphingosine kinase 2 (Sphk2) inhibitor,1,Datasheet_6281,15,C08
6284,BRD 73954,Enzymes,Class II HDACs,Inhibitor,Dual histone deacetylase (HDAC) 6/8 inhibitor,1,Datasheet_6284,15,C09
6289,JH-II-127,Enzymes,LRRK2,Inhibitor,Potent and selective LRRK2 inhibitor,1,Datasheet_6289,15,C11
6305,Lenalidomide,Enzymes,Ubiquitin E3 Ligases,Other,Cereblon binder; induces ubiquitination and degradation of CK1α by E3 ubiquitin ligase,2,Datasheet_6305,15,D04
6311,Tadalafil,Enzymes,Phosphodiesterases,Inhibitor,Potent and highly selective PDE5 inhibitor; orally bioavailable,1,Datasheet_6311,15,D05
6319,CBM 301940,Enzymes,Decarboxylases,Inhibitor,Potent malonyl-CoA decarboxylase inhibitor; orally bioavailable,1,Datasheet_6319,15,D06
6320,ESI 05,Enzymes,EPAC,Inhibitor,Epac2 inhibitor,1,Datasheet_6320,15,D07
6324,Autophinib,Enzymes,PI 3-Kinase,Inhibitor,Potent VPS34 inhibitor,1,Datasheet_6324,15,D08
6330,AZ 5704,Enzymes,ATM & ATR Kinase,Inhibitor,Potent and selective ATM kinase inhibitor; orally bioavailable,1,Datasheet_6330,15,D09
6340,Epiblastin A,Enzymes,Casein Kinase 1,Inhibitor,CK1 inhibitor; converts epiblast stem cells to ESCs and promotes ESC self-renewal,1,Datasheet_6340,15,D11
6343,Rosuvastatin calcium,Enzymes,HMG-CoA Reductase,Inhibitor,Potent HMG-CoA reductase inhibitor,1,Datasheet_6343,15,E03
6344,OUL 35,Enzymes,Poly(ADP-ribose) Polymerase,Inhibitor,Selective PARP-10 inhibitor,1,Datasheet_6344,15,E04
6346,PF 5006739,Enzymes,Casein Kinase 1,Inhibitor,Potent CK1δ/ε inhibitor,2,Datasheet_6346,15,E05
6349,Pelitinib,Enzyme-Linked Receptors,EGFR,Inhibitor,Potent and irreversible EGFR inhibitor; orally bioavailable,1,Datasheet_6349,15,E07
6363,Avagacestat,Enzymes,Gamma-Secretase,Inhibitor,Highly potent γ-secretase inhibitor; orally bioavailable,1,Datasheet_6363,15,E11
6364,Squarunkin A hydrochloride,Enzymes,Src Kinases,Other,UNC119 chaperone-cargo interaction inhibitor; disrupts Src activation,1,Datasheet_6364,15,F02
6374,PF 04457845,Enzymes,Fatty Acid Amide Hydrolase (FAAH),Inhibitor,Potent and selective irreversible FAAH inhibitor,1,Datasheet_6374,15,F05
6384,Ciclopirox,Enzymes,Histone Demethylases,Inhibitor,Pan-histone demethylase inhibitor,1,Datasheet_6384,15,F07
6387,A 485,Enzymes,Histone Acetyltransferases,Inhibitor,Potent and selective p300/CBP inhibitor; orally bioavailable,1,Datasheet_6387,15,F08
6405,PF 05180999,Enzymes,Phosphodiesterases,Inhibitor,Potent and selective PDE2A inhibitor,1,Datasheet_6405,15,F09
6407,Fendiline Hydrochloride,Enzymes,Ras GTPases,Inhibitor,Inhibits KRas localization to the plasma membrane; also L-type calcium channel blocker,1,Datasheet_6407,15,F10
6429,ML 210,Enzymes,Ras GTPases,Inhibitor,Selectively kills mutant HRAS-expressing cells; glutathione peroxidase inhibitor; induces ferroptosis,1,Datasheet_6429,15,G02
6435,ML 323,Enzymes,Deubiquitinating Enzymes,Inhibitor,Potent and selective USP1-UAF1 allosteric inhibitor,1,Datasheet_6435,15,G04
6438,BRD 6989,Enzymes,Cyclin-dependent Kinase,Inhibitor,Cdk8 inhibitor; enhances IL-10 production,1,Datasheet_6438,15,G05
6439,JNJ 0966,Enzymes,Matrix Metalloprotease,Inhibitor,Pro-MMP9 activation inhibitor,1,Datasheet_6439,15,G06
6448,ML 351,Enzymes,Lipoxygenase,Inhibitor,Selective 12/15 LOX inhibitor; active in vivo,1,Datasheet_6448,15,G07
6454,LY 2603618,Enzymes,Checkpoint Kinases,Inhibitor,Potent and selective Chk1 inhibitor,1,Datasheet_6454,15,G08
6479,CU CPT 9a,Enzyme-Linked Receptors,Toll-like Receptors,Inhibitor,Highly potent TLR8 inhibitor,1,Datasheet_6479,15,G10
6482,XMU MP 1,Enzymes,Other Kinases,Inhibitor,Potent and selective MST1/2 inhibitor; orally bioavailable,1,Datasheet_6482,15,G11
6492,GSK'872,Enzymes,RIP Kinases,Inhibitor,Potent and selective RIP3 kinase inhibitor,1,Datasheet_6492,15,H04
6505,Avasimibe,Enzymes,Acyl-CoA:Cholesterol Acyltransferase,Inhibitor,ACAT inhibitor,1,Datasheet_6505,15,H05
6506,PF 06551600 malonate,Enzymes,JAK Kinase,Inhibitor,Potent and selective JAK3 inhibitor,1,Datasheet_6506,15,H06
6507,Saxagliptin hydrochloride,Enzymes,Dipeptidyl Peptidase IV (DPP-IV),Inhibitor,High affinity DPP-IV inhibitor; active in vivo,1,Datasheet_6507,15,H07
6516,EPZ 015666,Enzymes,Protein Arginine Methyltransferases,Inhibitor,Potent and selective PRMT5 inhibitor,1,Datasheet_6516,15,H09
6520,Abiraterone acetate,Enzymes,Cytochrome P450,Inhibitor,Potent CYP17A1 inhibitor,1,Datasheet_6520,15,H11
6528,SGC AAK1 1,Enzymes,Other Kinases,Inhibitor,AAK1 and BMP2K inhibitor; activates Wnt signaling,1,Datasheet_6528,16,A02
6534,TH 5427 hydrochloride,Enzymes,Other Hydrolases,Inhibitor,Potent NUDT5 inhibitor,1,Datasheet_6534,16,A03
6537,UNC 2881,Enzyme-Linked Receptors,Other RTKs,Inhibitor,Potent Mer kinase inhibitor,1,Datasheet_6537,16,A04
6558,CP 43,Enzymes,Other Kinases,Inhibitor,Potent TAOK inhibitor,1,Datasheet_6558,16,A11
6559,LY 450139,Enzymes,Gamma-Secretase,Inhibitor,γ-secretase pseudo-inhibitor,1,Datasheet_6559,16,B02
6564,SGC GAK 1,Enzymes,Other Kinases,Inhibitor,High affinity cyclin G associated kinase (GAK) inhibitor,1,Datasheet_6564,16,B03
6577,Pyridone 6,Enzymes,JAK Kinase,Inhibitor,Potent pan-JAK inhibitor; induces intermediate mesoderm; cell-permeable,1,Datasheet_6577,16,B06
6579,BAY 826,Enzyme-Linked Receptors,Other RTKs,Inhibitor,Potent Tie2 inhibitor,1,Datasheet_6579,16,B08
6597,SPRi 3,Enzymes,Other Reductase,Inhibitor,Potent sepiapterin reductase (SPR) inhibitor; attenuates proliferation of CD4+ T cells,1,Datasheet_6597,16,B10
6598,OD 36 hydrochloride,Enzymes,RIP Kinases,Inhibitor,Potent RIP2 kinase inhibitor,1,Datasheet_6598,16,B11
6618,MB 05032,Enzymes,Other Transferases,Inhibitor,Potent FBPase inhibitor; promotes HSC expansion,1,Datasheet_6618,16,C03
6626,AP C5,Enzymes,Protein Kinase G,Inhibitor,Potent and selective PKG2 inhibitor,1,Datasheet_6626,16,C04
6641,Roflumilast,Enzymes,Phosphodiesterases,Inhibitor,Potent and selective PDE4 inhibitor,1,Datasheet_6641,16,C05
6652,NGI 1,Enzymes,Other Transferases,Inhibitor,Oligosaccharyltransferase (OST) inhibitor; anti-flaviviral,1,Datasheet_6652,16,C06
6654,VAS 2870,Enzymes,NADPH Oxidase,Inhibitor,NADPH oxidase (Nox) inhibitor,1,Datasheet_6654,16,C08
6692,WM 1119,Enzymes,Histone Acetyltransferases,Inhibitor,High affinity KAT6A (MOZ) competitive inhibitor,1,Datasheet_6692,16,D06
6701,1A-116,Enzymes,Rho,Inhibitor,Rac1 inhibitor; blocks Rac1-P-Rex1 interaction,1,Datasheet_6701,16,D07
6710,Darunavir,Enzymes,Other Proteases,Inhibitor,Highly potent HIV protease inhibitor,1,Datasheet_6710,16,D09
6712,A 77-01,Enzyme-Linked Receptors,TGF-beta Receptors,Inhibitor,Potent inhibitor of TGF-βRI,1,Datasheet_6712,16,D10
6728,RGFP 966,Enzymes,Class I HDACs,Inhibitor,Potent and selective HDAC3 inhibitor,1,Datasheet_6728,16,E02
6742,Acetazolamide,Enzymes,Carbonic anhydrases,Inhibitor,Carbonic anhydrase inhibitor,1,Datasheet_6742,16,E03
6753,CHS 828,Enzymes,NAMPT,Inhibitor,NAMPT inhibitor; active in vivo and cytotoxic,1,Datasheet_6753,16,E04
6754,LJI308,Enzymes,RSK,Inhibitor,Potent pan-RSK inhibitor,1,Datasheet_6754,16,E05
6755,Darapladib,Enzymes,Phospholipases,Inhibitor,Potent lp-PLA2 inhibitor,1,Datasheet_6755,16,E06
6760,Raphin 1,Enzymes,Protein Ser/Thr Phosphatases,Inhibitor,Inhibitor of the regulatory subunit PPP1R15B of protein phosphatase 1; orally bioavailable and brain penetrant,1,Datasheet_6760,16,E08
6765,JTP 103237,Enzymes,Other Transferases,Inhibitor,Potent and selective monoacyglycerol acyltransferase 2 (MOGAT2) inhibitor,1,Datasheet_6765,16,E10
6788,Quizartinib,Enzyme-Linked Receptors,FLT3,Inhibitor,Highly potent FLT3 inhibitor,1,Datasheet_6788,16,F07
6793,Dasatinib,Enzymes,Src Kinases,Inhibitor,Highly potent pan-Src/Bcr-Abl inhibitor,1,Datasheet_6793,16,F08
6803,MRK 740,Enzymes,Other Lysine Methyltransferases,Inhibitor,Potent PRDM9 inhibitor,1,Datasheet_6803,16,F09
6812,Afatinib dimaleate,Enzyme-Linked Receptors,EGFR,Inhibitor,Potent dual specificity EGFR/HER2 inhibitor; active in vivo,1,Datasheet_6812,16,F10
6816,Sitagliptin phosphate,Enzymes,Dipeptidyl Peptidase IV (DPP-IV),Inhibitor,Potent and selective DPP IV inhibitor,1,Datasheet_6816,16,F11
6821,ZAP 180013,Enzyme-Linked Receptors,Other RTKs,Inhibitor,Zap70 inhibitor; inhibits interaction with ITAMs,1,Datasheet_6821,16,G03
6857,BAY 293,Enzymes,Ras GTPases,Inhibitor,Potent KRas/SOS1 interaction inhibitor,1,Datasheet_6857,16,G05
6899,TH 257,Enzymes,LIMK,Inhibitor,Potent and selective allosteric LIMK 1/2 inhibitor,1,Datasheet_6899,16,H04
6904,Idasanutlin,Enzymes,Ubiquitin E3 Ligases,Inhibitor,Potent MDM2 inhibitor; inhibits MDM2-p53 interaction,1,Datasheet_6904,16,H05
6908,TR 14035,Enzyme-Linked Receptors,Integrins,Antagonist,Potent integrin α4β7 and α4β1 (VLA-4) antagonist; orally bioavailable,1,Datasheet_6908,16,H06
6978,AZD 5363,Enzymes,Akt (Protein Kinase B),Inhibitor,Potent pan-AKT inhibitor,1,Datasheet_6978,16,H09
7064,Ruxolitinib,Enzymes,JAK,Inhibitor,Potent and selective JAK1/JAK2 inhibitor; orally bioavailable,1,Datasheet_7064,1,E02
7158,FMF-04-159-2,Enzymes,Cyclin-dependent Kinase,Inhibitor,Potent covalent CDK14 and CDK16 inhibitor; also inhibits other TAIRE kinase family members,1,Datasheet_7158,2,C10
7226,Remdesivir,Enzymes,RNA Polymerase,Inhibitor,Viral RNA-dependent RNA polymerase (RdRP) inhibitor; broad spectrum antiviral nucelotide prodrug,1,Datasheet_7226,7,C05
7280,GRL 0617,Enzymes,Papain-like Proteases,Inhibitor,Coronavirus PLpro inhibitor,1,Datasheet_7280,14,G08
0189,DNQX,Ion Channels,AMPA Receptors,Antagonist,Selective non-NMDA iGluR antagonist,14,Datasheet_0189,1,A02
0190,CNQX,Ion Channels,AMPA Receptors,Antagonist,Potent and selective non-NMDA iGluR antagonist,34,Datasheet_0190,1,A03
0223,Kynurenic acid,Ion Channels,Non-selective Ionotropic Glutamate,Antagonist,Broad spectrum glutamatergic antagonist,58,Datasheet_0223,1,A04
0286,"5,7-Dichlorokynurenic acid",Ion Channels,NMDA Receptors,Antagonist,Potent NMDA antagonist; acts at glycine site,6,Datasheet_0286,1,A06
0373,NBQX,Ion Channels,AMPA Receptors,Antagonist,Potent AMPA antagonist; more selective than CNQX (Cat. No. 0190),16,Datasheet_0373,1,A09
0456,Chlormezanone,Ion Channels,GABAA Receptors,Benzodiazepine,Positive allosteric modulator of benzodiazepine site,4,Datasheet_0456,1,B03
0554,FG 7142,Ion Channels,GABAA Receptors,Benzodiazepine,Benzodiazepine inverse agonist,12,Datasheet_0554,1,B08
0593,NPPB,Ion Channels,Ca2+-Activated Chloride Channels,Blocker,Inhibits calcium-sensitive chloride currents,4,Datasheet_0593,1,B10
0640,MDL 72222,Ion Channels,5-HT3 Receptors,Antagonist,5-HT3 antagonist,3,Datasheet_0640,1,C02
0685,Diltiazem hydrochloride,Ion Channels,Cav1.x Channels,Blocker,CaV1.x blocker,4,Datasheet_0685,1,C07
0713,Cyclothiazide,Ion Channels,AMPA Receptors,Modulator,Positive allosteric modulator of AMPA receptors; inhibits AMPA desensitization,8,Datasheet_0713,1,C11
0742,"L-689,560",Ion Channels,NMDA Receptors,Antagonist,Highly potent NMDA antagonist,5,Datasheet_0742,1,D03
0807,THIP hydrochloride,Ion Channels,GABAA Receptors,Agonist,GABAA agonist,20,Datasheet_0807,1,D08
0911,Glibenclamide,Ion Channels,Inward rectifier Potassium Channels,Blocker,Kir6 (KATP) channel blocker,4,Datasheet_0911,1,E05
0924,(+)-MK 801 maleate,Ion Channels,NMDA Receptors,Antagonist,Non-competitive NMDA antagonist; acts at ion channel site,12,Datasheet_0924,1,E07
0955,(-)-MK 801 maleate,Ion Channels,NMDA Receptors,Antagonist,NMDA antagonist; less active enantiomer of (+)-MK 801,2,Datasheet_0955,1,F03
1000,ZD 7288,Ion Channels,HCN Channels,Blocker,Inhibits pacemaker (If) current,6,Datasheet_1000,1,F09
1041,1-EBIO,Ion Channels,Ca2+-Activated Potassium Channels,Activator,Activator of epithelial KCa channels,7,Datasheet_1041,1,G05
1262,SR 95531 hydrobromide,Ion Channels,GABAA Receptors,Antagonist,Competitive and selective GABAA antagonist,14,Datasheet_1262,2,B03
1327,"L-655,708",Ion Channels,GABAA Receptors,Benzodiazepine,Benzodiazepine inverse agonist; selective for α5-containing GABAA receptors,6,Datasheet_1327,2,B10
1328,Flumazenil,Ion Channels,GABAA Receptors,Benzodiazepine,Benzodiazepine antagonist,4,Datasheet_1328,2,B11
1412,Chromanol 293B,Ion Channels,Voltage-Gated Potassium Channels,Blocker,IKs blocker. Also blocks ICFTR,1,Datasheet_1412,2,C11
1422,DCEBIO,Ion Channels,CFTR,Activator,Activates Cl- conductance and hKCa3.1 channels,3,Datasheet_1422,2,D03
1454,GYKI 52466 dihydrochloride,Ion Channels,AMPA Receptors,Antagonist,Selective non-competitive AMPA antagonist,7,Datasheet_1454,2,D11
1470,Flecainide acetate,Ion Channels,Voltage-gated Sodium Channels,Blocker,Cardiac Na+ channel blocker. Antiarrhythmic,2,Datasheet_1470,2,E02
1475,"(-)-[3R,4S]-Chromanol 293B",Ion Channels,Voltage-Gated Potassium Channels,Blocker,IKs blocker. Enantiomer of Chromanol 293B (Cat. No. 1412),2,Datasheet_1475,2,E03
1545,(R)-(+)-Bay K 8644,Ion Channels,Cav1.x Channels,Blocker,CaV1.x blocker; (R)-(+)-enantiomer of (±)-Bay K 8644; also TMEM176B inhibitor,3,Datasheet_1545,2,E10
1546,(S)-(-)-Bay K 8644,Ion Channels,Cav1.x Channels,Activator,CaV1.x activator; (S)-(-)-enantiomer of (±)-Bay K 8644,7,Datasheet_1546,2,E11
1594,Ro 25-6981 maleate,Ion Channels,NMDA Receptors,Antagonist,GluN2B-selective NMDA antagonist,7,Datasheet_1594,2,F10
1615,SB 366791,Ion Channels,TRPV,Antagonist,"Potent, selective, competitive TRPV1 antagonist",1,Datasheet_1615,2,G03
1636,IEM 1460,Ion Channels,AMPA Receptors,Blocker,Open-channel blocker of AMPA currents; selective for non-GluA2-containing receptors,3,Datasheet_1636,2,G05
1795,Zacopride hydrochloride,Ion Channels,5-HT3 Receptors,Antagonist,Highly potent 5-HT3 antagonist; also 5-HT4 agonist,4,Datasheet_1795,3,A06
1808,E-4031 dihydrochloride,Ion Channels,Voltage-Gated Potassium Channels,Blocker,KV11.1 (hERG) channel blocker; inhibits rapid delayed rectifier K+ current (IKr),4,Datasheet_1808,3,A08
1999,Linopirdine dihydrochloride,Ion Channels,Voltage-Gated Potassium Channels,Blocker,KV7 (KCNQ) channel blocker,2,Datasheet_1999,3,C08
2005,Ro 04-5595 hydrochloride,Ion Channels,NMDA Receptors,Antagonist,GluN2B-selective NMDA antagonist,1,Datasheet_2005,3,C10
2079,UBP 302,Ion Channels,Kainate Receptors,Antagonist,Potent and selective kainate antagonist; active enantiomer of UBP 296 (Cat. No. 2078),5,Datasheet_2079,3,D09
2095,PNU 37883 hydrochloride,Ion Channels,Inward rectifier Potassium Channels,Blocker,Vascular Kir6 (KATP) channel blocker,1,Datasheet_2095,3,D11
2195,Eliprodil,Ion Channels,NMDA Receptors,Antagonist,Non-competitive and GluN2B-selective NMDA antagonist,1,Datasheet_2195,3,E11
2198,Mibefradil dihydrochloride,Ion Channels,Cav3.x Channels,Blocker,CaV3.x blocker,4,Datasheet_2198,3,F03
2303,PNU 282987,Ion Channels,Nicotinic (a7) Receptors,Agonist,Selective α7 nAChR agonist,5,Datasheet_2303,3,G09
2316,AMG 9810,Ion Channels,TRPV,Antagonist,"Potent and selective, competitive antagonist of TRPV1",2,Datasheet_2316,3,H03
2345,ZK 200775,Ion Channels,AMPA Receptors,Antagonist,Competitive non-NMDA iGluR antagonist,1,Datasheet_2345,3,H10
2348,Gavestinel,Ion Channels,NMDA Receptors,Antagonist,Potent and selective NMDA antagonist; acts at the glycine site,1,Datasheet_2348,4,A02
2349,Dihydro-beta-erythroidine hydrobromide,Ion Channels,Nicotinic Receptors (Other Subtypes),Antagonist,"α4β2, muscle type and Torpedo nAChR antagonist",11,Datasheet_2349,4,A03
2456,Co 101244 hydrochloride,Ion Channels,NMDA Receptors,Antagonist,GluN2B-selective NMDA antagonist,1,Datasheet_2456,4,B07
2498,PNU 120596,Ion Channels,Nicotinic (a7) Receptors,Modulator,Positive allosteric modulator of α7 nAChRs; active in vivo,3,Datasheet_2498,4,C09
2530,PPDA,Ion Channels,NMDA Receptors,Antagonist,GluN2C/GluN2D-selective NMDA antagonist,2,Datasheet_2530,4,D05
2571,Amlodipine besylate,Ion Channels,Cav1.x Channels,Blocker,CaV1.x blocker,1,Datasheet_2571,4,E05
2665,BMS 191011,Ion Channels,Ca2+-Activated Potassium Channels,Activator,Potent BKCa (KCa1.1) channel opener,2,Datasheet_2665,4,G04
2830,PD 118057,Ion Channels,Voltage-Gated Potassium Channels,Activator,Selective KV11.1 (hERG) channel activator,1,Datasheet_2830,5,B04
2867,Flupirtine maleate,Ion Channels,Voltage-Gated Potassium Channels,Activator,KV7 channel activator; also GABAA modulator and indirect NMDA antagonist,3,Datasheet_2867,5,C03
2896,HC 030031,Ion Channels,TRPA1,Blocker,Selective TRPA1 blocker,4,Datasheet_2896,5,C06
2960,Felodipine,Ion Channels,Cav1.x Channels,Blocker,CaV1.x blocker,1,Datasheet_2960,5,D09
2972,A 438079 hydrochloride,Ion Channels,P2X Receptors,Antagonist,Competitive P2X7 antagonist,5,Datasheet_2972,5,E02
2976,A 803467,Ion Channels,Voltage-gated Sodium Channels,Blocker,Selective NaV1.8 channel blocker,3,Datasheet_2976,5,E03
2995,NS 1738,Ion Channels,Nicotinic (a7) Receptors,Modulator,Positive allosteric modulator of α7 nAChRs; active in vivo,1,Datasheet_2995,5,E08
3062,NS 1643,Ion Channels,Voltage-Gated Potassium Channels,Activator,KV11.1 (hERG) channel activator; antiarrhythmic,1,Datasheet_3062,5,F07
3083,DMCM hydrochloride,Ion Channels,GABAA Receptors,Benzodiazepine,Benzodiazepine inverse agonist,3,Datasheet_3083,5,G03
3092,PHA 543613 hydrochloride,Ion Channels,Nicotinic (a7) Receptors,Agonist,Potent and selective α7 nAChR agonist,3,Datasheet_3092,5,G04
3134,PHA 568487,Ion Channels,Nicotinic (a7) Receptors,Agonist,Selective α7 nAChR agonist,2,Datasheet_3134,5,H05
3197,Polygodial,Ion Channels,TRPA1,Activator,TRPA1 channel activator; analgesic and antifungal,2,Datasheet_3197,6,A02
3250,"L-838,417",Ion Channels,GABAA Receptors,Agonist,GABAA partial agonist; displays subtype selectivity,5,Datasheet_3250,6,B03
3296,AP 18,Ion Channels,TRPA1,Blocker,Reversible TRPA1 channel blocker,2,Datasheet_3296,6,C07
3323,AZ 10606120 dihydrochloride,Ion Channels,P2X Receptors,Antagonist,Potent P2X7 receptor antagonist,2,Datasheet_3323,6,D07
3361,JNJ 17203212,Ion Channels,TRPV,Antagonist,"Reversible, competitive and potent TRPV1 antagonist",1,Datasheet_3361,6,E07
3378,EIPA,Ion Channels,TRPP,Blocker,Inhibits TRPP3-mediated currents; also inhibits the Na+/H+ exchanger (NHE),2,Datasheet_3378,6,F04
3379,Phenamil,Ion Channels,TRPP,Blocker,Inhibits TRPP3-mediated currents; also inhibits epithelial Na+ channels,1,Datasheet_3379,6,F05
3579,5-BDBD,Ion Channels,P2X Receptors,Antagonist,Potent and selective P2X4 antagonist,2,Datasheet_3579,7,A07
3620,Topiramate,Ion Channels,Kainate Receptors,Antagonist,GluK1 antagonist; inhibits carbonic anhydrase (CA) II and IV; also positive allosteric modulator of GABAA receptors,1,Datasheet_3620,7,B06
3621,UBP 310,Ion Channels,Kainate Receptors,Antagonist,GluK1-selective kainate antagonist,4,Datasheet_3621,7,B07
3670,SKA 31,Ion Channels,Ca2+-Activated Potassium Channels,Activator,Activator of KCa3.1 and KCa2 channels,1,Datasheet_3670,7,C10
3679,DS2,Ion Channels,GABAA Receptors,Modulator,Positive allosteric modulator of GABAA receptors; displays subunit selectivity,2,Datasheet_3679,7,C11
3694,Kynurenic acid sodium salt,Ion Channels,Non-selective Ionotropic Glutamate,Antagonist,Sodium salt of kynurenic acid (Cat. No. 0223),2,Datasheet_3694,7,D04
3701,A 740003,Ion Channels,P2X Receptors,Antagonist,Potent and selective P2X7 antagonist,3,Datasheet_3701,7,D06
3745,RN 1747,Ion Channels,TRPV,Agonist,Selective TRPV4 agonist,2,Datasheet_3745,7,E07
3746,RN 1734,Ion Channels,TRPV,Antagonist,Selective TRPV4 antagonist,2,Datasheet_3746,7,E08
3754,Varenicline tartrate,Ion Channels,Nicotinic (a4b2) Receptors,Agonist,Selective α4β2 nAChR partial agonist; orally active,3,Datasheet_3754,7,E11
3757,Dofetilide,Ion Channels,Voltage-Gated Potassium Channels,Blocker,KV11.1 (hERG) channel blocker; inhibits rapid delayed rectifier K+ current (IKr),1,Datasheet_3757,7,F03
3817,MRK 016,Ion Channels,GABAA Receptors,Inverse Agonist,α5-selective GABAA inverse agonist,3,Datasheet_3817,7,G06
3837,CCMI,Ion Channels,Nicotinic (a7) Receptors,Modulator,Positive allosteric modulator of α7 nAChRs,1,Datasheet_3837,7,H02
3865,Licarbazepine,Ion Channels,Voltage-gated Sodium Channels,Blocker,Active metabolite of oxcarbazepine (Cat. No. 3864),1,Datasheet_3865,7,H07
3875,BCTC,Ion Channels,TRPV,Antagonist,TRPV1 antagonist,1,Datasheet_3875,7,H11
3891,VU 590 dihydrochloride,Ion Channels,Inward rectifier Potassium Channels,Blocker,Inhibitor of Kir1.1 (ROMK) and Kir7.1,1,Datasheet_3891,8,A04
3895,NS 309,Ion Channels,Ca2+-Activated Potassium Channels,Activator,Positive modulator of KCa2 and KCa3.1 channels,2,Datasheet_3895,8,A05
3911,S 18986,Ion Channels,AMPA Receptors,Modulator,Positive allosteric modulator of AMPA receptors,1,Datasheet_3911,8,A10
3938,TCS 5861528,Ion Channels,TRPA1,Blocker,TRPA1 blocker,1,Datasheet_3938,8,B09
3939,YM 58483,Ion Channels,Other Calcium Channels,Inhibitor,Inhibitor of SOCE in non-excitable cells,2,Datasheet_3939,8,B10
4105,CIQ,Ion Channels,NMDA Receptors,Modulator,Potentiator of NMDA receptors containing GluN2C/GluN2D,3,Datasheet_4105,8,F03
4117,Bepridil hydrochloride,Ion Channels,Non-selective Cav Channels,Blocker,Non-selective Ca2+ channel blocker; also NCX inhibitor,3,Datasheet_4117,8,F05
4141,LY 2087101,Ion Channels,Nicotinic (a7) Receptors,Modulator,"Allosteric potentiator of α7, α4β2 and α4β4 nAChRs",2,Datasheet_4141,8,G02
4166,NS 5806,Ion Channels,Voltage-Gated Potassium Channels,Activator,KV4.3 channel activator,1,Datasheet_4166,8,G07
4198,IEM 1925 dihydrobromide,Ion Channels,AMPA Receptors,Antagonist,Voltage- and use-dependent open-channel AMPA blocker,1,Datasheet_4198,8,H10
4249,A 887826,Ion Channels,Voltage-gated Sodium Channels,Blocker,Potent voltage-dependent NaV1.8 channel blocker,1,Datasheet_4249,9,A08
4305,ICA 069673,Ion Channels,Voltage-Gated Potassium Channels,Activator,KV7.2/KV7.3 channel opener,2,Datasheet_4305,9,C03
4311,GW 542573X,Ion Channels,Ca2+-Activated Potassium Channels,Activator,Selective activator of KCa2.1 channels,1,Datasheet_4311,9,C07
4319,A 784168,Ion Channels,TRPV,Antagonist,Potent and selective TRPV1 antagonist,2,Datasheet_4319,9,C09
4414,TP 003,Ion Channels,GABAA Receptors,Benzodiazepine,GABAA partial agonist; acts at benzodiazepine site,1,Datasheet_4414,9,E11
4435,TC-N 1752,Ion Channels,Voltage-gated Sodium Channels,Blocker,NaV channel blocker,1,Datasheet_4435,9,F09
4462,NS 3623,Ion Channels,Voltage-Gated Potassium Channels,Activator,KV11.1 (hERG)  and KV4.3 channel activator; antiarrhythmic,1,Datasheet_4462,9,G08
4473,A 804598,Ion Channels,P2X Receptors,Antagonist,Potent and selective P2X7 antagonist,2,Datasheet_4473,9,H04
4491,DQP 1105,Ion Channels,NMDA Receptors,Antagonist,GluN2C/GluN2D-selective NMDA antagonist,1,Datasheet_4491,10,A02
4507,ML 218 hydrochloride,Ion Channels,Cav3.x Channels,Blocker,CaV3.x blocker,1,Datasheet_4507,10,A05
4519,ML 213,Ion Channels,Voltage-Gated Potassium Channels,Activator,KV7.2 and KV7.4 channel opener,1,Datasheet_4519,10,A11
4597,NS 8593 hydrochloride,Ion Channels,Ca2+-Activated Potassium Channels,Modulator,Selective KCa2 (SK) channel negative modulator; inhibits SK currents,1,Datasheet_4597,10,C06
4632,TC-I 2000,Ion Channels,TRPM,Blocker,TRPM8 blocker,1,Datasheet_4632,10,D11
4691,NAV 26,Ion Channels,Voltage-gated Sodium Channels,Blocker,Selective Nav1.7 channel blocker,1,Datasheet_4691,10,F04
4716,A 967079,Ion Channels,TRPA1,Blocker,Selective TRPA1 channel blocker,1,Datasheet_4716,10,F09
4732,ML 204,Ion Channels,TRPC,Blocker,Selective TRPC4 blocker,1,Datasheet_4732,10,G02
4746,ML SA1,Ion Channels,TRPML,Activator,Activator of TRPML channels,1,Datasheet_4746,10,G06
4777,ML 277,Ion Channels,Voltage-Gated Potassium Channels,Activator,Selective KV7.1 (KCNQ1) potassium channel activator; augments IKs current,1,Datasheet_4777,10,H04
4788,NS 11021,Ion Channels,Ca2+-Activated Potassium Channels,Activator,Activator of BKCa (KCa1.1) channels,1,Datasheet_4788,10,H10
4876,Eact,Ion Channels,Ca2+-Activated Chloride Channels,Activator,Activator of Ca2+-activated Cl- channel transmembrane protein 16A (TMEM16A),1,Datasheet_4876,11,C05
4907,SN 2,Ion Channels,TRPML,Activator,Selective TRPML3 channel activator,1,Datasheet_4907,11,D05
4916,PF 04885614,Ion Channels,Voltage-gated Sodium Channels,Blocker,Potent and selective NaV1.8 channel blocker; active in vivo,1,Datasheet_4916,11,D06
4949,MaxiPost,Ion Channels,Voltage-Gated Potassium Channels,Modulator,Potassium channel modulator; exerts subtype-specific effects,2,Datasheet_4949,11,D09
5011,HMR 1556,Ion Channels,Voltage-Gated Potassium Channels,Blocker,Potent and selective Iks channel blocker,3,Datasheet_5011,11,F03
5032,Talampanel,Ion Channels,AMPA Receptors,Antagonist,Non-competitive non-NMDA iGluR antagonist,1,Datasheet_5032,11,F07
5066,ICA 121431,Ion Channels,Voltage-gated Sodium Channels,Blocker,Potent and selective NaV1.3 and NaV1.1 channel blocker,1,Datasheet_5066,11,G05
5083,QO 58,Ion Channels,Voltage-Gated Potassium Channels,Activator,Kv7 channel opener,1,Datasheet_5083,11,H03
5106,GSK 2193874,Ion Channels,TRPV,Antagonist,Potent and selective TRPV4 antagonist; orally active,2,Datasheet_5106,11,H09
5112,NS 9283,Ion Channels,Nicotinic (a4b2) Receptors,Modulator,Positive allosteric modulator of α4β2 nAChRs,1,Datasheet_5112,12,A02
5149,CX 614,Ion Channels,AMPA Receptors,Modulator,Positive allosteric modulator of AMPA receptors,2,Datasheet_5149,12,A09
5276,NS 19504,Ion Channels,Ca2+-Activated Potassium Channels,Activator,Activator of BKCa (KCa1.1) channels,1,Datasheet_5276,12,D08
5297,LY 404187,Ion Channels,AMPA Receptors,Modulator,Selective positive allosteric modulator of AMPA receptors,1,Datasheet_5297,12,E05
5299,JNJ 47965567,Ion Channels,P2X Receptors,Antagonist,Potent and selective P2X7 antagonist; brain penetrant,5,Datasheet_5299,12,E06
5324,M8 B hydrochloride,Ion Channels,TRPM,Blocker,Potent and selective TRPM8 channel blocker,1,Datasheet_5324,12,F06
5337,ML 365,Ion Channels,Two-P Potassium Channels,Blocker,Potent and selective K2P3.1 (TASK-1) channel blocker,1,Datasheet_5337,12,G03
5338,PK-THPP,Ion Channels,Two-P Potassium Channels,Blocker,Potent K2P9.1 (TASK-3) channel blocker,1,Datasheet_5338,12,G04
5380,ML 297,Ion Channels,Inward rectifier Potassium Channels,Activator,Selective Kir3.1/3.2 (GIRK1/2) channel activator,1,Datasheet_5380,12,H05
5388,RQ 00203078,Ion Channels,TRPM,Antagonist,Potent and selective TRPM8 antagonist; orally active,1,Datasheet_5388,12,H06
5410,TC-I 2014,Ion Channels,TRPM,Antagonist,Potent TRPM8 antagonist,1,Datasheet_5410,13,A02
5425,TGN 020,Ion Channels,Aquaporins,Blocker,Aquaporin 4 (AQP4) channel blocker,2,Datasheet_5425,13,A06
5449,Erastin,Ion Channels,Other Channel Modulators,Other,Mitochondrial VDAC modulator; also Ferroptosis activator,2,Datasheet_5449,13,B02
5521,CIM 0216,Ion Channels,TRPM,Agonist,Selective TRPM3 agonist,1,Datasheet_5521,13,B09
5586,Yoda 1,Ion Channels,Piezo Channels,Activator,Piezo1 channel activator,2,Datasheet_5586,13,C08
5678,RN 9893 hydrochloride,Ion Channels,TRPV,Antagonist,Potent and selective TRPV4 antagonist,1,Datasheet_5678,13,F04
5781,A 425619,Ion Channels,TRPV,Antagonist,Potent TRPV1 antagonist,1,Datasheet_5781,13,H11
5914,AM 0902,Ion Channels,TRPA1,Blocker,Potent and selective TRPA1 antagonist,1,Datasheet_5914,14,C03
5931,PF 05089771,Ion Channels,Voltage-gated Sodium Channels,Blocker,Potent and selective Nav1.7 channel blocker,1,Datasheet_5931,14,C07
5995,AMG 517,Ion Channels,TRPV,Antagonist,Potent TRPV1 antagonist,1,Datasheet_5995,14,D09
6239,SAK 3,Ion Channels,Cav3.x Channels,Activator,Potent CaV3.1 and 3.3 activator; orally bioavailable,1,Datasheet_6239,15,B07
6278,JNJ 55511118,Ion Channels,AMPA Receptors,Modulator,High affinity and selective negative modulator of AMPA receptors containing TARP-γ8,1,Datasheet_6278,15,C05
6353,UoS 12258,Ion Channels,AMPA Receptors,Modulator,Positive allosteric modulator of AMPA receptors,1,Datasheet_6353,15,E09
6367,Z 944,Ion Channels,Cav3.x Channels,Blocker,CaV3.x blocker,1,Datasheet_6367,15,F03
6369,GNE 9278,Ion Channels,NMDA Receptors,Modulator,Positive allosteric modulator of NMDA receptors; acts in transmembrane domain,1,Datasheet_6369,15,F04
6508,GSK 1702934A,Ion Channels,TRPC,Activator,Potent and selective TRPC3/6 activator,1,Datasheet_6508,15,H08
6542,Ivabradine hydrochloride,Ion Channels,HCN Channels,Blocker,HCN channel blocker; inhibits If pacemaker current,1,Datasheet_6542,16,A08
6545,OB-1,Ion Channels,Piezo Channels,Other,Stomatin-like protein-3 (STOML3) oligomerization inhibitor,1,Datasheet_6545,16,A10
6568,Dooku 1,Ion Channels,Piezo Channels,Modulator,Reversibly blocks Yoda1 activity; does not affect constitutive Piezo1 activity,1,Datasheet_6568,16,B04
6576,ABT 594 hydrochloride,Ion Channels,Nicotinic (a4b2) Receptors,Agonist,Selective α4β2 nAChR agonist,1,Datasheet_6576,16,B05
6614,Jedi2,Ion Channels,Piezo Channels,Activator,Piezo1 channel activator,1,Datasheet_6614,16,C02
6689,GI 530159,Ion Channels,Two-P Potassium Channels,Activator,K2P2.1 (TREK-1) and K2P10.1 (TREK-2) channel activator,1,Datasheet_6689,16,D05
6724,CBA,Ion Channels,TRPM,Blocker,Selective TRPM4 blocker,1,Datasheet_6724,16,D11
6764,B 973B,Ion Channels,Nicotinic (a7) Receptors,Modulator,Positive allosteric modulator of α7 nAChRs; analgesic,1,Datasheet_6764,16,E09
6766,AC 1903,Ion Channels,TRPC,Blocker,Selective TRPC5 blocker,1,Datasheet_6766,16,E11
6770,ABT 639,Ion Channels,Cav3.x Channels,Blocker,CaV3.2 and CaV3.1 channel blocker; orally bioavailable,1,Datasheet_6770,16,F02
6874,AMG 333,Ion Channels,TRPM,Antagonist,Potent and selective TRPM8 antagonist; active in vivo,1,Datasheet_6874,16,G07
6877,VU 0134992,Ion Channels,Inward rectifier Potassium Channels,Blocker,Kir4.1 blocker,1,Datasheet_6877,16,G08
6886,ML 67-33,Ion Channels,Two-P Potassium Channels,Activator,"K2P2.1 (TREK-1), K2P10.1 (TREK-2) and K2P4.1 (TRAAK) channel activator",1,Datasheet_6886,16,G10
6888,ML 402,Ion Channels,Two-P Potassium Channels,Activator,Selective TREK channel activator,1,Datasheet_6888,16,G11
6889,ML 418,Ion Channels,Inward rectifier Potassium Channels,Blocker,Kir 7.1 inhibitor; also inhibits Kir 6.2,1,Datasheet_6889,16,H02
6972,A 1899,Ion Channels,Two-P Potassium Channels,Blocker,Potent K2P3.1 (TASK-1) and K2P9.1 (TASK-3) blocker,1,Datasheet_6972,16,H08
0760,AM 580,Nuclear Receptors,Retinoic Acid Receptors,Agonist,Retinoic acid analog; RARα agonist,3,Datasheet_0760,1,D04
0999,Tamoxifen citrate,Nuclear Receptors,Estrogen and Related Receptors,Modulator,Estrogen receptor partial agonist/antagonist,4,Datasheet_0999,1,F08
1047,"ICI 182,780",Nuclear Receptors,Estrogen and Related Receptors,Antagonist,Estrogen receptor antagonist,22,Datasheet_1047,1,G06
1312,WY 14643,Nuclear Receptors,PPARalpha Receptors,Agonist,Selective PPARα agonist,5,Datasheet_1312,2,B07
1426,PPT,Nuclear Receptors,Estrogen and Related Receptors,Agonist,Subtype-selective ERα agonist,8,Datasheet_1426,2,D04
1479,Mifepristone,Nuclear Receptors,Progesterone Receptor,Antagonist,Progesterone and glucocorticoid receptor antagonist,2,Datasheet_1479,2,E04
1508,GW 9662,Nuclear Receptors,PPARgamma Receptors,Antagonist,Selective covalent PPARγ antagonist,1,Datasheet_1508,2,E06
1549,CD 437,Nuclear Receptors,Retinoic Acid Receptors,Agonist,RARγ-selective agonist,4,Datasheet_1549,2,F02
1677,GW 7647,Nuclear Receptors,PPARalpha Receptors,Agonist,"Highly selective, potent PPARα agonist. Orally active",3,Datasheet_1677,2,G11
1803,ITE,Nuclear Receptors,Aryl Hydrocarbon Receptors,Agonist,Endogenous agonist for the transcription factor aryl hydrocarbon receptor,12,Datasheet_1803,3,A07
1856,"L-165,041",Nuclear Receptors,PPARdelta Receptors,Agonist,Potent PPARδ agonist,3,Datasheet_1856,3,B02
1991,MPP dihydrochloride,Nuclear Receptors,Estrogen and Related Receptors,Antagonist,Highly selective ERα antagonist,8,Datasheet_1991,3,C06
2020,Ch 55,Nuclear Receptors,Retinoic Acid Receptors,Agonist,Potent RAR agonist,1,Datasheet_2020,3,D06
2021,LE 135,Nuclear Receptors,Retinoic Acid Receptors,Antagonist,Selective RARβ antagonist,2,Datasheet_2021,3,D07
2183,ZK 164015,Nuclear Receptors,Estrogen and Related Receptors,Antagonist,Potent estrogen receptor antagonist,1,Datasheet_2183,3,E07
2229,GW 0742,Nuclear Receptors,PPARdelta Receptors,Agonist,"Highly selective, potent PPARδ agonist",4,Datasheet_2229,3,F07
2266,DY131,Nuclear Receptors,Estrogen and Related Receptors,Agonist,Agonist selective for estrogen-related receptors ERRβ and ERRγ,1,Datasheet_2266,3,F10
2280,Raloxifene hydrochloride,Nuclear Receptors,Estrogen and Related Receptors,Modulator,Selective estrogen receptor modulator (SERM),2,Datasheet_2280,3,G03
2301,T 0070907,Nuclear Receptors,PPARgamma Receptors,Antagonist,Highly potent and selective covalent PPARγ antagonist,1,Datasheet_2301,3,G08
2373,T 0901317,Nuclear Receptors,LXR-like Receptors,Agonist,Potent liver X receptor (LXR) agonist; also CAR inverse agonist,2,Datasheet_2373,4,A04
2474,GW 3965 hydrochloride,Nuclear Receptors,LXR-like Receptors,Agonist,Orally active liver X receptor (LXR) agonist,2,Datasheet_2474,4,C03
2554,CD 1530,Nuclear Receptors,Retinoic Acid Receptors,Agonist,Potent and selective RARγ agonist,2,Datasheet_2554,4,D10
2563,Fexaramine,Nuclear Receptors,LXR-like Receptors,Agonist,"Potent, selective farnesoid X receptor (FXR) agonist",2,Datasheet_2563,4,E04
2662,PHTPP,Nuclear Receptors,Estrogen and Related Receptors,Antagonist,Selective ERβ antagonist,2,Datasheet_2662,4,G02
2705,Liarozole dihydrochloride,Nuclear Receptors,Retinoic Acid Receptors,Other,Blocks retinoic acid metabolism,3,Datasheet_2705,4,G10
3114,Troglitazone,Nuclear Receptors,PPARgamma Receptors,Agonist,Selective PPARγ agonist; antidiabetic agent,5,Datasheet_3114,5,G11
3302,CD 3254,Nuclear Receptors,Retinoid X Receptor,Agonist,Potent and selective RXRα agonist,2,Datasheet_3302,6,C10
3366,WAY 200070,Nuclear Receptors,Estrogen and Related Receptors,Agonist,Selective ERβ agonist,1,Datasheet_3366,6,E09
3389,Bicalutamide,Nuclear Receptors,Androgen Receptor,Antagonist,Non-steroidal androgen receptor antagonist,1,Datasheet_3389,6,F09
3410,BMS 961,Nuclear Receptors,Retinoic Acid Receptors,Agonist,Selective RARγ agonist,1,Datasheet_3410,6,F10
3411,SR 11237,Nuclear Receptors,Retinoid X Receptor,Agonist,Pan RXR agonist,3,Datasheet_3411,6,F11
3433,GSK 0660,Nuclear Receptors,PPARdelta Receptors,Antagonist,Selective PPARδ antagonist,1,Datasheet_3433,6,G03
3505,BMS 753,Nuclear Receptors,Retinoic Acid Receptors,Agonist,RARα-selective agonist,1,Datasheet_3505,6,G07
3507,AM 80,Nuclear Receptors,Retinoic Acid Receptors,Agonist,RARα agonist; anticancer agent,2,Datasheet_3507,6,G09
3523,FERb 033,Nuclear Receptors,Estrogen and Related Receptors,Agonist,Potent and selective ERβ agonist,1,Datasheet_3523,6,G10
3570,Z-Guggulsterone,Nuclear Receptors,Other Nuclear Receptors,Other,Broad spectrum steroid receptor ligand. More active isomer of guggulsterone (Cat. No. 2013),1,Datasheet_3570,7,A02
3663,GSK 4112,Nuclear Receptors,Rev-Erb Receptors,Agonist,Selective Rev-Erbα agonist,1,Datasheet_3663,7,C08
3683,CITCO,Nuclear Receptors,Constitutive Androstane Receptor,Agonist,Selective CAR agonist,2,Datasheet_3683,7,D02
3685,Corticosterone,Nuclear Receptors,Glucocorticoid Receptor,Agonist,Endogenous glucocorticoid,2,Datasheet_3685,7,D03
3800,CD 2665,Nuclear Receptors,Retinoic Acid Receptors,Antagonist,Selective RARβ/γ antagonist,3,Datasheet_3800,7,G03
3822,MM 11253,Nuclear Receptors,Retinoic Acid Receptors,Antagonist,RARγ-selective antagonist,2,Datasheet_3822,7,G07
3823,ER 50891,Nuclear Receptors,Retinoic Acid Receptors,Antagonist,Selective RARα antagonist,1,Datasheet_3823,7,G08
3824,CD 2314,Nuclear Receptors,Retinoic Acid Receptors,Agonist,Selective RARβ agonist,3,Datasheet_3824,7,G09
3912,HX 531,Nuclear Receptors,Retinoid X Receptor,Antagonist,Potent RXR antagonist,3,Datasheet_3912,8,A11
3961,GSK 3787,Nuclear Receptors,PPARdelta Receptors,Antagonist,Potent and selective PPARδ antagonist,3,Datasheet_3961,8,C04
4046,AC 261066,Nuclear Receptors,Retinoic Acid Receptors,Agonist,RARβ2 agonist,1,Datasheet_4046,8,D09
4093,Hydrocortisone,Nuclear Receptors,Glucocorticoid Receptor,Other,Adrenal glucocorticoid; immunosuppressant,3,Datasheet_4093,8,E11
4124,Pioglitazone hydrochloride,Nuclear Receptors,PPARgamma Receptors,Agonist,Selective PPARγ agonist; antidiabetic agent,1,Datasheet_4124,8,F07
4190,CP 775146,Nuclear Receptors,PPARalpha Receptors,Agonist,"Selective, high affinity PPARα agonist",1,Datasheet_4190,8,H08
4463,SR 8278,Nuclear Receptors,Rev-Erb Receptors,Antagonist,Rev-Erbα antagonist,2,Datasheet_4463,9,G09
4494,(R)-DPN,Nuclear Receptors,Estrogen and Related Receptors,Agonist,Enantiomer of DPN (Cat. No. 1494),1,Datasheet_4494,10,A03
4554,GC 1,Nuclear Receptors,Other Nuclear Receptors,Agonist,High affinity thyroid receptor α (TRα) and TRβ agonist; thyromimetic,6,Datasheet_4554,10,B09
4618,GW 6471,Nuclear Receptors,PPARalpha Receptors,Antagonist,PPARα antagonist,6,Datasheet_4618,10,D05
4784,Edaglitazone,Nuclear Receptors,PPARgamma Receptors,Agonist,Potent and selective PPARγ agonist; antidiabetic,1,Datasheet_4784,10,H09
4868,SR 1001,Nuclear Receptors,Retinoic Acid-related Orphan Receptors,Inverse Agonist,RORα/γ inverse agonist,1,Datasheet_4868,11,B10
4869,SR 2211,Nuclear Receptors,Retinoic Acid-related Orphan Receptors,Inverse Agonist,Selective RORγ inverse agonist,2,Datasheet_4869,11,B11
4874,SR 1078,Nuclear Receptors,Retinoic Acid-related Orphan Receptors,Agonist,RORα/γ agonist,1,Datasheet_4874,11,C04
5053,AC 186,Nuclear Receptors,Estrogen and Related Receptors,Agonist,Potent and selective ERβ agonist; neuroprotective,1,Datasheet_5053,11,G02
5086,PA 452,Nuclear Receptors,Retinoid X Receptor,Antagonist,RXR antagonist,1,Datasheet_5086,11,H04
5263,Bazedoxifene acetate,Nuclear Receptors,Estrogen and Related Receptors,Modulator,Potent and selective estrogen receptor modulator (SERM),1,Datasheet_5263,12,D02
5325,Rosiglitazone,Nuclear Receptors,PPARgamma Receptors,Agonist,Potent and selective PPARγ agonist; antidiabetic agent,1,Datasheet_5325,12,F07
5605,CINPA 1,Nuclear Receptors,Constitutive Androstane Receptor,Antagonist,Potent CAR antagonist,1,Datasheet_5605,13,D04
5694,GSK 2033,Nuclear Receptors,LXR-like Receptors,Antagonist,Potent LXR antagonist,1,Datasheet_5694,13,F10
5699,IP7e,Nuclear Receptors,Nerve Growth Factor IB-like Receptors,Activator,Potent Nurr1 activator,1,Datasheet_5699,13,F11
5854,SR 9238,Nuclear Receptors,LXR-like Receptors,Inverse Agonist,Potent and selective LXR inverse agonist,1,Datasheet_5854,14,B02
5855,SR 9009,Nuclear Receptors,Rev-Erb Receptors,Agonist,Rev-Erbα/β agonist,1,Datasheet_5855,14,B03
5868,SR 0987,Nuclear Receptors,Retinoic Acid-related Orphan Receptors,Agonist,T cell-specific RORγ (RORγt) agonist,1,Datasheet_5868,14,B05
5920,LG 100268,Nuclear Receptors,Retinoid X Receptor,Agonist,Potent and selective RXR agonist; also activates RXR/PPARγ heterodimers,1,Datasheet_5920,14,C05
5951,WAY 252623,Nuclear Receptors,LXR-like Receptors,Agonist,Potent LXR agonist,1,Datasheet_5951,14,C11
5984,LY 2955303,Nuclear Receptors,Retinoic Acid Receptors,Antagonist,High affinity and selective RARγ antagonist,1,Datasheet_5984,14,D06
6223,XY 018,Nuclear Receptors,Retinoic Acid-related Orphan Receptors,Antagonist,RORγ antagonist; inhibits AR expression,1,Datasheet_6223,15,A11
6285,Megestrol Acetate,Nuclear Receptors,Progesterone Receptor,Agonist,Synthetic progesterone analog,1,Datasheet_6285,15,C10
6342,Tamoxifen,Nuclear Receptors,Estrogen and Related Receptors,Modulator,Estrogen receptor partial agonist/antagonist,1,Datasheet_6342,15,E02
6383,SR 16832,Nuclear Receptors,PPARgamma Receptors,Antagonist,Dual site PPARγ inhibitor,1,Datasheet_6383,15,F06
0237,7-Chlorokynurenic acid,Transporters,Glutamate Transporters,Inhibitor,Potent competitive inhibitor of L-glutamate uptake,6,Datasheet_0237,1,A05
0421,GBR 12909 dihydrochloride,Transporters,Dopamine Transporters,Inhibitor,Selective DA uptake inhibitor; also σ ligand,5,Datasheet_0421,1,A11
0589,PRE-084 hydrochloride,Other Pharmacology,Sigma1 Receptors,Agonist,Highly selective σ1 agonist,2,Datasheet_0589,1,B09
0653,(+/-)-Vesamicol hydrochloride,Transporters,Acetylcholine Transporters,Inhibitor,Inhibits ACh transport,5,Datasheet_0653,1,C03
0670,PK 11195,Other Pharmacology,Translocator Protein,Ligand,Antagonist at peripheral benzodiazepine receptors,11,Datasheet_0670,1,C05
0691,Dipyridamole,Transporters,Nucleoside Transporters,Inhibitor,Adenosine transport inhibitor,4,Datasheet_0691,1,C08
0927,Fluoxetine hydrochloride,Transporters,5-HT Transporters,Inhibitor,5-HT reuptake inhibitor,5,Datasheet_0927,1,E08
0956,BD 1047 dihydrobromide,Other Pharmacology,Sigma1 Receptors,Antagonist,σ1 selective antagonist,4,Datasheet_0956,1,F04
1081,SKF 89976A hydrochloride,Transporters,GABA Transporters,Inhibitor,Potent GAT-1 inhibitor; brain penetrant,1,Datasheet_1081,1,H02
1098,Tranilast,Other Pharmacology,Miscellaneous Compounds,Other,Antiallergic; inhibits inflammatory mediator release from mast cells,1,Datasheet_1098,1,H05
1114,CGP 37157,Transporters,Na+/Ca2+ Exchanger,Inhibitor,Antagonist of mitochondrial Na+/Ca2+ exchange,4,Datasheet_1114,1,H09
1223,DL-TBOA,Transporters,Glutamate Transporters,Inhibitor,Selective non-transportable inhibitor of EAATs,15,Datasheet_1223,2,A08
1244,KB-R7943 mesylate,Transporters,Na+/Ca2+ Exchanger,Inhibitor,Na+/Ca2+ exchange inhibitor (reverse mode),3,Datasheet_1244,2,A10
1296,CI 966 hydrochloride,Transporters,GABA Transporters,Inhibitor,Selective inhibitor of GAT-1,1,Datasheet_1296,2,B05
1588,Indatraline hydrochloride,Transporters,5-HT Transporters,Inhibitor,Potent 5-HT uptake inhibitor; also inhibits dopamine and noradrenalin uptake,8,Datasheet_1588,2,F07
1757,ALX 5407 hydrochloride,Transporters,Glycine Transporters,Inhibitor,Selective non-transportable GlyT1 inhibitor,5,Datasheet_1757,3,A02
1779,NNC 711,Transporters,GABA Transporters,Inhibitor,Selective GAT-1 inhibitor,2,Datasheet_1779,3,A04
1982,Reboxetine mesylate,Transporters,Adrenergic Transporters,Inhibitor,Potent and selective noradrenalin uptake inhibitor; orally active,6,Datasheet_1982,3,C04
1992,Nomifensine,Transporters,Dopamine Transporters,Inhibitor,Potent noradrenalin and dopamine uptake inhibitor. Antidepressant,1,Datasheet_1992,3,C07
2175,Tetrabenazine,Transporters,Vesicular Monoamine Transporters,Inhibitor,Potent inhibitor of vesicular monoamine transport,4,Datasheet_2175,3,E05
2184,SN-6,Transporters,Na+/Ca2+ Exchanger,Inhibitor,Selective Na+/Ca2+ exchange inhibitor (reverse mode),2,Datasheet_2184,3,E08
2332,(+)-Igmesine hydrochloride,Other Pharmacology,Sigma1 Receptors,Ligand,Selective σ1 ligand; antidepressant,1,Datasheet_2332,3,H06
2395,Sertraline hydrochloride,Transporters,5-HT Transporters,Inhibitor,5-HT reuptake inhibitor,3,Datasheet_2395,4,A10
2532,TFB-TBOA,Transporters,Glutamate Transporters,Inhibitor,High affinity EAAT1 and EAAT2 blocker,4,Datasheet_2532,4,D06
2606,PD 144418 oxalate,Other Pharmacology,Sigma1 Receptors,Ligand,"High affinity, selective σ1 ligand",1,Datasheet_2606,4,E10
2652,WAY 213613,Transporters,Glutamate Transporters,Inhibitor,"Potent, non-substrate EAAT2 inhibitor",1,Datasheet_2652,4,F11
2727,Zoniporide dihydrochloride,Transporters,Na+/H+ Exchanger,Inhibitor,Selective NHE1 inhibitor,2,Datasheet_2727,4,H06
2747,NNC 05-2090 hydrochloride,Transporters,GABA Transporters,Inhibitor,GABA uptake inhibitor; moderately BGT-1 selective,1,Datasheet_2747,4,H08
2831,Bupropion hydrochloride,Transporters,Dopamine Transporters,Inhibitor,Non-selective inhibitor of dopamine and noradrenalin transporters,2,Datasheet_2831,5,B05
2917,Venlafaxine hydrochloride,Transporters,5-HT Transporters,Inhibitor,5-HT and NA reuptake inhibitor (SNRI),1,Datasheet_2917,5,D02
2924,NBMPR,Transporters,Nucleoside Transporters,Inhibitor,Equilibrative nucleoside transporter 1 (ENT1) inhibitor,3,Datasheet_2924,5,D04
3108,Bumetanide,Transporters,Na+/K+/Cl- Symporter,Inhibitor,Na+/2Cl-/K+ (NKCC) symporter inhibitor,3,Datasheet_3108,5,G08
3109,Furosemide,Transporters,Na+/K+/Cl- Symporter,Inhibitor,Na+/2Cl-/K+ (NKCC) symporter inhibitor; also GABAA antagonist,1,Datasheet_3109,5,G09
3113,Etifoxine hydrochloride,Other Pharmacology,Translocator Protein,Ligand,Ligand of the translocator protein (TSPO); also GABAA receptor potentiator,1,Datasheet_3113,5,G10
3133,NE 100 hydrochloride,Other Pharmacology,Sigma1 Receptors,Antagonist,Selective σ1 antagonist,3,Datasheet_3133,5,H04
3241,Ko 143,Transporters,Multidrug Transporters,Inhibitor,Potent and selective BCRP inhibitor,4,Datasheet_3241,6,B02
3380,Benzamil,Transporters,Na+/Ca2+ Exchanger,Inhibitor,"NCX inhibitor, Deg/ENaC channel blocker; amiloride (Cat. No. 0890) derivative",3,Datasheet_3380,6,F06
3722,Reversan,Transporters,Multidrug Transporters,Inhibitor,Selective MRP1 and P-gp inhibitor,1,Datasheet_3722,7,D11
3793,A 1120,Other Pharmacology,Miscellaneous Compounds,Other,High affinity retinol-binding protein 4 (RBP4) ligand,1,Datasheet_3793,7,F11
4107,Probenecid,Transporters,Multidrug Transporters,Inhibitor,MRP inhibitor,1,Datasheet_4107,8,F04
4186,UK 5099,Transporters,Monocarboxylate Transporters,Inhibitor,MCT inhibitor; also inhibits of pyruvate transport,1,Datasheet_4186,8,H05
4256,Tiagabine hydrochloride,Transporters,GABA Transporters,Inhibitor,Selective GAT-1 inhibitor; anticonvulsant,1,Datasheet_4256,9,A10
4351,JHW 007 hydrochloride,Transporters,Dopamine Transporters,Inhibitor,High affinity dopamine uptake inhibitor,1,Datasheet_4351,9,D09
4447,Org 24598,Transporters,Glycine Transporters,Inhibitor,Potent and selective inhibitor of the glial glycine transporter GlyT1b; active in vivo,1,Datasheet_4447,9,G04
4544,YM 244769,Transporters,Na+/Ca2+ Exchanger,Inhibitor,Na+/Ca2+ exchange inhibitor (reverse mode); neuroprotective,1,Datasheet_4544,10,B06
4588,8MDP,Transporters,Nucleoside Transporters,Inhibitor,Potent equilibrative nucleoside transporter (ENT) inhibitor,1,Datasheet_4588,10,C03
4782,Org 25543 hydrochloride,Transporters,Glycine Transporters,Inhibitor,Potent and selective GlyT2 inhibitor,1,Datasheet_4782,10,H08
4796,Escitalopram oxalate,Transporters,5-HT Transporters,Inhibitor,Selective serotonin reuptake inhibitor (SSRI),2,Datasheet_4796,11,A03
4798,(S)-Duloxetine hydrochloride,Transporters,5-HT Transporters,Inhibitor,Potent 5-HT and NA reuptake inhibitor (SNRI); also blocks dopamine reuptake,1,Datasheet_4798,11,A04
4951,SA 4503 dihydrochloride,Other Pharmacology,Sigma1 Receptors,Agonist,Selective σ1 receptor agonist,2,Datasheet_4951,11,D10
5029,CHC,Transporters,Monocarboxylate Transporters,Inhibitor,MCT inhibitor; decreases glycoloysis,2,Datasheet_5029,11,F06
5270,Toyocamycin,Other Pharmacology,Antibiotics,Other,Adenosine analog; antifungal antibiotic,1,Datasheet_5270,12,D05
5281,AC 5216,Other Pharmacology,Translocator Protein,Ligand,Selective TSPO ligand,1,Datasheet_5281,12,D10
5358,Cariporide,Transporters,Na+/H+ Exchanger,Inhibitor,Selective NHE1 inhibitor; cardioprotective and antitumor,1,Datasheet_5358,12,G10
5456,Zosuquidar trihydrochloride,Transporters,Multidrug Transporters,Inhibitor,High affinity P-gp inhibitor,1,Datasheet_5456,13,B04
5692,ITH 12575,Transporters,Na+/Ca2+ Exchanger,Inhibitor,Mitochondrial Na+/Ca2+ exchange (mNCX) inhibitor,1,Datasheet_5692,13,F08
5757,Tariquidar dihydrochloride,Transporters,Multidrug Transporters,Inhibitor,Potent P-glycoprotein (P-gp) inhibitor,1,Datasheet_5757,13,H05
6143,WZB 117,Transporters,Glucose Transporters,Inhibitor,GLUT inhibitor,1,Datasheet_6143,14,G09
6164,SEA 0400,Transporters,Na+/Ca2+ Exchanger,Inhibitor,Potent Na+/Ca2+ exchanger (NCX) inhibitor,1,Datasheet_6164,14,H03
6518,BI 01383298,Transporters,Other Ion Pumps/Transporters,Inhibitor, Potent and selective SLC13A5 (Na+/citrate cotransporter) inhibitor,1,Datasheet_6518,15,H10
6578,GT 949,Transporters,Glutamate Transporters,Modulator,Potent and selective positive allosteric modulator of EAAT2,1,Datasheet_6578,16,B07
0369,W-7 hydrochloride,Cell biology,Calcium Binding Protein,Antagonist,Calmodulin antagonist. Inhibits myosin light chain kinase,8,Datasheet_0369,1,A08
0880,ODQ,Cell biology,Other Nitric Oxide,Inhibitor,Selective inhibitor of NO-sensitive guanylyl cyclase,6,Datasheet_0880,1,D09
1097,Taxol,Cell biology,Microtubules,Other,Promotes assembly and inhibits disassembly of microtubules,8,Datasheet_1097,1,H04
1140,"8-Bromo-cAMP, sodium salt",Cell biology,cAMP,Other,Cell-permeable cAMP analog,8,Datasheet_1140,1,H11
1141,"Dibutyryl-cAMP, sodium salt",Cell biology,cAMP,Other,Cell-permeable cAMP analog,14,Datasheet_1141,2,A02
1743,Bay 11-7085,Cell biology,NF-kB/IkB,Inhibitor,Irreversible inhibitor of TNF-α-induced IκBα phosphorylation,2,Datasheet_1743,2,H10
1974,SANT-1,Cell biology,Hedgehog Signaling,Inhibitor,Inhibitor of hedgehog (Hh) signaling; antagonizes smoothened activity,1,Datasheet_1974,3,C02
2160,Bax channel blocker,Cell biology,Bcl-2 Family,Inhibitor,Allosteric inhibitor of Bax channel activation,1,Datasheet_2160,3,E03
2185,NSC 146109 hydrochloride,Cell biology,p53,Activator,"Cell-permeable, genotype-selective antitumor agent; activates p53-dependent transcription",1,Datasheet_2185,3,E09
2408,Ro 90-7501,Cell biology,Amyloid Beta Peptides,Inhibitor,Inhibitor of Aβ42 fibril formation,4,Datasheet_2408,4,A11
2634,DAPT,Cell biology,Neural Stem Cells,Other,γ-secretase inhibitor; induces neuronal differentiation,8,Datasheet_2634,4,F07
2706,Temozolomide,Cell biology,Apoptosis Inducers,Other,DNA-methylating antitumor agent,2,Datasheet_2706,4,G11
2748,KF 38789,Cell biology,Cell Adhesion Molecules,Other,Selective inhibitor of P-selectin-mediated cell adhesion,2,Datasheet_2748,4,H09
2839,Levetiracetam,Cell biology,"Translocation, Exocytosis & Endocytosis",Other,Antiepileptic; binds SV2A,1,Datasheet_2839,5,B07
3023,CP 31398 dihydrochloride,Cell biology,p53,Other,p53-stabilizing agent,1,Datasheet_3023,5,E10
3191,GANT 61,Cell biology,Hedgehog Signaling,Inhibitor,GLI antagonist; inhibits Hedgehog (Hh) signaling,2,Datasheet_3191,5,H11
3259,Gemcitabine hydrochloride,Cell biology,"DNA, RNA and Protein Synthesis",Inhibitor,DNA synthesis inhibitor,3,Datasheet_3259,6,B08
3270,GIT 27,Cell biology,Cytokines,Other,Immunomodulator; reduces production of pro-inflammatory cytokines,1,Datasheet_3270,6,C02
3333,NDT 9513727,Cell biology,Complement,Modulator,"Potent, selective human C5a receptor negative allosteric modulator (NAM)",2,Datasheet_3333,6,D11
3354,PF 429242 dihydrochloride,Cell biology,SREBP,Inhibitor,Competitive inhibitor of SREBP site 1 protease,3,Datasheet_3354,6,E06
3367,AT 101,Cell biology,Bcl-2 Family,Other,Downregulates Bcl-2 and Mcl-1; pro-apoptotic,4,Datasheet_3367,6,E10
3495,Fludarabine,Cell biology,"DNA, RNA and Protein Synthesis",Inhibitor,Purine analog; inhibits DNA synthesis,1,Datasheet_3495,6,G05
3534,PNU 74654,Cell biology,Beta-catenin,Other,β-catenin binder; inhibits Wnt signaling,1,Datasheet_3534,6,H04
3710,PRIMA-1MET,Cell biology,p53,Other,Restores mutant p53 activity,6,Datasheet_3710,7,D08
3771,Azithromycin,Cell biology,"DNA, RNA and Protein Synthesis",Other,Antibiotic; inhibits 50S ribosomal subunit formation and elongation at transpeptidation,1,Datasheet_3771,7,F07
3803,VER 155008,Cell biology,Hsp70,Inhibitor,Hsp70 inhibitor,2,Datasheet_3803,7,G04
3843,Cyclic Pifithrin-alpha hydrobromide,Cell biology,p53,Inhibitor,p53 inhibitor,2,Datasheet_3843,7,H04
3863,Trovafloxacin mesylate,Cell biology,"DNA, RNA and Protein Synthesis",Inhibitor,Antibiotic; inhibits bacterial DNA synthesis,1,Datasheet_3863,7,H06
3877,TCS 2210,Cell biology,Neural Stem Cells,Other,Inducer of neuronal differentiation in MSCs,1,Datasheet_3877,8,A02
4056,Docetaxel,Cell biology,Microtubules,Other,Microtubule stabilizer,2,Datasheet_4056,8,E02
4067,YK 4-279,Cell biology,"DNA, RNA and Protein Synthesis",Inhibitor,Inhibitor of RNA helicase A (RHA),1,Datasheet_4067,8,E04
4089,Puromycin dihydrochloride,Cell biology,"DNA, RNA and Protein Synthesis",Inhibitor,Protein synthesis inhibitor,10,Datasheet_4089,8,E09
4288,ISO 1,Cell biology,Cytokines,Inhibitor,Macrophage migration inhibitory factor (MIF) inhibitor,2,Datasheet_4288,9,B08
4297,SMER 28,Cell biology,Autophagy,Activator,Positive regulator of autophagy,1,Datasheet_4297,9,B11
4299,iCRT 14,Cell biology,Beta-catenin,Other,Inhibits β-catenin-responsive transcription (CRT),1,Datasheet_4299,9,C02
4326,PhiKan 083,Cell biology,p53,Other,p53 stabilizing agent,1,Datasheet_4326,9,C11
4344,FH 535,Cell biology,Beta-catenin,Other,Inhibitor of Wnt/β-catenin signaling,1,Datasheet_4344,9,D05
4354,ML 130,Cell biology,NF-kB/IkB,Inhibitor,Inhibits NOD1-induced NF-κB activation,1,Datasheet_4354,9,D10
4400,(+/-)-CPSI 1306,Cell biology,Cytokines,Other,Reported macrophage migration inhibitory factor (MIF) inhibitor,1,Datasheet_4400,9,E09
4434,Wiskostatin,Cell biology,Actin,Inhibitor,N-WASP inhibitor; inhibits Arp2/3 activation,1,Datasheet_4434,9,F08
4439,ISX 9,Cell biology,Neural Stem Cells,Other,Neurogenic agent; induces neuronal differentiation of SVZ progenitors and also induces cardiomyogenic differentiation,2,Datasheet_4439,9,F10
4444,Fatostatin A,Cell biology,SREBP,Inhibitor,Cell permeable inhibitor of SREBP activation,2,Datasheet_4444,9,G02
4445,PFI 1,Cell biology,Bromodomains,Inhibitor,BET bromodomain inhibitor,1,Datasheet_4445,9,G03
4499,(+)-JQ1,Cell biology,Bromodomains,Inhibitor,Potent and selective BET bromodomain inhibitor; cell permeable,11,Datasheet_4499,10,A04
4513,Kartogenin,Cell biology,Mesenchymal Stem Cells,Other,Potently induces chondrogenesis in MSCs,1,Datasheet_4513,10,A07
4565,ML 228,Cell biology,Hypoxia Inducible Factors,Activator,HIF pathway activator,1,Datasheet_4565,10,C02
4608,BIIB 021,Cell biology,Hsp90,Inhibitor,Selective Hsp90 inhibitor,1,Datasheet_4608,10,C11
4641,BI 6015,Cell biology,Other Transcription Factors,Antagonist,Hepatocyte nuclear factor 4α (HNF4α) antagonist,1,Datasheet_4641,10,E02
4650,I-BET 151 dihydrochloride,Cell biology,Bromodomains,Inhibitor,BET bromodomain inhibitor; also promotes differentiation of hiPSCs into megakaryocytes,5,Datasheet_4650,10,E05
4655,NSC 74859,Cell biology,STAT,Inhibitor,Selective STAT3 inhibitor,1,Datasheet_4655,10,E07
4694,Ro 5-3335,Cell biology,Other Transcription Factors,Inhibitor,Core binding factor inhibitor; attenuates hematopoiesis,2,Datasheet_4694,10,F05
4731,KY 02111,Cell biology,Cardiomyocyte Stem Cells,Other,Inhibits canonical Wnt signaling. Promotes differentiation of human ESCs and iPSCs into cardiomyocytes,1,Datasheet_4731,10,F11
4737,CDDO Im,Cell biology,Nrf2,Activator,Nrf2 signaling activator,2,Datasheet_4737,10,G04
4758,Bromosporine,Cell biology,Bromodomains,Inhibitor,Broad spectrum bromodomain inhibitor,1,Datasheet_4758,10,G08
4767,WAY 316606 hydrochloride,Cell biology,Beta-catenin,Other,Secreted Frizzled-related protein-1 (sFRP-1) inhibitor; increases Wnt signaling,1,Datasheet_4767,10,G09
4888,KHS 101 hydrochloride,Cell biology,Neural Stem Cells,Other,Selective inducer of neuronal differentiation in hippocampal neural progenitors,1,Datasheet_4888,11,C08
4891,I-CBP 112,Cell biology,Bromodomains,Inhibitor,Selective CBP/p300 BRD inhibitor,1,Datasheet_4891,11,C09
4963,SC 144 hydrochloride,Cell biology,Cytokines,Other,gp130 inhibitor; blocks cytokine-triggered gp130 signaling,3,Datasheet_4963,11,E03
4978,Pyrintegrin,Cell biology,Stem Cell Proliferation,Other,Enhances survival of human ESCs following enzymatic dissociation,2,Datasheet_4978,11,E08
5065,NSC 319726,Cell biology,p53,Activator,Reactivator of mutant p53,1,Datasheet_5065,11,G04
5072,PFI 3,Cell biology,Bromodomains,Inhibitor,Potent and selective SMARCA2/4 and polybromo 1 inhibitor,3,Datasheet_5072,11,G09
5081,J 147,Cell biology,Amyloid Beta Peptides,Other,Neuroprotective and neurotrophic compound; reduces Aβ40 and Aβ42 levels,1,Datasheet_5081,11,H02
5180,Ferrostatin 1,Cell biology,Ferroptosis,Inhibitor,Selective inhibitor of erastin induced ferroptosis,1,Datasheet_5180,12,B05
5185,JTE 607 dihydrochloride,Cell biology,Cytokines,Other,Cytokine release inhibitor; anti-inflammatory,1,Datasheet_5185,12,B07
5258,BMS 309403,Cell biology,Other Lipid Metabolism,Inhibitor,Potent and selective FABP4 inhibitor,1,Datasheet_5258,12,C09
5266,BAZ2-ICR,Cell biology,Bromodomains,Inhibitor,Selective BAZ2 inhibitor,1,Datasheet_5266,12,D03
5277,CCG 203971,Cell biology,Other Transcription Factors,Other,Inhibits the MRTF/SRF gene transcription pathway; antifibrotic agent,1,Datasheet_5277,12,D09
5282,SAG 21k,Cell biology,Hedgehog Signaling,Activator,Hedgehog signaling activator; brain penetrant and orally bioavailable,2,Datasheet_5282,12,D11
5293,NK 252,Cell biology,Nrf2,Activator,Nrf2 activator,1,Datasheet_5293,12,E04
5309,SP 100030,Cell biology,NF-kB/IkB,Inhibitor,NF-κB and AP-1 dual inhibitor,1,Datasheet_5309,12,E10
5331,CPI 203,Cell biology,Bromodomains,Inhibitor,BET bromodomain inhibitor; arrests cell cycle at G1 phase,1,Datasheet_5331,12,F11
5389,Ro 48-8071 fumarate,Cell biology,Other Lipid Metabolism,Inhibitor,"2,3-Oxidosqualene cyclase (OSC) inhibitor; blocks cholesterol synthesis",1,Datasheet_5389,12,H07
5455,W 54011,Cell biology,Complement,Antagonist,High affinity C5a receptor antagonist,1,Datasheet_5455,13,B03
5496,LP 99,Cell biology,Bromodomains,Inhibitor,Selective BRD7 and BRD9 inhibitor,1,Datasheet_5496,13,B06
5497,ent-LP 99,Cell biology,Bromodomains,Control,Negative Control for LP 99,1,Datasheet_5497,13,B07
5522,Napabucasin,Cell biology,STAT,Inhibitor,STAT3 inhibitor; also blocks cancer stem cell self-renewal,1,Datasheet_5522,13,B10
5590,BI 9564,Cell biology,Bromodomains,Inhibitor,Potent and selective BRD9 and BRD7 inhibitor; orally active,1,Datasheet_5590,13,C10
5601,DMXAA,Cell biology,STING-Dependent Signaling,Agonist,mSTING agonist; induces antitumor immunological responses,1,Datasheet_5601,13,D02
5603,(-)-JQ1,Cell biology,Bromodomains,Control,Inactive control for (+)-JQ1,1,Datasheet_5603,13,D03
5625,ML 334,Cell biology,Nrf2,Activator,Inhibitor of Keap1- Nrf2 interaction,1,Datasheet_5625,13,D10
5653,JW 74,Cell biology,Other Wnt Signaling,Inhibitor,Wnt pathway inhibitor,1,Datasheet_5653,13,E06
5655,GN 44028,Cell biology,Hypoxia Inducible Factors,Inhibitor,Potent HIF-1α inhibitor,1,Datasheet_5655,13,E08
5661,666-15,Cell biology,Other Transcription Factors,Inhibitor,Potent and selective CREB inhibitor,2,Datasheet_5661,13,E09
5707,RA 839,Cell biology,Nrf2,Activator,Nrf2 activator; inhibits Nrf2/Keap1 interaction,1,Datasheet_5707,13,G03
5737,BAM 15,Cell biology,Oxidative Phosphorylation,Other,Mitochondrial protonophore uncoupler,2,Datasheet_5737,13,G09
5744,NVS-CECR2-1,Cell biology,Bromodomains,Inhibitor,"Potent and selective inhibitor of cat eye syndrome chromosome region, candidate 2 (CECR2)",1,Datasheet_5744,13,G11
5813,NSC 668036,Cell biology,Other Wnt Signaling,Inhibitor,Wnt signaling inhibitor; binds the PDZ domain of the Dishevelled (Dvl) protein,1,Datasheet_5813,14,A04
5944,G10,Cell biology,STING-Dependent Signaling,Other,Activator of STING-dependent signaling,1,Datasheet_5944,14,C10
5970,BAY 299,Cell biology,Bromodomains,Inhibitor,Potent and selective BRD1 and TAF1 inhibitor,1,Datasheet_5970,14,D04
5999,TP 472N,Cell biology,Bromodomains,Control,Negative control for TP 472,1,Datasheet_5999,14,D10
6000,TP 472,Cell biology,Bromodomains,Inhibitor,Potent BRD9/7 inhibitor,1,Datasheet_6000,14,D11
6068,Lin28 1632,Cell biology,"DNA, RNA and Protein Synthesis",Inhibitor,RNA binding protein Lin28 inhibitor; promotes mESC differentiation; also bromodomain inhibitor,2,Datasheet_6068,14,F02
6113,Liproxstatin-1 hydrochloride,Cell biology,Ferroptosis,Inhibitor,Potent ferroptosis inhibitor,1,Datasheet_6113,14,F11
6181,OTX 015,Cell biology,Bromodomains,Inhibitor,BET bromodomain inhibitor; orally bioavailable,1,Datasheet_6181,14,H10
6198,GSK 6853,Cell biology,Bromodomains,Inhibitor,Potent and selective BRPF1 inhibitor,1,Datasheet_6198,15,A05
6203,GSK 9311 hydrochloride,Cell biology,Bromodomains,Control,Negative control for GSK 6853,1,Datasheet_6203,15,A08
6237,FPS ZM1,Cell biology,RAGE,Antagonist,High affinity antagonist of RAGE,1,Datasheet_6237,15,B06
6243,ML 385,Cell biology,Nrf2,Inhibitor,Nrf2 inhibitor; phenotypically lethal,1,Datasheet_6243,15,B08
6251,L Moses dihydrochloride,Cell biology,Bromodomains,Inhibitor,High affinity and selective PCAF bromodomain inhibitor,1,Datasheet_6251,15,C02
6280,FIN 56,Cell biology,Ferroptosis,Activator,Ferroptosis activator,1,Datasheet_6280,15,C07
6359,Nelarabine,Cell biology,"DNA, RNA and Protein Synthesis",Inhibitor,Purine nuceloside analog; inhibits DNA synthesis,1,Datasheet_6359,15,E10
6470,A 410099.1,Cell biology,Inhibitor of Apoptosis (IAP),Inhibitor,High affinity XIAP antagonist; active in vivo,1,Datasheet_6470,15,G09
6491,YM 155,Cell biology,Inhibitor of Apoptosis (IAP),Inhibitor,Survivin suppressor,1,Datasheet_6491,15,H03
6539,Obatoclax mesylate,Cell biology,Bcl-2 Family,Inhibitor,Inhibitor of Bcl-2 family members; antiapoptotic,1,Datasheet_6539,16,A06
6583,UCLA GP130 2,Cell biology,Cytokines,Agonist,gp130 agonist; brain penetrant and neuroprotectant,1,Datasheet_6583,16,B09
6653,FM19G11,Cell biology,Hypoxia Inducible Factors,Inhibitor,HIF α-subunit inhibitor,1,Datasheet_6653,16,C07
6662,4-Octyl itaconate,Cell biology,Nrf2,Activator,Nrf2 activator; cell permeable,1,Datasheet_6662,16,C10
6675,H 151,Cell biology,STING-Dependent Signaling,Antagonist,STING antagonist,1,Datasheet_6675,16,D03
6677,CMA,Cell biology,STING-Dependent Signaling,Agonist,Murine-selective STING agonist,1,Datasheet_6677,16,D04
6759,AA 147,Cell biology,Other ER stress/UPR,Other,ER proteostasis regulator,1,Datasheet_6759,16,E07
6774,16673-34-0 NLRP3i,Cell biology,Inflammasomes,Inhibitor,NLRP3 inflammasome inhibitor,1,Datasheet_6774,16,F03
6819,Mefloquine hydrochloride,Cell biology,Gap Channels,Blocker,Cx36 and Cx50 gap channel blocker; also antimalarial and antischistosomal,1,Datasheet_6819,16,G02
6884,TC SL C5,Cell biology,"DNA, RNA and Protein Synthesis",Inhibitor,Metastasis-associated lung adenocarcinoma transcript 1 (Malat1) RNA inhibitor,1,Datasheet_6884,16,G09
6960,ABT 199,Cell biology,Bcl-2 Family,Inhibitor,"Selective, high affinity Bcl-2 inhibitor; orally bioavailable",1,Datasheet_6960,16,H07
6980,BAY 87-2243,Cell biology,Oxidative Phosphorylation,Inhibitor,Mitochondrial complex I inhibitor,1,Datasheet_6980,16,H10
7163,Chroman 1,Cell biology,Rho-kinases,Inhibitor,Highly potent and selective ROCK 2 inhibitor; improves cell survival after cryogeneisis,1,Datasheet_7163,7,C04
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,
,,,,,,,,,